date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2017-12-19 13:01:20.705,420.0,424.5,415.35,419.15,673749.0,"Buy TCS, Beger Paints, Cadila Healthcare, says Prabhudas Lilladher","Few trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher",neutral,neutral,-0.2023809523809578,neutral,0.8792775665399213,neutral
2017-12-21 18:01:55.975,425.0,429.4,422.0,423.3,518559.0,Zydus Healthcare moves India marketing operations to Mumbai,Zydus Healthcare is a wholly owned subsidiary of Cadila Healthcare,neutral,neutral,-0.3999999999999973,neutral,0.4930734914299185,neutral
2017-12-26 13:01:10.283,428.8,437.0,426.2,430.9,1224998.0,Cadila Healthcare works to build Zydus brand,Cadila Laboratories was formed by two friends Ramanbhai Patel and IA Modi in 1952,neutral,neutral,0.4897388059701413,neutral,-1.975280120133998,negative
2017-12-29 13:01:36.297,424.3,436.0,425.95,434.8,1158640.0,Cadila Healthcare rises over 2% as Zydus receives USFDA nod for antiobsessional drug,The Group now has more than 180 approvals and has so far filed over 310 ANDAs since the commencement of filing process in FY04.,neutral,neutral,2.4746641527221303,positive,-1.6079370509750284,negative
2017-12-29 18:01:07.017,424.3,436.0,425.95,434.8,1158640.0,Zydus Pharmaceuticals receives USFDA nod to market OCD treatment drug,Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd,neutral,neutral,2.4746641527221303,positive,-1.6079370509750284,negative
2018-01-11 18:01:09.877,445.8,450.0,441.6,449.0,528578.0,"Weak US sales, INR appreciation to drag earnings; Dr Reddy, Cadila top pick: Edelweiss","The USFDA granted 246 nods in Q3FY18, which is the highest-ever approvals in a single quarter. Cadila Healthcare received 23 and Aurobindo Pharma got 18 approvals.",positive,positive,0.7178106774338243,neutral,-2.0544142143253747,negative
2018-01-19 13:00:44.698,437.75,450.8,433.55,441.2,1328542.0,Cadila Healthcare gains 3% after Dabhasa API unit successfully completes USFDA inspection,"The US Food and Drug Administration inspected its API manufacturing facility at Dabhasa (in Gujarat) from January 15-19, 2018",positive,neutral,0.7881210736721848,neutral,-0.7818696883852665,neutral
2018-01-21 13:01:31.879,441.25,445.0,435.3,437.8,489666.0,Pharma weekly wrap: Pharma stocks extend losses ahead of Q3 results,"Most stocks including Sun Pharma (-2.24 percent), Cipla (-1.79 percent), Aurobindo Pharma (-3.98 percent) and Cadila Healthcare (-2.1 percent) saw declines",negative,negative,-0.7818696883852665,neutral,-1.988862370723946,negative
2018-01-25 13:03:39.204,426.95,429.5,415.7,419.8,642451.0,Cadila Healthcare turns focus on vaccines and biosimilars,"Analysts expect the two segments to contribute 25% of domestic revenue in 2 years; vaccines contribute less than 1% of revenues at present, while biosimilars account for 4.5% of domestic revenues",neutral,neutral,-1.6746691650076069,negative,-0.2143878037160633,neutral
2018-02-07 18:02:50.886,399.85,415.1,398.6,402.5,3103956.0,Zydus Wellness Q3 net profit up 44% to Rs 362 mn on robust income,"The personal care arm of Cadila Healthcare, Ahmedabad based Zydus Wellness has reported a 43.8 per cent year on year jump in net profit for the third quarter of the current fiscal to Rs 361.6 million on the back of robust growth in income from",positive,positive,0.6627485306990064,neutral,5.195460277427497,positive
2018-02-08 18:01:17.272,396.5,422.85,390.1,417.1,1640927.0,Cadila Healthcare Q3 net profit grows 68% to Rs 543 cr,"Revenue from operations stood at Rs 3,191.8 crore, up 38.63 per cent, yoy.",positive,positive,5.195460277427497,positive,-1.2403463608705854,negative
2018-02-09 13:02:42.459,396.5,422.85,390.1,417.1,1640927.0,Cadila Healthcare standalone net leaps,Healthcare player Cadila Healthcare Ltd (Zydus Cadila) posted standalone net profit of ₹306 crore for the quarter ended December 2017 up from ₹22 crore reported in the corresponding quarter a year ago,neutral,positive,5.195460277427497,positive,-1.2403463608705854,negative
2018-02-14 18:02:28.082,419.9,422.1,414.5,416.45,629876.0,Accumulate Cadila Healthcare; target of Rs 436: KR Choksey,"KR Choksey has recommended accumulate rating on Cadila Healthcare with a target price of Rs 436 in its research report dated February 09, 2018.",neutral,positive,-0.8216241962371966,neutral,-1.1933174224343674,negative
2018-02-23 18:01:27.257,400.95,408.6,400.25,405.5,618262.0,Here's what Cadila has to say about US price erosion concerns,"The Indian Pharmaceutical Alliance's (IPA) quality forum is currently underway in Hyderbad. CNBC-TV18’s Arachana Shukla caught up with the Managing Director of Cadila Healthcare, Sharvil Patel on the sidelines of that forum and asked him about price erosion in the US market.",neutral,positive,1.1348048385085452,positive,-0.0122294239941326,neutral
2018-03-13 13:00:43.958,389.85,392.45,388.0,388.25,237555.0,Cadila Healthcare up 2% on USFDA approval to market Tizanidine tablets,"The drug is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury and works by helping to relax the muscles.",positive,neutral,-0.4104142618956067,neutral,-1.4652956298200486,negative
2018-03-13 18:00:30.837,389.85,392.45,388.0,388.25,237555.0,Zydus Cadila gets USFDA nod for Tizanidine tablets,Cadila Healthcare today said its group firm Zydus Cadila has received final approval from the US health regulator for its generic version of Tizanidine tablets used for treatment of muscle spasms.The,neutral,positive,-0.4104142618956067,neutral,-1.4652956298200486,negative
2018-03-26 13:00:22.893,390.95,390.95,380.0,382.3,950574.0,Cadila Healthcare gains 4% on USFDA nod for Metoprolol Succinate tablets,The stock was trading 4% higher at Rs 385 as compared to 0.01% rise in the S&P BSE Sensex at 09:45 am.,positive,positive,-2.21255915078654,negative,-1.124476987447687,negative
2018-03-27 13:02:42.059,382.4,385.15,372.5,378.1,1533288.0,Zydus Cadila gets USFDA nod for cardiac drug Metoprolol Succinate,Cadila Healthcare stock was trading 4.27 per cent up at Rs 385.75 in the afternoon on BSE,neutral,positive,-1.124476987447687,negative,-0.875386199794021,neutral
2018-04-04 13:03:09.880,397.0,403.45,393.0,393.25,1131081.0,Cadila Healthcare appeals against Delhi HC order refusing to stay CCI verdict,"In November 2015, CCI had passed an order directing the director general to investigate Cadila Healthcare for alleged anti-competitive practices",positive,neutral,-0.9445843828715366,negative,-0.2538071065989847,neutral
2018-04-17 13:01:43.282,388.65,390.95,383.35,384.9,478246.0,Cadila Healthcare Q4 PAT seen up 39.7% YoY to Rs. 538.4 cr: Edelweiss,"Net Sales are expected to increase by 27.7 percent Y-o-Y (down 2.9 percent Q-o-Q) to Rs. 3,163.5 crore, according to Edelweiss.",positive,positive,-0.96487842531841,negative,0.3246753246753247,neutral
2018-04-26 13:33:56.657,412.0,415.7,405.1,406.65,777114.0,"Cadila Healthcare up 3% on USFDA approval for Methylprednisolone, Cinacalcet Hydrochloride tablets","Zydus Cadila, the group company, has received final approval from the US Food and Drug Administration to market Methylprednisolone tablets USP in the strengths of 4 mg, 8 mg, 16 mg and 32 mg.",positive,positive,-1.298543689320394,negative,1.2254901960784317,positive
2018-05-10 18:02:26.822,394.7,398.35,390.05,393.35,322975.0,Cadila Healthcare gains 1% on USFDA final approval for Parkinson's drug,"The said drug will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad.",positive,neutral,-0.3420319229794694,neutral,-0.5076142131979695,neutral
2018-05-24 23:00:18.882,365.0,408.05,352.0,379.3,4761699.0,"Tech Mahindra, BoB, Sun Pharma results","Over 130 firms including Asahi India, BEML, BoB, Cadila Healthcare, Central Bank, Engineers India, Eris Life, Future Enterprises, Future Market, Gujarat Fluoro, Hotel Leela, Himatsingka Seide, Hind Co",neutral,neutral,3.917808219178085,positive,-4.656547465912006,negative
2018-05-25 18:00:46.145,365.0,408.05,352.0,379.3,4761699.0,Cadila Healthcare Q4 profit rises 53% at Rs590.8 crore,Cadila Healthcare reported 53.26% jump in consolidated net profit at Rs590.8 crore for the fourth quarter ended 31 March 2018,positive,positive,3.917808219178085,positive,-4.656547465912006,negative
2018-06-01 18:01:58.904,361.3,366.9,351.75,354.0,861047.0,Accumulate Cadila Healthcare; target of Rs 438: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Cadila Healthcare with a target price of Rs 438 in its research report dated May 26, 2018.",neutral,positive,-2.0204815942430145,negative,-1.7966573816155955,negative
2018-06-04 13:00:19.249,352.0,354.3,344.0,350.0,665583.0,Cadila Healthcare rises 2% on USFDA approval to antibiotic drug,This medication is also used for prophylaxis of malaria.,neutral,neutral,-0.5681818181818182,neutral,0.2865329512893982,neutral
2018-06-06 10:02:46.016,349.0,359.95,345.75,350.0,1366488.0,"Hold  Cadila Healthcare, target Rs  380:   Emkay Global Financial Services",Hold  Cadila Healthcare Ltd.  at a price target of Rs  380.0    .,neutral,positive,0.2865329512893982,neutral,1.2363222964331293,positive
2018-06-08 13:00:37.657,357.0,370.0,354.5,364.15,2142172.0,Pharma shares in focus as Nifty Pharma index rises 2%,"Sun Pharma, Cadila Healthcare, Dr Reddy's Laboratories, Cipla, Glenmark Pharma and Lupin from the Nifty Pharma index were up in the range of 2% to 3% on the NSE.",positive,positive,2.002801120448173,positive,0.8764721993974222,neutral
2018-07-03 18:00:56.778,388.2,396.8,388.2,394.1,1227985.0,Cadila Healthcare rises 1% on USFDA approval for tablets to control high blood pressure,"Zydus Cadila has received the final approval from the USFDA to market Nifedipine extended-release tablets USP in the strengths of 30 mg, 60 mg, and 90 mg.",neutral,positive,1.519835136527572,positive,-1.8370708222475611,negative
2018-07-10 13:02:36.797,381.0,383.95,369.35,369.65,1883637.0,"Cadila Healthcare stock erases opening gains, Zydus gets USFDA nod for oral iron chelator",Zydus has received tentative approval from the US Food and Drug Administration for Deferasirox.,positive,positive,-2.9790026246719217,negative,-1.8893206485327496,negative
2018-07-11 13:02:49.986,373.15,373.15,362.2,366.1,2009005.0,Cadila Healthcare loses 2% on report of US FDA issuing observations to Cadila-Hospira JV unit,"The company’s joint venture with Hospira has received two observations from the US Food and Drug Administration, CNBC-TV18 reported, quoting sources.",neutral,neutral,-1.8893206485327496,negative,-0.5178522758244691,neutral
2018-07-12 13:02:10.925,366.9,369.3,361.0,365.0,1100017.0,Cadila Healthcare receives on USFDA nod for migraine drug,"The drug will be manufactured at the group’s manufacturing facility at Moraiya, Ahmedabad.",neutral,neutral,-0.5178522758244691,neutral,-4.201450663747098,negative
2018-07-12 23:01:39.515,366.9,369.3,361.0,365.0,1100017.0,Company news: Cadila Healthcare,"Zydus Hospira Oncology Pvt Ltd, a 50:50 joint venture company between Zydus Cadila and Hospira Inc, US (now part of Pfizer Group), has received an establishment inspection report (EIR) from the USFDA.",neutral,neutral,-0.5178522758244691,neutral,-4.201450663747098,negative
2018-07-17 13:03:05.743,361.9,365.95,348.6,353.5,2123036.0,Cadila Healthcare jumps nearly 3%,"Shares of Cadila Healthcare jumped nearly 3 per cent to Rs 360 as Zydus Cadila has received final approval from the US health regulator to market Clindamycin Phosphate Topical Solution, used to treat",positive,positive,-2.321083172146996,negative,-4.389152921442547,negative
2018-08-03 23:02:01.137,378.1,382.6,376.6,377.0,1428695.0,"Tata, Dabur among suitors selected for Kraft Heinz’s $1 billion India sale: report",The Kraft Heinz India sale has also drawn interest from an arm of Cadila Healthcare and other potential buyers,neutral,positive,-0.2909283258397309,neutral,-0.2363755745239598,neutral
2018-08-13 10:01:43.567,373.1,382.65,351.0,352.9,5662830.0,"Wipro, ITC, Cadila take lead in race to acquire Complan","Wipro, ITC and Cadila Healthcare expected to submit binding bids in the range of $700-800 million for Kraft Heinz’s Complan by 15 September",positive,positive,-5.4140980970249375,negative,-4.183098591549302,negative
2018-08-13 13:00:18.141,355.0,356.9,336.0,340.15,9558049.0,Deals Buzz: Troubled Jet Airways plans $400-million stake sale to PEs,"In other news, ITC, Wipro Consumer Care and Cadila Healthcare are readying to submit binding offers to buy Kraft Heinz India’s popular nutritional drink brand, Complan",neutral,neutral,-4.183098591549302,negative,-0.0728862973760933,neutral
2018-08-14 10:02:10.644,355.0,356.9,336.0,340.15,9558049.0,Growth worries ahead for Cadila Healthcare after Q1 estimate miss,"With mega products in US facing rising competition, analysts watchful on new launches",negative,neutral,-4.183098591549302,negative,-0.0728862973760933,neutral
2018-08-14 18:00:39.180,355.0,356.9,336.0,340.15,9558049.0,Cadila Healthcare nears 52-week low post June quarter results,"The stock slipped 5% to Rs 336, extending its 6% decline on Monday, trading close to its 52-week low of Rs 333 touched on July 20, 2018 on the BSE in intra-day trade.",negative,negative,-4.183098591549302,negative,-0.0728862973760933,neutral
2018-08-24 18:02:06.739,390.7,402.5,381.2,400.55,3743246.0,Cadila Healthcare rises 3% post USFDA successful inspection; no observation issues,"The USFDA (US Food & Drug Administration) inspected company's Biologics manufacturing facility (Zydus Biologics) located at the Zydus Biotech Park in Ahmedabad, from August 14 to 24.",neutral,neutral,2.521115945738424,positive,-1.8610421836228288,negative
2018-08-24 23:00:13.711,390.7,402.5,381.2,400.55,3743246.0,Cadila Healthcare’s Biologics facility completes USFDA inspection,Cadila Healthcare has informed the exchanges that the US Food and Drug Administration (FDA) has inspected the drug maker’s biologics manufacturing facility (Zydus Biologics) located at the Zydus Biote,neutral,neutral,2.521115945738424,positive,-1.8610421836228288,negative
2018-08-29 18:02:05.449,386.8,396.25,384.0,390.0,5002385.0,Cadila gets 5 observations from USFDA,Cadila Healthcare has received five observations from USFDA after the inspection of Liva Pharmaceuticals’ injectables manufacturing facility. Liva is a 100 per cent subsidiary of Cadila Healthcare. “T,neutral,neutral,0.8273009307135442,neutral,3.4991027941553385,positive
2018-08-30 18:02:13.327,390.1,406.6,390.1,403.75,4497948.0,Cadila Healthcare rises 2% on USFDA approval for Gemfibrozil & Aripiprazole tablets,"Zydus Cadila has received the final approval from the USFDA to market Gemfibrozil Tablets USP 600 mg and Aripiprazole Orally Disintegrating Tablets USP in strengths of 10 mg, 15 mg, 20 mg, and 30 mg.",positive,positive,3.4991027941553385,positive,-0.7389162561576355,neutral
2018-09-05 13:00:27.206,405.15,425.55,400.25,424.35,5080444.0,Zydus Cadila gets USFDA nod for herpes viruses treatment drug,"The company has received final approval from the United States Food and Drug Administration (USFDA) to market Acyclovir Sodium Injection, 500 mg/10 mL and 1,000 mg/20mL single-dosevials, Cadila Healthcare said in a BSE filing.",neutral,positive,4.73898556090338,positive,1.3549160671462774,positive
2018-09-05 13:02:03.800,405.15,425.55,400.25,424.35,5080444.0,Cadila Healthcare rises 2% on USFDA final approval for antiviral drug,Acyclovir is an antiviral drug. It slows the growth and spread of the herpes virus in the body.,positive,negative,4.73898556090338,positive,1.3549160671462774,positive
2018-09-14 13:00:54.508,415.0,420.0,410.2,411.85,2469098.0,Cadila Healthcare rises nearly 3% as co receives USFDA final approval,"Zydus Cadila has received the final approval from the USFDA to market Risedronate Sodium Delayed-Release Tablets, 35 mg.",positive,positive,-0.7590361445783077,neutral,-0.1456487437795766,neutral
2018-09-17 10:01:25.186,411.95,417.9,408.1,411.35,1611861.0,Cadila Healthcare plans to launch 50 products in US market in FY19,"Of over 140 products in pipeline, at least 10 are para IV filings",positive,neutral,-0.1456487437795766,neutral,-0.9062348960850652,negative
2018-10-01 13:02:13.692,385.0,398.85,376.5,398.0,1592248.0,Cadila Healthcare received final approval from USFDA; shares down 2%,"Zydus Cadila has received the final approval from the USFDA to market Desoximetasone Cream USP (US RLD- Topicort Cream), 0.25%.",negative,positive,3.3766233766233764,positive,-1.7462311557788917,negative
2018-10-05 10:00:41.649,387.6,389.45,376.0,377.0,1803679.0,Cadila Healthcare rises nearly 2% on EIR from USFDA,"The plant had completed the USFDA audit from August 14 to 24, 2018 with Zero 483 observations.",neutral,neutral,-2.734778121775032,negative,0.0266666666666727,neutral
2018-10-05 13:02:10.755,387.6,389.45,376.0,377.0,1803679.0,"Stocks To Watch: Cadila Healthcare, Jet Airways, Lupin, United Spirits ","The S&P BSE Sensex and the NSE Nifty 50 Index fell more than 2 percent to 35,169.16 and 10,599.25, respectively. The Indian rupee slumped to a fresh low of 73.58 against the U.S. dollar, raising fears of a widening current account deficit.",neutral,negative,-2.734778121775032,negative,0.0266666666666727,neutral
2018-10-12 13:01:31.077,377.0,381.95,374.3,377.4,760828.0,Zydus Cadila gets tentative USFDA nod for diabetes drug,"The United States Food and Drug Administration (USFDA) has granted tentative approval to market the drug in strengths of 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/ 1,000 mg, Cadila Healthcare said in a BSE filing.",positive,positive,0.1061007957559621,neutral,1.5421430470619395,positive
2018-10-12 13:01:44.826,377.0,381.95,374.3,377.4,760828.0,Cadila Healthcare up 1% on tentative USFDA nod for blood sugar control drug,"It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad",positive,neutral,0.1061007957559621,neutral,1.5421430470619395,positive
2018-10-19 10:00:45.281,376.9,380.8,366.0,372.75,890289.0,"Stocks in the news: Indiabulls Housing, Reliance Industries, ICICI Securities and Cadila Healthcare",Here's a look at the top stocks that may hog the limelight in today's session.,neutral,neutral,-1.1010878217033635,negative,0.1070663811563108,neutral
2018-10-23 23:01:08.319,377.75,380.9,352.15,357.45,2746815.0,"Kraft agrees to sell package of Indian assets, including Complan to Zydus","Zydus, which is a unit of Indian drugmaker Cadila Healthcare Ltd, could announce a deal as soon as this week",neutral,neutral,-5.373924553275979,negative,-3.7183656157217526,negative
2018-10-24 18:01:32.502,353.65,354.0,339.0,340.5,2923060.0,"Zydus Wellness, Cadila Healthcare to buy Heinz India biz for Rs 4,595 cr","Consumer brands Complan, Glucon-D, Nycil, Sampriti Ghee to change hands",neutral,neutral,-3.7183656157217526,negative,-1.1111111111111145,negative
2018-10-24 23:01:58.549,353.65,354.0,339.0,340.5,2923060.0,Zydus to acquire Heinz India,"Zydus Wellness Ltd., which is into consumer healthcare, has entered into a definitive agreement to acquire Heinz India Private Limited, the subsidiary of Kraft Heinz, jointly with Cadila Healthcare Lt",neutral,positive,-3.7183656157217526,negative,-1.1111111111111145,negative
2018-11-16 18:00:20.530,359.3,364.45,351.6,356.5,1168659.0,Cadila Healthcare gains nearly 2% on USFDA nod,Abacavir and Lamivudine tablets are used with other antiretroviral medicines to treat Human Immunodeficiency Virus-type 1 (HIV-1) infection.,positive,neutral,-0.7792930698580605,neutral,1.2431903897192311,positive
2018-11-29 13:02:49.627,356.0,367.45,354.35,363.9,1222215.0,"Cadila Healthcare gains 1% on USFDA nod for Lansoprazole, Linagliptin tablets",Zydus Cadila has received the final approval from the USFDA to market Lansoprazole delayed release orally disintegrating tablets and tentative approval for Linagliptin tablets.,positive,positive,2.2191011235954994,positive,-2.9539295392953866,negative
2018-12-05 13:00:04.462,356.65,358.05,350.25,353.65,774581.0,"Cadila Healthcare gains 3% after CLSA upgrades, hikes price target",CLSA upgraded the stock to buy from outperform as risk-reward is favourable.,positive,positive,-0.8411608019066312,neutral,-1.5497323189630885,negative
2018-12-07 23:00:19.161,354.9,355.85,348.7,349.4,869291.0,"Zydus Wellness to raise Rs 2,575 crore from Cadila, promoters and PEs to fund Heinz India acquisition","Cadila Healthcare holds around 72.08 percent of Zydus Wellness, while the Zydus Family Trust holds about 0.45 percent.",positive,neutral,-1.5497323189630885,negative,-0.8284883720930298,neutral
2018-12-11 13:01:13.766,348.0,354.9,348.0,353.05,1310915.0,Cadila Healthcare up 1% on USFDA approval for Ranitidine injection,"Ranitidine belongs to the class of medications called H2—antagonists and is used to treat stomach and duodenal (intestinal) ulcers, and prevent them from recurring.",positive,neutral,1.4511494252873596,positive,-0.8926041371493276,neutral
2018-12-11 18:00:54.166,348.0,354.9,348.0,353.05,1310915.0,Cadila Healthcare arm gets USFDA nod for ulcer treatment injection,"The company has more than 237 approvals, and has so far filed over 340 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.",neutral,neutral,1.4511494252873596,positive,-0.8926041371493276,neutral
2018-12-17 13:00:52.285,347.25,347.95,341.45,345.5,1374704.0,Cadila Healthcare gains 2% on USFDA nod for Albendazole tablets that treat tapeworm infections,"Albendazole tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.",positive,neutral,-0.5039596832253419,neutral,-1.4367816091954022,negative
2018-12-31 13:02:01.533,348.65,352.9,348.35,349.75,690604.0,Cadila Healthcare may test Rs 435: Anand Rathi,We expect 11 percent and 17 percent CAGRs over FY18-20 in revenue & earnings respectively.,neutral,neutral,0.3155026530904984,neutral,-0.5164992826398884,neutral
2018-12-31 18:02:28.190,348.65,352.9,348.35,349.75,690604.0,Cadila Healthcare gains over 1% on USFDA approval for anti-acne cream,Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin.,positive,neutral,0.3155026530904984,neutral,-0.5164992826398884,neutral
2019-01-07 13:01:41.828,349.2,352.95,347.1,349.5,997877.0,"Cadila, Cipla shares gain after HSBC upgrades to buy",HSBC said risk-reward turned favourable post corrections in Cadila Healthcare & Cipla.,positive,positive,0.0859106529209654,neutral,-0.4581245526127481,neutral
2019-01-11 18:02:28.046,348.3,352.7,347.25,347.6,890800.0,Cadila Healthcare Q3 PAT may dip 12.8% YoY to Rs. 473.7 cr: ICICI Direct,"Net Sales are expected to decrease by 1.1 percent Y-o-Y (up 8.8 percent Q-o-Q) to Rs. 3,222.2 crore, according to ICICI Direct.",neutral,negative,-0.2009761699684147,neutral,1.2990720913633154,positive
2019-01-14 13:00:59.895,355.1,357.85,352.9,354.0,1068269.0,"Cadila Healthcare gains over 1% on USFDA nod for skin, blood pressure drugs",Atorvastatin is used in combination with diet and exercise to treat high cholesterol. It works by blocking an enzyme that is needed to make cholesterol in the body.,positive,neutral,-0.3097718952407836,neutral,-0.5633802816901409,neutral
2019-01-25 23:01:01.029,346.0,350.9,343.0,344.15,783388.0,"CCI clears Zydus Wellness' share sale of Rs 2,575 cr to Cadilla Healthcare, 3 others","The firm, last month, approved issuing equity shares of face value of Rs 10 each on a preferential basis to Cadila Healthcare, True North, Pioneer Investment Fund and Zydus Family Trust.",neutral,positive,-0.534682080924862,neutral,-2.507288629737616,negative
2019-02-07 10:01:23.721,320.05,334.5,318.25,323.3,7511717.0,"Tata Motors, Suzlon, SAIL, P&G results today"," About 100 companies including Amtek Auto, Allsec Tech, Arvind, Aurobindo Pharma, Bajaj Electricals, Britannia, Balmer Lawrie, Cadila Healthcare, Elgi Rubber, Eros, Future Supply Chain, Gillette, Gras",neutral,neutral,1.0154663333854084,positive,-1.7699115044247822,negative
2019-02-08 10:01:27.936,327.7,327.7,319.6,321.9,1634617.0,Analysts positive on Cadila Healthcare riding on a strong US momentum,Analysts positive on Cadila Healthcare riding on a strong US momentum,positive,positive,-1.7699115044247822,negative,0.4651162790697674,neutral
2019-02-18 10:01:21.497,310.4,317.35,309.3,311.75,772455.0,"Late Flu Surge In U.S. To Help Lupin, Cadila Healthcare And Natco Pharma","Flu season usually ends mid-February, but this time influenza is widespread in 30 U.S. states causing a shortage of medications.",neutral,neutral,0.4349226804123785,neutral,-0.0641025641025604,neutral
2019-02-27 13:00:31.206,321.5,329.35,315.15,318.05,4430608.0,Top intraday trading ideas for afternoon trade for Wednesday 27 February 2019,"Cadila Healthcare is a 'Buy' call with a target price of Rs 340 and a stop loss of Rs 317.
",neutral,neutral,-1.0730948678071504,negative,0.6705130204272678,neutral
2019-03-05 18:01:46.690,332.0,338.3,327.5,329.75,1355212.0,Cadila Healthcare gains on USFDA nod for memory loss drug,The group now has 252 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.,positive,neutral,-0.677710843373494,neutral,-1.5108022359873094,negative
2019-03-12 13:02:06.500,336.75,338.4,327.35,330.85,2256000.0,Cadila Healthcare rises 3% on USFDA approval for drugs to treat high blood pressure,"It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.",positive,neutral,-1.7520415738678476,negative,-0.7369529252519141,neutral
2019-03-18 18:00:55.082,340.85,344.4,335.8,337.15,854974.0,Hold Cadila Healthcare; target of Rs 358: Geojit,"Geojit recommended hold rating on Cadila Healthcare with a target price of Rs 358 in its research report dated March 15, 2019.",neutral,positive,-1.0855214903916812,negative,-0.0592592592592558,neutral
2019-04-02 13:02:18.753,345.8,346.25,337.55,338.8,609191.0,Cadila Healthcare gains on USFDA's tentative approval to market a drug,Zydus Cadila has received the tentative approval from the USFDA to market Mirabegron Extended-Release Tablets.,positive,positive,-2.0242914979757085,negative,1.766264350897851,positive
2019-04-08 18:01:53.706,342.5,344.5,339.05,341.5,444370.0,Cadila Healthcare gains on tentative approvals from USFDA,"The drugs will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.",positive,neutral,-0.291970802919708,neutral,0.7046388725777971,neutral
2019-05-03 10:00:37.746,312.5,318.8,300.05,301.0,2042890.0,Cadila Healthcare (₹315.2): Sell,"The stock of Cadila Healthcare slumped 3 per cent accompanied by above average volume on Thursday, decisively breaching a key support around ₹325 as well as the 50-day moving average. Investors with a",neutral,negative,-3.68,negative,4.931740614334467,positive
2019-05-06 10:01:00.383,293.0,311.45,292.85,307.45,4492812.0,Cadila Healthcare Swings After U.S. FDA Issues 14 Observations For Moraiya Plant,Cadila Healthcare Swings After U.S. FDA Issues 14 Observations For Moraiya Plant,neutral,neutral,4.931740614334467,positive,-2.44299674267101,negative
2019-05-08 18:00:13.927,284.25,292.45,282.3,291.3,2108130.0,"Bosch, Amara Raja, Reliance Infra, Shriram City Union hit 52-week low","Godrej Consumer Products, Cadila Healthcare, IDBI Bank, Jubilant Life Sciences, Eveready Industries and Vodafone Idea were among 26 stocks on BSE500 index that hit 52-week lows today",neutral,neutral,2.4802110817942,positive,0.3472222222222222,neutral
2019-05-13 18:00:26.118,268.0,269.0,259.4,261.2,2819247.0,"Eicher Motors, M&M, Sun Pharma hit 52-week low","Biocon, Cadila Healthcare, SPARC and Wockhardt from the pharma and Amara Raja Batteries, Bharat Forge, Motherson Sumi, and TVS Srichakra Tyres auto-related sectors hit 52-week lows on Monday",negative,neutral,-2.537313432835825,negative,-1.254752851711031,negative
2019-05-14 18:01:11.482,263.0,264.55,255.1,259.7,2944583.0,Zydus among generic companies facing lawsuit by US states: Cadila,"Drug firm, Cadila Healthcare, on Tuesday, announced that Zydus Pharmaceuticals Inc, is included in the lawsuit filed against some generic companies by a few states of the US.Zydus Pharmaceuticals Inc",neutral,neutral,-1.254752851711031,negative,-1.479631053036113,negative
2019-05-16 13:00:22.418,257.7,260.2,247.2,250.05,4217501.0,Cadila Healthcare at over 4.5 year low; chart points to more downside,"Trend intensity(TI) indicator rose to 36, suggesting a strong downtrend for the stock.",negative,positive,-2.9685681024446944,negative,-0.3983270264887473,neutral
2019-05-29 10:01:01.293,264.0,270.7,257.55,263.1,10124806.0,"M&M, IDFC, Rpower, Adani Power results"," Wednesday will see around 200 companies declaring their Q4 &amp;amp; FY19 results. Among these are Adani Power, Adani Enterprises, Balmer Lawrie, Cadila Healthcare, Cox &amp;amp; Kings, Dynamatic Tec",neutral,neutral,-0.3409090909090823,neutral,-2.9639418538795628,negative
2019-05-29 18:00:41.471,264.85,265.35,253.6,257.0,4297303.0,Cadila Healthcare posts Q4 net profit of Rs 460 crore,Shares of Cadila Healthcare were trading at Rs 262.70 per scrip on the BSE,neutral,neutral,-2.9639418538795628,negative,-3.640256959314784,negative
2019-05-30 13:01:31.118,256.85,256.85,244.5,247.5,5123123.0,Q4 impact: Global brokerages cut target price for Cadila Healthcare,Citigroup maintained its sell rating on Cadila Healthcare while Credit Suisse maintained its neutral rating on Cadila Healthcare post Q4 results ,negative,positive,-3.640256959314784,negative,1.104417670682731,positive
2019-05-31 18:01:58.762,256.85,256.85,244.5,247.5,5123123.0,"Add  Cadila Healthcare, target Rs  292:   ICICI Securities  ","Cadila Healthcare is a largecap company, operating in pharmaceuticals and health care sector.  ",neutral,neutral,-3.640256959314784,negative,1.104417670682731,positive
2019-06-03 18:00:58.491,253.0,260.25,250.9,258.9,2301986.0,Hold Cadila Healthcare; target of Rs 290: Sharekhan,"Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 290 in its research report dated May 29, 2019.",neutral,positive,2.332015810276671,positive,-4.19103313840156,negative
2019-06-05 23:00:35.720,256.5,258.9,245.0,245.75,2938658.0,"Riding on Heinz, Zydus Wellness eyes Rs 4,500-crore turnover in 5 years","Consumer business crucial for Cadila Healthcare, at a time when US and India have pricing pressure",neutral,neutral,-4.19103313840156,negative,-0.85889570552147,neutral
2019-06-17 10:01:24.931,246.5,248.85,242.0,242.5,1508040.0,Cadila’s arm Alidac Pharma gets EIR for Ahmedabad unit,Alidac is a 100% subsidiary of Cadila Healthcare Ltd.,neutral,neutral,-1.6227180527383367,negative,-3.917525773195876,negative
2019-06-18 13:00:17.265,232.1,239.0,231.8,237.8,2588351.0,Hold Cadila Healthcare; target of Rs 280: ICICI Direct,"ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 280 in its research report dated May 30, 2019.",neutral,positive,2.455838000861705,positive,2.101723413198823,positive
2019-07-12 18:02:16.659,235.0,239.2,232.5,236.0,1240533.0,Cadila Healthcare Q1 PAT may dip 22.4% YoY to Rs. 366.7 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 13.9 percent Y-o-Y (down 11.7 percent Q-o-Q) to Rs. 3,296.1 crore, according to Prabhudas Lilladher.",neutral,positive,0.425531914893617,neutral,0.6140165149269483,neutral
2019-07-19 18:00:34.800,234.7,235.55,227.3,228.0,1478250.0,Zydus’ Nesher Pharma gets USFDA nod to market generic ADHD drug,Cadila Healthcare on Friday said Zydus’ Nesher Pharmaceuticals has received final nod from the US health regulator to market generic version of Adderall XR capsules in the US. The final approval from,neutral,positive,-2.854708138048568,negative,3.504928806133625,positive
2019-07-19 23:00:25.023,234.7,235.55,227.3,228.0,1478250.0,Company news: Cadila Healthcare,"Cadila Healthcare on Friday informed the exchanges that the US Food and Drug Administration inspected its formulations manufacturing facility at Baddi from July 15 to 19. At the end of the inspection,",neutral,neutral,-2.854708138048568,negative,3.504928806133625,positive
2019-08-09 10:01:37.410,236.0,236.1,223.15,232.3,2839567.0,"BPCL, BHEL, GAIL, MRF, RCom, Hindalco results"," Over 125 companies will declare their quarterly numbers on Friday. Among these are Arvind Fashions, 63 moons, Balaji Tele, BHEL, BPCL, Britannia, Cadila Healthcare, Century Ply, GAIL, Hindalco, Inox",neutral,neutral,-1.567796610169487,negative,-6.033376123234914,negative
2019-08-09 18:00:54.658,236.0,236.1,223.15,232.3,2839567.0,Cadila Healthcare's Q1FY20 PAT falls 34% yoy in Q1FY20 to Rs303cr,"Its revenue was up 20.8% yoy at Rs3,496.3cr against Rs2,893.7cr.",neutral,positive,-1.567796610169487,negative,-6.033376123234914,negative
2019-09-11 10:01:50.793,236.75,242.5,236.75,239.0,1463188.0,"'BUY' or 'SELL' ideas from experts for Wednesday, 11 September, 2019",Cadila Healthcare is a 'Buy' call with a target price of Rs 250 and a stop loss of Rs 230.,neutral,neutral,0.9503695881731784,positive,-0.8695652173913019,neutral
2019-09-12 10:00:35.274,241.5,243.8,236.9,239.4,1996431.0,"Cadila Healthcare recovers on India, emerging market sales forecast",Restructuring and consumer acquisition to be key drivers of revenue,positive,neutral,-0.8695652173913019,neutral,0.4999999999999952,neutral
2019-09-13 10:00:40.107,240.0,242.75,235.65,241.2,1048814.0,"Dr Reddy's to Lupin, Indian pharma players get a leg up from domestic sales","Dr Reddy's, Lupin, Sun Pharma and Cadila Healthcare outperformed the local industry growth in recent months, a trend expected to continue",positive,positive,0.4999999999999952,neutral,0.6663890045814221,neutral
2019-10-01 10:03:16.941,236.5,236.9,227.75,233.3,1224999.0,"Stocks in the news: YES Bank, Tata Comm, NBCC, DHFL and Cadila Healthcare",State-owned construction firm NBCC has bagged a Rs 400-crore contract .,neutral,neutral,-1.353065539112046,negative,0.4291845493562232,neutral
2019-10-09 18:01:28.234,235.4,236.7,231.5,232.25,457946.0,Cadila Healthcare gains 4% on USFDA approval for cholesterol-lowering drug,The drug will be manufactured at the group’s formulations-manufacturing facility at Ahmedabad's SEZ.,positive,neutral,-1.3381478334749386,negative,-0.7105943152454682,neutral
2019-10-10 10:03:49.994,235.4,236.7,231.5,232.25,457946.0,What to watch: USFDA nod may buoy Cadila Healthcare,Cadila Healthcare Ltd on Wednesday said it has received the final approval from the US heath regulator (USFDA) to market generic cholesterol-lowering Colesevelam Hydrochloride tablets with strength of,neutral,positive,-1.3381478334749386,negative,-0.7105943152454682,neutral
2019-10-14 10:02:14.355,232.55,235.2,229.35,233.0,1626064.0,"Top stocks in focus: Cadila Healthcare, NMDC, Indraprastha Gas",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.1935067727370409,neutral,0.4291845493562232,neutral
2019-10-14 18:03:32.102,233.0,234.85,232.4,234.0,488482.0,Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay,"Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.",neutral,positive,0.4291845493562232,neutral,-0.0851063829787185,neutral
2019-10-24 13:04:57.891,244.5,248.4,240.7,243.5,923143.0,Cadila Healthcare gets USFDA nod for Haloperidol Decanoate injection,Haloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome.,neutral,neutral,-0.408997955010225,neutral,0.5942622950819625,neutral
2019-10-29 18:01:24.652,250.2,251.9,246.6,249.0,591030.0,D-Street Buzz: Indiabulls Housing among most active on BSE; 78 stocks at 52-week low,"Cipla, Piramal Enterprises, Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs are among major gainers in the pharma space.",neutral,positive,-0.4796163069544319,neutral,0.659868026394712,neutral
2019-10-31 13:01:50.291,251.95,257.9,248.5,255.0,672031.0,Cadila Healthcare rises nearly 5% on EIR from USFDA,The share price declined 25 percent in the last 1 year.,positive,negative,1.2105576503274504,positive,-6.267029972752031,negative
2019-10-31 18:00:51.796,251.95,257.9,248.5,255.0,672031.0,Cadila Healthcare gets EIR from USFDA for Baddi facility,"""The company's formulations manufacturing facility located at Baddi, India, has received an EIR. The United States Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 15 to 19, 2019,"" Cadila Healthcare said in a filing to BSE.",neutral,neutral,1.2105576503274504,positive,-6.267029972752031,negative
2019-11-04 18:01:00.708,241.5,244.5,238.5,239.4,1356245.0,Cadila Healthcare dips 8% as USFDA issues warning letter for Moraiya plant,The company said the warning letter does not affect the existing business of the company in the US and the existing product supplies from the Moraiya facility will continue.,neutral,neutral,-0.8695652173913019,neutral,1.0750421585160252,positive
2019-11-04 18:04:09.297,241.5,244.5,238.5,239.4,1356245.0,USFDA issues warning letter for Cadila Healthcare's Moraiya facility,The formulation unit 45% of the firm's US sales; Cadila says letter does not impact its existing business in the United States for now,neutral,neutral,-0.8695652173913019,neutral,1.0750421585160252,positive
2019-11-05 10:03:22.306,241.5,244.5,238.5,239.4,1356245.0,What to watch: USFDA warning may keep Cadila in focus,Cadila Healthcare on Monday said it has received a warning letter from the USFDA for its Moraiya-based formulation facility. The company said it has already taken multiple steps after the inspection b,neutral,negative,-0.8695652173913019,neutral,1.0750421585160252,positive
2019-11-05 13:00:20.227,237.2,245.3,237.2,239.75,774230.0,Zydus Cadila gets USFDA nod for generic muscle relaxing injection,Cadila Healthcare on Tuesday said group firm Zydus Cadila has received final approval from the US health regulator for its generic version of muscle relaxant Cisatracurium Besylate Injection given bef,neutral,positive,1.0750421585160252,positive,-2.1888680425265794,negative
2019-11-13 10:00:27.913,231.85,232.55,223.15,225.5,1397739.0,"Board Meetings Today: SpiceJet, IRCTC, BHEL, ABB and Muthoot Finance","Muthoot Finance, HUDCO, NIA and Cadila Healthcare will be among firms that will disclose quarterly results on Wednesday.",neutral,neutral,-2.738839767090789,negative,4.943820224719101,positive
2019-11-13 23:04:03.881,222.5,235.4,220.0,233.5,4370098.0,"Cadila Healthcare acquires remaining stake in 2 subsidiaries for $250,000","While Cadila Healthcare is spending $225,000 for Zydus Technologies, it will buy the stake in Zydus Noveltech for $25,000.The company expects the acquisition to complete within a month, as per a filing with exchanges",neutral,neutral,4.943820224719101,positive,-0.1490312965722777,neutral
2019-11-14 13:02:59.724,234.85,237.3,230.7,234.5,946235.0,"Brokerages remain bullish, Cadila Healthcare share price up 3%","Macquarie also retained its outperform rating on the stock as it would buy the stock if it falls, but slashed its target price to Rs 270 (from Rs 292 earlier), implying 20.2 percent potential upside from current levels.",positive,positive,-0.1490312965722777,neutral,2.1141649048625792,positive
2019-11-14 18:02:20.876,234.85,237.3,230.7,234.5,946235.0,"Following the acquisition of the remaining 15% stake each in its subsidiaries Zydus Technologies Ltd and Zydus Noveltech Inc, the two companies will become wholly-owned subsidiaries of Cadila Healthcare Ltd","Following the acquisition of the remaining 15% stake each in its subsidiaries Zydus Technologies Ltd and Zydus Noveltech Inc, the two companies will become wholly-owned subsidiaries of Cadila Healthcare Ltd",neutral,neutral,-0.1490312965722777,neutral,2.1141649048625792,positive
2019-11-15 18:01:30.501,234.85,237.3,230.7,234.5,946235.0,Hold Cadila Healthcare; target of Rs 260: ICICI Direct,"ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 260 in its research report dated November 14, 2019.",neutral,positive,-0.1490312965722777,neutral,2.1141649048625792,positive
2019-11-18 18:04:13.185,242.0,246.95,239.25,243.9,1756141.0,Cadila Healthcare share price rises 4% after USFDA nod for arthritis drug,"Zydus Cadila announced the second Phase III DREAM-D trials of Desidustat, an Investigational New Drug (IND) targeted at treating anemia in dialysis dependent CKD patients, the company said in a filing to the exchanges.",positive,neutral,0.785123966942151,neutral,2.833675564681727,positive
2019-11-19 13:01:45.449,243.5,251.95,241.5,250.4,2577744.0,Hold Cadila Healthcare target of Rs 275: Sharekhan,"Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated November 14, 2019.",neutral,positive,2.833675564681727,positive,2.048192771084335,positive
2019-11-20 18:02:29.113,249.0,255.9,247.7,254.1,2440554.0,Hold Cadila Healthcare; target of Rs 220: Prabhudas Lilladher,"Prabhudas Lilladher recommended Hold rating on Cadila Healthcare with a target price of Rs 220 in its research report dated November 13, 2019.",neutral,positive,2.048192771084335,positive,-1.0025555337133805,negative
2019-11-20 23:02:41.249,249.0,255.9,247.7,254.1,2440554.0,"Cadila Healthcare heading for tough waters due to lack of big approvals in US, Moraiya warning letter","Shares of Ahmedabad-based drug maker had dropped 30 percent in 2019 on BSE, compared to 5.4 percent decline of S&amp;P BSE Healthcare index in the same period.",negative,negative,2.048192771084335,positive,-1.0025555337133805,negative
2019-11-21 13:02:37.452,254.35,256.35,247.55,251.8,1369358.0,"Cadila Healthcare gets USFDA approval for Isosorbide Dinitrate, Desonide; shares volatile","Isosorbide Dinitrate Tablets are used to prevent attacks of chest pain (angina). Desonide Cream is a mild corticosteroid, used to treat a variety of skin conditions.",neutral,neutral,-1.0025555337133805,negative,1.903251387787475,positive
2019-11-21 18:04:00.693,254.35,256.35,247.55,251.8,1369358.0,Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year,Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year,negative,negative,-1.0025555337133805,negative,1.903251387787475,positive
2019-11-21 23:00:33.359,254.35,256.35,247.55,251.8,1369358.0,Cadila Healthcare,Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest pain. The drug firm has also received final approva,neutral,positive,-1.0025555337133805,negative,1.903251387787475,positive
2019-11-22 23:00:54.441,254.35,256.35,247.55,251.8,1369358.0,"Titan & Nestle India to enter Sensex; YES Bank, Tata Motors exit","Glenmark Pharma, Cadila Healthcare, Edelweiss Financial will be removed from BSE 100 index.",neutral,neutral,-1.0025555337133805,negative,1.903251387787475,positive
2019-11-29 13:01:30.148,259.05,265.6,252.05,253.85,2749906.0,"Geojit maintains hold on Cadila Healthcare, target price Rs 270"," The stock closed Rs 259, up 1.6 per cent on Thursday.",positive,positive,-2.007334491410931,negative,1.574803149606299,positive
2019-12-02 13:01:31.221,256.85,262.3,254.4,261.0,4702455.0,Cadila Healthcare gets board nod for amalgamation,Scheme of amalgamation cleared for four wholly-owned subsidiaries with parent,neutral,neutral,1.6157290247225915,positive,1.019034800999799,positive
2019-12-02 18:03:00.470,256.85,262.3,254.4,261.0,4702455.0,Cadila Healthcare board approves merger of four subsidiaries to consolidate pharma business,"Gandhinagar (Gujarat) [India], Dec 2 (ANI): The board of directors at Cadila Healthcare on Monday approved the amalgamation of Zydus Technologies Ltd (ZTL), Alidac Pharmaceuticals Ltd (APL), Liva Pharmaceuticals Ltd (LPL) and Dialforhealth India Ltd (DHIL) with Cadila Healthcare Ltd (CHL).",neutral,positive,1.6157290247225915,positive,1.019034800999799,positive
2019-12-05 18:02:30.347,258.0,260.65,253.3,255.3,1242349.0,Cadila Healthcare files NDA with DCGI for liver disease drug Saroglitazar Mg,"If the latest NDA is approved, Saroglitazar Mg could become the first medicine indicated for the treatment of Non-alcoholic Steatohepatitis (NASH).",neutral,positive,-1.0465116279069724,negative,1.2128325508607176,positive
2019-12-12 13:00:43.397,264.0,264.0,259.0,260.45,863385.0,Cadila Healthcare stock rises on diabetic drug launch,Cadila Healthcare shares moved up on Thursday on the bourses after the company said in its BSE release that it has launched affordable oral anti-diabetic tablet Vinglyn. The drug belongs to the class,positive,positive,-1.344696969696974,negative,0.134073932196884,neutral
2019-12-20 18:03:50.589,261.7,268.2,260.0,266.2,2189985.0,Cadila Healthcare share price rose up to 2.52% to Rs 268.15 compared to the previous close of Rs 261.55 on BSE,Cadila Healthcare share price rose up to 2.52% to Rs 268.15 compared to the previous close of Rs 261.55 on BSE,positive,positive,1.7195261750095532,positive,-2.790178571428571,negative
2019-12-30 10:01:43.146,255.7,256.35,252.25,255.2,986016.0,Cadila Healthcare calls reports of divestment speculative,"Earlier, media reports said that the company was in talks with strategic investors to divest from its anti-infectives and gynaecological divisions for Rs1,200cr.",neutral,neutral,-0.1955416503715291,neutral,-0.8398437500000022,neutral
2020-01-03 23:00:37.972,257.0,264.0,255.95,259.9,1476408.0,"Info Edge, Muthoot Fin, RECL, 2 others enter large-cap space","Info Edge (India), Adani Transmission, RECL, Kansai Nerolac and Muthoot Finance have migrated to large-cap category from mid-cap, according to AMFI. They have replaced Cadila Healthcare, New India Ass",neutral,neutral,1.1284046692606915,positive,-1.7341040462427744,negative
2020-01-10 13:00:31.369,258.9,264.3,257.25,257.85,871050.0,"Pharma shares in focus; Dr Reddy's, Divi's, Granules hit 52-week highs","Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.",positive,positive,-0.4055619930474911,neutral,-0.4263565891472957,neutral
2020-02-04 23:01:36.544,266.4,274.5,265.0,272.8,2402758.0,USFDA completes inspection of Cadila Healthcare's Ahmedabad facility,"United States Food and Drug Administration (USFDA) inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned subsidiary, at SEZ, Ahmedabad from January 27 to February 4, 2020, Cadila Healthcare said in a BSE filing.

",neutral,neutral,2.402402402402416,positive,-0.6199854121079462,neutral
2020-02-04 23:03:24.757,266.4,274.5,265.0,272.8,2402758.0,USFDA completes inspection of Cadila Healthcare's Ahmedabad facility,"Shares of Cadila Healthcare closed at Rs 264.05 per scrip on the BSE, up 1.46 per cent from its previous close",neutral,positive,2.402402402402416,positive,-0.6199854121079462,neutral
2020-02-05 13:01:30.396,274.2,288.6,270.4,272.5,8096857.0,Cadila Healthcare rises 2% after USFDA inspection of Ahmedabad facility,The company will declare its third-quarter earnings today.,neutral,neutral,-0.6199854121079462,neutral,0.419708029197072,neutral
2020-02-06 10:01:46.619,274.2,288.6,270.4,272.5,8096857.0,Cadila Healthcare gains 3% as profit grows 249% sequentially,CLSA maintained buy rating and raised target to Rs 330 from Rs 310 per share.,positive,positive,-0.6199854121079462,neutral,0.419708029197072,neutral
2020-02-06 13:02:54.969,274.0,279.0,270.55,275.15,2059237.0,Drug firm Cadila Healthcare reported a 249% rise in Q3 net profit at Rs 373.9 crore compared to Rs 82.90 crore profit in Q2 of current fiscal ,Drug firm Cadila Healthcare reported a 249% rise in Q3 net profit at Rs 373.9 crore compared to Rs 82.90 crore profit in Q2 of current fiscal ,positive,positive,0.419708029197072,neutral,0.3629764065335753,neutral
2020-02-07 18:04:30.947,274.0,279.0,270.55,275.15,2059237.0,Hold Cadila Healthcare; target of Rs 247: Prabhudas Lilladher,"Prabhudas Lilladher recommended hold rating on Cadila Healthcare with a target price of Rs 247 in its research report dated February 06, 2019.
",neutral,positive,0.419708029197072,neutral,0.3629764065335753,neutral
2020-02-10 18:01:24.270,279.0,279.0,273.0,274.15,1250640.0,Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility,"The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit, Cadila Healthcare said in a filing to the BSE.  The facility completed the USFDA audit from December 16 to 20, 2019 with zero 483 observations, it added.",neutral,positive,-1.738351254480295,negative,-1.9742800217351888,negative
2020-02-10 18:02:10.063,279.0,279.0,273.0,274.15,1250640.0,Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility,"The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit, Cadila Healthcare said in a filing to the BSE.  The facility completed the USFDA audit from December 16 to 20, 2019 with zero 483 observations, it added.",neutral,positive,-1.738351254480295,negative,-1.9742800217351888,negative
2020-02-10 18:02:16.634,279.0,279.0,273.0,274.15,1250640.0,Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility,"The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit, Cadila Healthcare said in a filing to the BSE.",neutral,positive,-1.738351254480295,negative,-1.9742800217351888,negative
2020-02-11 13:03:59.227,276.05,276.1,270.2,270.6,946367.0,"Top intraday trading ideas for afternoon trade on Tuesday, February 11, 2020","Cadila Healthcare is a 'Buy' call with a target price of Rs 294 and a stop loss of Rs 275.
",neutral,neutral,-1.9742800217351888,negative,-0.2958579881656636,neutral
2020-02-11 18:00:47.351,276.05,276.1,270.2,270.6,946367.0,Hold Cadila Healthcare; target of Rs 285: ICICI Direct,"ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 285 in its research report dated February 10, 2019.",neutral,positive,-1.9742800217351888,negative,-0.2958579881656636,neutral
2020-03-05 18:01:05.839,259.95,268.65,254.6,265.0,2569904.0,Cadila Healthcare receives approval from DCGI for its NDA; stock up 3%,stock is trading higher by more than 3% on the NSE post the news announcement.,positive,positive,1.942681284862478,positive,-3.340883352208368,negative
2020-03-06 10:02:53.924,259.95,268.65,254.6,265.0,2569904.0,What to watch: Nod for liver drug may boost Cadila Healthcare,Cadila Healthcare on Thursday announced that the Drug Controller General of India has approved its New Drug Application for Saioglitazar for the treatment of Non-Cirrhotic Non-Alcoholic Steato Hepatit,positive,positive,1.942681284862478,positive,-3.340883352208368,negative
2020-03-11 18:01:29.096,250.8,252.6,234.5,238.0,2130548.0,Cadila Healthcare approves transfer of Animal Health Business to arm; stock ends 1% higher,"Further, the meeting of the board of directors of the company will be held on Monday, March 16, 2020, to consider, the proposal for declaration of Interim Dividend, if any, for FY19-20.",positive,neutral,-5.103668261563002,negative,15.52511415525114,positive
2020-03-11 18:03:24.645,250.8,252.6,234.5,238.0,2130548.0,Cadila board approves transfer of animal healthcare arm to Zydus Health,"The transfer of animal healthcare business is through execution of a definitive agreement, Cadila Healthcare said in a filing to BSE",neutral,positive,-5.103668261563002,negative,15.52511415525114,positive
2020-03-12 10:00:32.127,250.8,252.6,234.5,238.0,2130548.0,Cadila board okays transfer of animal healthcare business to subsidiary,Drug firm Cadila Healthcare on Wednesday said its board has approved the transfer of its animal healthcare business to its wholly-owned arm Zydus Animal Health and Investments Ltd (ZAHL) as part of i,neutral,positive,-5.103668261563002,negative,15.52511415525114,positive
2020-03-20 18:00:30.281,252.0,290.0,252.0,285.2,7506706.0,"Pharma stocks advance; Ipca Labs, Cadila Healthcare soar up to 19%","Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say.",positive,positive,13.174603174603169,positive,-2.4474917549036665,negative
2020-03-23 10:01:22.921,288.05,305.9,274.5,281.0,6347964.0,Ipca and Cadila Healthcare gear up to make drug for coronavirus,"Ipca is the biggest producer of the drug. Cadila Healthcare, based in Ahmedabad, too is a major player",positive,neutral,-2.4474917549036665,negative,-6.936026936026944,negative
2020-03-23 23:02:20.864,297.0,299.5,273.3,276.4,2613888.0,"Covid-19 throws up drug supply opportunity for Ipca, other pharma firms","Sun Pharma, Dr Reddy's, Torrent Pharma, Cipla, Cadila Healthcare and Natco Pharma would also benefit from malaria drug supplies, Alembic Pharma from azithromycin sales",neutral,positive,-6.936026936026944,negative,-2.388888888888885,negative
2020-03-30 13:02:51.492,258.0,271.15,255.1,267.95,1918082.0,Zydus Cadila gets tentative nod from USFDA for Parkinson's treatment capsule,"The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.",neutral,neutral,3.8565891472868175,positive,-2.9629629629629632,negative
2020-03-30 13:03:34.749,258.0,271.15,255.1,267.95,1918082.0,Cadila Healthcare share price rises over 2% on USFDA approval to Zydus for Parkinson's drug,"The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.",positive,neutral,3.8565891472868175,positive,-2.9629629629629632,negative
2020-03-31 18:04:17.579,270.0,273.3,261.15,262.0,3043754.0,"Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19",Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.,positive,neutral,-2.9629629629629632,negative,3.846882698502928,positive
2020-04-07 13:01:15.410,334.0,366.7,330.0,353.0,34938634.0,Cadila Healthcare share price surges 15% on USFDA approval,The drug will be manufactured at the group’s formulation manufacturing facility at Baddi.,positive,neutral,5.688622754491018,positive,-5.509383378016089,negative
2020-04-08 09:35:00.000,334.0,366.7,330.0,353.0,34938634.0,Cadila Healthcare soars 31% in 2 days on USFDA nod for Perphenazine tablets,"Zydus Cadila has received final approval from the United States Food and Drug Administration to market Perphenazine tablets USP, 2 mg, 4 mg, 8 mg and 16 mg",neutral,positive,5.688622754491018,positive,-5.509383378016089,negative
2020-04-08 10:01:22.850,334.0,366.7,330.0,353.0,34938634.0,"Coronavirus impact: Ipca, Cadila Healthcare stocks gain on India's HCQ move","Apart from the US, Brazil and Sweden have requested for the drug to battle the Covid-19 scare in their countries.",positive,neutral,5.688622754491018,positive,-5.509383378016089,negative
2020-04-08 10:02:45.099,334.0,366.7,330.0,353.0,34938634.0,Multiple growth levers make Cadila Healthcare attractive on the Street,"HCQ supplies for Covid-19 treatment to propel US growth, even as domestic pharma and consumer businesses are in a sweet spot",positive,positive,5.688622754491018,positive,-5.509383378016089,negative
2020-04-08 14:47:55.000,373.0,374.0,348.0,352.45,21195247.0,"Pharma shares jump, Cadila Healthcare, IPCA Labs reach new highs on hopes of surging drug sales","After leading the rally on Dalal Street yesterday, pharmaceutical stocks are back, leading from the front yet again.",positive,positive,-5.509383378016089,negative,-2.987119758838032,negative
2020-04-08 18:01:59.944,373.0,374.0,348.0,352.45,21195247.0,"F&O: Market setup shaky; don’t get carried away by bounce, stay light","A good amount of long buildup was seen in Cadila Healthcare , Torrent Pharma and STFC.",neutral,neutral,-5.509383378016089,negative,-2.987119758838032,negative
2020-04-09 12:03:00.000,373.0,374.0,348.0,352.45,21195247.0,Cadila Healthcare share price hits 52-week high on USFDA nod for cancer drug,The drug will be manufactured at the group’s Ahmedabad SEZ facility.,positive,neutral,-5.509383378016089,negative,-2.987119758838032,negative
2020-04-09 13:01:52.414,373.0,374.0,348.0,352.45,21195247.0,Cadila Healthcare shares climb 2% on USFDA nod for new drug,"Cadila Healthcare said on Thursday that Zydus had received the final approval from the US FDA to market Imatinib Mesylate tablets, a drug used in the treatment of leukaemia, bone marrow disorders, ski",positive,positive,-5.509383378016089,negative,-2.987119758838032,negative
2020-04-13 09:52:00.000,364.9,364.9,351.75,354.0,14941733.0,Cadila Healthcare gains 2% on USFDA nod for Empagliflozin tablets,"The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.",positive,neutral,-2.987119758838032,negative,-4.104372355430186,negative
2020-04-13 15:04:00.000,364.9,364.9,351.75,354.0,14941733.0,Cadila Healthcare shares rise 2% on USFDA nod to market diabetes drug,"Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD: Jardiance Tablets), the company said in a filing to the exchanges",positive,positive,-2.987119758838032,negative,-4.104372355430186,negative
2020-04-13 15:42:37.000,364.9,364.9,351.75,354.0,14941733.0,"Pharmaceutical stocks rally yet again: Cipla shares hit all-time high; Cadila Healthcare, Lupin jump","Even after a three-day break from trading, the story for pharma shares such as Cipla, Cadila Healthcare and Lupin remains the same -- hitting fresh highs and moving up, defying the benchmark indices which have been unable to exit the red on Monday.",positive,neutral,-2.987119758838032,negative,-4.104372355430186,negative
2020-04-16 06:00:00.000,336.0,346.2,329.15,344.4,7471494.0,Cadila Healthcare to disinvest 2% stake in this subsidiary,"On completion of the transaction, Cadila’s stake in Windlas Healthcare will reduce to 49% compared to the existing 51%.",neutral,neutral,2.4999999999999933,positive,-4.412607449856727,negative
2020-04-17 05:30:00.000,349.0,352.0,332.0,333.6,7828745.0,BRIEF-Cadila Healthcare-Zydus Receives Final Approval From USFDA For Erlotinib Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-4.412607449856727,negative,-2.2794117647058822,negative
2020-04-17 06:00:00.000,349.0,352.0,332.0,333.6,7828745.0,Cadila Healthcare gets USFDA nod for Erlotinib Tablets; shares down 2%,"Erlotinib Tablets, a cancer medicine, is build to interfere with the growth of cancer cells and slows their spread in the body.",negative,negative,-4.412607449856727,negative,-2.2794117647058822,negative
2020-04-17 08:32:00.000,349.0,352.0,332.0,333.6,7828745.0,"Stocks in news: TCS, Emami, United Spirits, Cadila Healthcare and more","Stocks to watch today on April 18: Emami, United Spirits, Cadila Healthcare and more among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-4.412607449856727,negative,-2.2794117647058822,negative
2020-04-17 12:23:00.000,349.0,352.0,332.0,333.6,7828745.0,Share market update: Pharma shares slip; Cadila Healthcare dips 2%,The Nifty Pharma index was trading 0.84 per cent down at 9121.65.,negative,negative,-4.412607449856727,negative,-2.2794117647058822,negative
2020-04-20 06:00:00.000,340.0,340.9,330.2,332.25,9728460.0,Cadila Healthcare explores a route to treat novel Coronavirus,The company is manufacturing Hydroxychloroquine which is found effective in treating patients suffering from COVID-19.,neutral,positive,-2.2794117647058822,negative,4.564063684609556,positive
2020-04-20 12:25:00.000,329.75,349.9,326.35,344.8,12645322.0,"Cadila Healthcare at the forefront, looks at biologic drug to treat Covid","Company is already working on developing 2 vaccine candidates, diagnostic kits and also making HCQ",neutral,neutral,4.564063684609556,positive,-2.3529411764705883,negative
2020-04-20 13:40:00.000,329.75,349.9,326.35,344.8,12645322.0,"Cadila Healthcare says exploring cancer, hepatitis drug Interferon alpha-2b for COVID-19",The Ahmedabad-based drug maker said it is ready to undertake clinical trials based on government’s response.,neutral,neutral,4.564063684609556,positive,-2.3529411764705883,negative
2020-04-21 02:08:00.000,329.75,349.9,326.35,344.8,12645322.0,"Coronavirus update: DBT approves funding for Cadila Healthcare, Bharat Biotech and Serum Institute for developing vaccine","The three companies are Cadila Healthcare Ltd, Bharat Biotech International Ltd and Serum Institute of India Private Limited",neutral,neutral,4.564063684609556,positive,-2.3529411764705883,negative
2020-04-21 12:10:00.000,340.0,340.9,327.4,332.0,8460795.0,D-Street Buzz: Pharma stocks rally led by Aurobindo Pharma; Dr Reddy’s Labs jumps 3%,"Aurobindo Pharma was the top gainer followed by Divis Labs, Dr Reddy’s Labs and Cadila Healthcare.",positive,positive,-2.3529411764705883,negative,0.2859723058398521,neutral
2020-04-24 13:44:00.000,333.25,344.0,330.9,336.05,8611203.0,"Hold Cadila Healthcare, target price Rs 328: Anand Rathi",The brokerage expects Cadila to report an ~8% year on year decline in revenue to Rs 34 billion.,neutral,negative,0.8402100525131317,neutral,1.120193763245531,positive
2020-04-30 05:30:00.000,330.5,332.0,321.3,323.95,5081199.0,BRIEF-Cadila Healthcare Signs Deal To Sell 49% Of Windlas Healthcare - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.9818456883509867,negative,2.1453928075320228,positive
2020-04-30 08:58:00.000,330.5,332.0,321.3,323.95,5081199.0,Cadila stock down after selling 49% of Windlas Healthcare shares,Cadila Healthcare shares slipped after signing a deal to sell 49% of Windlas Healthcare Private Limited (WHPL) to Windlas Biotech Private Limited (WBPL).,negative,negative,-1.9818456883509867,negative,2.1453928075320228,positive
2020-05-04 09:18:00.000,323.95,337.25,320.2,330.9,10063981.0,"Stocks in the news: RIL, YES Bank, Adani Ports,Cadila Healthcare, HUL and TechM",Here are a few stocks that are likely to see some action in Mondays trade.,neutral,neutral,2.1453928075320228,positive,-2.633928571428578,negative
2020-05-04 10:59:00.000,323.95,337.25,320.2,330.9,10063981.0,Trending stocks: Cadila Healthcare shares rise nearly 3%,Shares of Cadila Healthcare traded 2.79 per cent up in trade at 10:55AM on Monday.,positive,positive,2.1453928075320228,positive,-2.633928571428578,negative
2020-05-07 05:30:00.000,328.15,332.55,320.3,320.95,4518705.0,BRIEF-Cadila Healthcare Gets Final U.S. FDA Nod For Deferasirox Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.194118543349075,negative,-0.7573415765069517,neutral
2020-05-07 15:05:00.000,323.5,327.45,318.0,321.05,5407349.0,Coronavirus outbreak: Cadila Healthcare dismisses reports of workers at plant getting COVID-19,"The company is taking utmost care and precautions to safeguard the health of its employees across the country, Cadila said",neutral,neutral,-0.7573415765069517,neutral,-1.1418269230769265,negative
2020-05-08 05:30:00.000,323.5,327.45,318.0,321.05,5407349.0,BRIEF-Cadila Healthcare Unit Launches Prostate Cancer Drug Enzalutamide - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.7573415765069517,neutral,-1.1418269230769265,negative
2020-05-08 07:38:00.000,323.5,327.45,318.0,321.05,5407349.0,"In pics | Stocks in the news: RIL, RBL Bank, Gillette India, Cyient, HUL, Bosch, Tata Motors",5paisa Capital | ICICI Securities |SKF India | Apollo Pipes | Gammon Infrastructure | Just Dial | Sobha | Endurance Technologies | Astral Poly Technik | Cadila Healthcare | S Chand and Company are also the stocks in focus today.,neutral,neutral,-0.7573415765069517,neutral,-1.1418269230769265,negative
2020-05-08 11:35:00.000,323.5,327.45,318.0,321.05,5407349.0,Trending stocks: Cadila Healthcare shares down 1%,Shares of Cadila Healthcare Ltd. traded 0.86 per cent down in trade at 11:31AM on Friday .,negative,negative,-0.7573415765069517,neutral,-1.1418269230769265,negative
2020-05-08 14:14:35.000,323.5,327.45,318.0,321.05,5407349.0,"Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%","Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a ‘buy’ rating on them",positive,positive,-0.7573415765069517,neutral,-1.1418269230769265,negative
2020-05-11 08:03:00.000,332.8,333.0,325.2,329.0,5367189.0,Zydus Cadila to manufacture indigenous IgG ELISA test kits; stock gains 2.5%,The kits will be manufactured through a tech transfer by Cadila Healthcare at Moraiya Ahmedabad.,positive,neutral,-1.1418269230769265,negative,-0.5522319374137173,neutral
2020-05-14 12:29:00.000,340.0,343.0,330.0,331.0,5085097.0,Share market update: Pharma shares gain; Cadila Healthcare climbs 5%,The Nifty Pharma index was trading 1.01 per cent up at 9240.55.,positive,positive,-2.647058823529412,negative,-2.616541353383455,negative
2020-05-17 12:44:40.000,332.5,335.65,323.15,323.8,3085588.0,Stock query: Cadila Healthcare faces a vital barrier,The stock is moving sideways in the band between ₹320 and ₹350,neutral,neutral,-2.616541353383455,negative,0.2913663548535465,neutral
2020-05-26 14:18:00.000,339.8,340.7,333.0,336.55,2895614.0,Share market update: Pharma shares down; Cadila Healthcare dips 3%,The Nifty Pharma index was trading 1.21 per cent down at 9484.35.,negative,negative,-0.9564449676280165,negative,0.4901960784313657,neutral
2020-05-28 05:30:00.000,336.6,342.9,333.35,338.25,2381131.0,BRIEF-Cadila Healthcare Says Baddi Unit Gets Establishment Inspection Report - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.4901960784313657,neutral,0.5263927474777047,neutral
2020-05-29 08:50:00.000,341.95,352.5,341.3,343.75,6495976.0,"Stocks to watch: RIL, Voda Idea, Wipro, Voltas, YES Bank, Cadila Healthcare",Heres a look at the top stocks that may remain in focus today,neutral,neutral,0.5263927474777047,neutral,0.9540329575021717,positive
2020-05-29 09:01:00.000,341.95,352.5,341.3,343.75,6495976.0,"In pics | Stocks in the news: RIL, NIIT Tech, Union Bank, HCL Tech, CEAT, YES Bank, Cadila Health",Yes Bank | KPIT Technologies | Aksh Optifibre | Cadila Healthcare | Automobile Corporation of Goa | Rain Industries | D-Link India | Pidilite Industries | Welspun Enterprises | HeidelbergCement India | LT Foods | NHPC | R M Drip &amp; Sprink are also in focus today.,neutral,neutral,0.5263927474777047,neutral,0.9540329575021717,positive
2020-05-29 09:28:00.000,341.95,352.5,341.3,343.75,6495976.0,Cadila Healthcare share price rises 3% on EIR from USFDA,"The USFDA had conducted an inspection at the facility from 2 to 9 March, 2020.",positive,neutral,0.5263927474777047,neutral,0.9540329575021717,positive
2020-05-29 09:57:00.000,341.95,352.5,341.3,343.75,6495976.0,Cadila Healthcare stock soars 4% after receiving EIR for Baddi facility,"The EIR report stated that the classification of the facility is No Action Indicated (NAI), Cadila said in the filing.",neutral,neutral,0.5263927474777047,neutral,0.9540329575021717,positive
2020-05-29 10:44:00.000,341.95,352.5,341.3,343.75,6495976.0,Trending stocks: Cadila Healthcare shares gain nearly 3%,"A total of 156,390 shares changed hands on the counter till 10:42AM (IST).",positive,neutral,0.5263927474777047,neutral,0.9540329575021717,positive
2020-05-29 12:31:00.000,341.95,352.5,341.3,343.75,6495976.0,"Stocks in the news: Vodafone Idea, RIL, Cadila Healthcare, PNB Housing and Voltas",Google is said to be exploring taking a minority stake in British telecom group Vodafones struggling India business.,neutral,neutral,0.5263927474777047,neutral,0.9540329575021717,positive
2020-05-29 13:44:00.000,341.95,352.5,341.3,343.75,6495976.0,Cadila Healthcare share price rises over 4% on EIR from USFDA,Cadila Healthcare share price rose in early trade today after the firm received an EIR from USFDA. Share price of Cadila Healthcare gained up to 4.24% to Rs 352.4 compared to the previous close of Rs 338.05 on BSE. Cadila Healthcare share is trading highe,positive,positive,0.5263927474777047,neutral,0.9540329575021717,positive
2020-06-04 21:01:00.000,364.85,367.55,357.7,359.0,4166267.0,ICMR comes out with list of antibody detection kits to be used for sero-surveys,"The apex health research body has so far approved three batches of ‘COVID Kavach ELISA IgG kits’ developed by Zydus Cadila Healthcare Ltd, Ahmedabad, Gujarat.",neutral,positive,-1.6033986569823275,negative,-1.888888888888892,negative
2020-06-05 05:30:00.000,364.85,367.55,357.7,359.0,4166267.0,BRIEF-Cadila Healthcare’s Zydus Cadila Gets Final U.S. FDA Nod For Atazanavir - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.6033986569823275,negative,-1.888888888888892,negative
2020-06-05 08:07:00.000,364.85,367.55,357.7,359.0,4166267.0,Cadila Healthcare receives final USFDA approval for Atazanavir capsules,"Cadila will manufacture this capsule at their group’s manufacturing facility at SEZ, Ahmedabad.",positive,neutral,-1.6033986569823275,negative,-1.888888888888892,negative
2020-06-10 10:23:05.000,360.5,371.3,358.65,369.0,5014093.0,"Sensex trades higher, Nifty holds 10,050; check what’s moving Dalal Street today","Nifty Pharma index was up 0.75 per cent led by gains in Cadila Healthcare, Lupin and Cipla. While Nifty Metal index was down half a per cent dragged by Tata Steel, Ratnamani Metals & Tubes and Welspun Corp.",positive,positive,2.3578363384188625,positive,-0.067604110329908,neutral
2020-06-12 05:30:00.000,361.95,376.4,359.7,375.5,4642424.0,BRIEF-Cadila Healthcare’s Zydus Signs Non-Exclusive Pact With Gilead Sciences For Remdesivir - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,3.743610995993925,positive,-2.421052631578944,negative
2020-06-12 21:56:00.000,361.95,376.4,359.7,375.5,4642424.0,India’s Zydus Cadila to make Gilead’s potential COVID-19 drug remdesivir,"Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for the drug.",neutral,positive,3.743610995993925,positive,-2.421052631578944,negative
2020-06-16 11:20:05.000,366.0,374.75,356.35,360.5,7047001.0,Zydus Cadila Gets USFDA Approval To Market Generic Version Of Deferasirox Tablets,"The approval by the US Food and Drug Administration (USFDA) for Deferasirox tablets is for multiple strengths of 90 mg, 180 mg and 360 mg, Cadila Healthcare said in a regulatory filing.",neutral,neutral,-1.5027322404371584,negative,-1.4864864864864866,negative
2020-06-16 11:50:00.000,366.0,374.75,356.35,360.5,7047001.0,Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets,"Zydus Cadila, part of Cadila Healthcare group, on Tuesday said it has received final approval from the US health regulator to market its generic version of Deferasirox tablets used in treatment of chronic iron overload due to blood transfusions.",positive,positive,-1.5027322404371584,negative,-1.4864864864864866,negative
2020-06-16 18:49:08.000,370.0,371.8,362.65,364.5,6061152.0,Analysts See No Earnings Impact For Indian Suppliers As U.S. Bars Anti-Malarial Drugs For Covid-19,India is one of the largest suppliers of hydroxychloroquine to the U.S. Cadila Healthcare and Ipca Labs are the largest exporters.,neutral,neutral,-1.4864864864864866,negative,-0.0136612021857954,neutral
2020-06-19 05:30:00.000,368.7,369.7,360.25,361.75,5005202.0,BRIEF-India’s Cadila Healthcare March-Qtr Consol Net Profit Falls - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 08:08:00.000,368.7,369.7,360.25,361.75,5005202.0,Cadila Healthcare Limited net profit declined by ~15%yoy in Q4FY20,The consolidated net profit posted by Cadila Healthcare Limited for Q4FY20 is ~Rs392cr,negative,neutral,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 08:27:00.000,368.7,369.7,360.25,361.75,5005202.0,"Board Meetings Today: PNB, Oil India, Nestle India, Bajaj Electricals, Cadila Healthcare and LIC Housing","PTC India, The Ramco Cements, and Zuari Agro Chemicals are slated to announce their March quarter earnings on Friday.",neutral,neutral,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 10:22:00.000,368.7,369.7,360.25,361.75,5005202.0,Cadila Healthcare sees 15% yoy drop in Q4 PAT to Rs392cr; filed additional 30 ANDAs with USFDA,"For FY20, Cadila recorded a net profit of Rs1,176.6cr versus Rs1,848.8cr in FY19.",negative,positive,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 10:39:00.000,368.7,369.7,360.25,361.75,5005202.0,Trending stocks: Cadila Healthcare shares flat ahead of Q4 results,"A total of 28,973 shares changed hands on the counter till 10:36AM (IST).",neutral,neutral,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 11:15:00.000,368.7,369.7,360.25,361.75,5005202.0,"Stocks in the news: RIL, Tata Motors, PNB Housing, HDFC AMC and Cadila Healthcare and Coal India",Moody’s downgraded Tata Motors corporate family rating (CFR) and the company’s senior unsecured instruments rating .,neutral,negative,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 14:32:05.000,368.7,369.7,360.25,361.75,5005202.0,Cadila Healthcare Reports 15% YoY Fall In Net Profit; Revenue Improves Marginally,"The company’s consolidated revenue for Q4FY20 was Rs 3,752.1 crore against Rs 3,732.8 crore in the same period last year.",neutral,negative,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 15:54:00.000,368.7,369.7,360.25,361.75,5005202.0,Cadila Healthcare Q4 results: Net profit declines 15% at Rs 392 crore,"Net profit of the company for the fiscal ended March this year was Rs 1,176.6 crore as against Rs 1,848.8 crore for the previous fiscal, Cadila Healthcare said.",negative,negative,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 16:19:02.000,368.7,369.7,360.25,361.75,5005202.0,Cadila Healthcare Q4 consolidated net profit dips 15%,"Cadila Healthcare Ltd on Friday posted a standalone net profit of ₹619 crore for the quarter ended March 2020, against ₹242 crore in the same quarter last year, showing a sharp jump of 155 per cent",neutral,positive,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-19 17:29:00.000,368.7,369.7,360.25,361.75,5005202.0,"Cadila Healthcare’s Q4 PBT falls 14% to Rs 522 cr, total income rises 0.66%","Cadila has also been working on a DNA vaccine to fight Covid-19, which is currently in the animal testing stage",neutral,neutral,-1.8850013561160803,negative,-1.1886869790954957,negative
2020-06-22 07:48:46.000,365.95,368.5,356.55,361.6,5177138.0,Buy Cadila Healthcare; Target Of Rs 420: Motilal Oswal,"Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 420 in its research report dated June 20, 2020.",neutral,positive,-1.1886869790954957,negative,1.3259668508287323,positive
2020-06-22 09:35:13.000,365.95,368.5,356.55,361.6,5177138.0,"What Should Investors Do With Cadila Healthcare, Buy, Sell Or Hold?","The company’s consolidated revenue for Q4FY20 came at Rs 3,752.1 crore, slightly higher from the Q4FY19 revenue at Rs 3,732.8 crore.",neutral,positive,-1.1886869790954957,negative,1.3259668508287323,positive
2020-06-22 10:50:00.000,365.95,368.5,356.55,361.6,5177138.0,Trending stocks: Cadila Healthcare shares down 1%,"A total of 107,029 shares changed hands on the counter till 10:48AM (IST).",negative,neutral,-1.1886869790954957,negative,1.3259668508287323,positive
2020-06-23 00:27:13.000,362.0,368.85,361.0,366.8,2416627.0,Analyst Corner: Cadila Healthcare rating ’buy – Performance was in line with estimates,"Earnings are expected to recover, led by gradual revival of US sales and better growth in DF; ‘Buy’ retained with TP of Rs 420",positive,positive,1.3259668508287323,positive,-1.24932102118413,negative
2020-06-23 10:49:00.000,362.0,368.85,361.0,366.8,2416627.0,"Add Cadila Healthcare, target price Rs 400: ICICI Securities",Valuations look reasonable at 20.0 times FY21E and 18.1 times FY22E earnings and EV/EBITDA multiples of 13.1 times FY21E and 12.0 times FY22E.,neutral,neutral,1.3259668508287323,positive,-1.24932102118413,negative
2020-06-23 18:12:06.000,368.2,373.3,361.55,363.6,3089901.0,Buy Cadila Healthcare; Target Of Rs 420: ICICI Direct,"ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 420 in its research report dated June 22, 2020.",neutral,positive,-1.24932102118413,negative,0.0826901874310946,neutral
2020-06-24 05:30:00.000,368.2,373.3,361.55,363.6,3089901.0,BRIEF-Cadila Healthcare Gets Final U.S. FDA Nod For Meclizine Hydrochloride Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.24932102118413,negative,0.0826901874310946,neutral
2020-06-24 09:04:00.000,368.2,373.3,361.55,363.6,3089901.0,"Neutral on Cadila Healthcare, target price Rs 370: Nomura",The brokerage expects some slowdown from a high base of 4QFY20.,neutral,negative,-1.24932102118413,negative,0.0826901874310946,neutral
2020-07-03 10:10:00.000,380.0,380.0,362.5,364.9,8832166.0,"Stocks in the news: HDFC Life, SBI Card, JB Chemicals, Motherson Sumi, Future Retail and Cadila Healthcare","Vedanta will be replaced by HDFC Life Insurance in the Nifty50 index, effective July 31.",neutral,neutral,-3.9736842105263217,negative,-2.874331550802139,negative
2020-07-03 12:09:00.000,380.0,380.0,362.5,364.9,8832166.0,Cadila Healthcare jumps 5% on receiving nod for human trials of Covid-19 drug,"The approval process was fast-tracked, following recommendation by the subject expert committee and considering the emergency and unmet medical need during the pandemic.",neutral,neutral,-3.9736842105263217,negative,-2.874331550802139,negative
2020-07-03 15:27:05.000,380.0,380.0,362.5,364.9,8832166.0,Cadila Health shares rise after its covid vaccine gets DCGI nod for human trials,Shares of the pharmaceuticals company rose by as much as 4.61% on Friday .The vaccine developed by Cadila Healthcare was found to elicit a strong immune response in multiple animal species,positive,positive,-3.9736842105263217,negative,-2.874331550802139,negative
2020-07-03 16:34:00.000,380.0,380.0,362.5,364.9,8832166.0,Cadila Healthcare share rises 5% on nod for human trial of Covid-19 vaccine,Cadila Healthcare stock trades mere points away from its 52-week high of Rs 383.65. Cadila Healthcare stock has risen 4.73% in the last 2 sessions,positive,positive,-3.9736842105263217,negative,-2.874331550802139,negative
2020-07-06 10:32:23.000,374.0,374.0,360.1,363.25,3385622.0,Zydus Cadila gets approval from Mexican authority to test COVID-19 drug,"“Clinical and regulatory development of Desidustat in COVID-19 is being executed in Mexico by Avant Sant″ Research Center S.A. de C.V., a leading contract research organisation headquartered in Monterrey, Mexico,” Cadila Healthcare said in a regulatory filing.",positive,neutral,-2.874331550802139,negative,0.1798063623789701,neutral
2020-07-14 18:41:00.000,357.05,358.15,353.35,355.0,2720346.0,These 7 pharma stocks gave over 50% return since COVID-19 outbreak,"Sun Pharma, Dr Reddy’s Laboratories, Cipla, Torrent Pharmaceuticals, Lupin and Cadila Healthcare have given over 50 per cent return since January 30 when the first coronavirus case was reported",positive,neutral,-0.5741492788124943,neutral,1.3475575519371172,positive
2020-07-14 21:14:00.000,357.05,358.15,353.35,355.0,2720346.0,"Human trials for COVID-19 vaccine initiated in India, with 1,000 volunteers: ICMR - The Economic Times",The Drugs Controller General of India (DCGI) has permitted two vaccines -- one developed by Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research and another one by Zydas Cadila Healthcare Ltd to go in for the first and second phase of human clinical trial…,neutral,neutral,-0.5741492788124943,neutral,1.3475575519371172,positive
2020-07-15 05:30:00.000,357.05,358.15,353.35,355.0,2720346.0,BRIEF-Cadila Healthcare Zydus Starts Human Dosing Of Its Vaccine ZyCoV-D - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.5741492788124943,neutral,1.3475575519371172,positive
2020-07-15 13:42:00.000,356.2,362.65,352.1,361.0,4024728.0,Cadila Healthcare rises on starting human trials for COVID-19 vaccine,Cadila Healthcare gained 0.68% to Rs 356.06 after the company said that it has started human studies for its potential coronavirus vaccine.,neutral,positive,1.3475575519371172,positive,4.277041942604857,positive
2020-07-16 09:04:00.000,356.2,362.65,352.1,361.0,4024728.0,"Stocks in the news: Infosys, YES Bank, Titan, Cadila Healthcare, IDBI Bank and L&T Finance - The Economic Times","YES Bank’s Rs 15,000 crore FPO was subscribed 22 per cent at the end of first day of the bidding process.",neutral,neutral,1.3475575519371172,positive,4.277041942604857,positive
2020-07-16 09:08:26.000,356.2,362.65,352.1,361.0,4024728.0,"Stocks in focus: Infosys, Cadila Healthcare, Titan, L&T Finance, SBI, among others to remain in news","L&T Finance Holdings, L&T Technology Services, Bajaj Consumer Care, Aditya Birla Money, Cyient are among companies that are scheduled to announce their June quarter earnings later in the day today.",neutral,neutral,1.3475575519371172,positive,4.277041942604857,positive
2020-07-16 12:11:00.000,362.4,378.6,362.2,377.9,9204358.0,Cadila Healthcare gets sANDA approval for Doxycycline injection,The drug maker on Thursday (16 July) said it received supplemental Abbreviated New Drug Application (sANDA) approval from the US drug regulator for manufacturing of Doxycycline injection.,positive,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-16 13:53:00.000,362.4,378.6,362.2,377.9,9204358.0,Zydus Cadila Gets USFDA Nod for Manufacturing Doxycycline Injection at Vadodara,"Shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 355.60 apiece on BSE, up 0.37 per cent against their previous close.",neutral,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-17 08:26:00.000,362.4,378.6,362.2,377.9,9204358.0,Here’s a Bull Spread strategy for Cadila Healthcare by HDFC Securities,Long build up is seen in the Cadila Futures where we have seen 6%(Prov) rise in the Open Interest with price moving up by 2%,neutral,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-17 09:40:00.000,362.4,378.6,362.2,377.9,9204358.0,Cadila Health rises on getting approval to test Covid19 drug in Mexico,Cadila Healthcare rose 1.5% to Rs 366.40 after the company said it received regulatory approval to conduct clinical trials with its biological therapy in Mexico to treat novel Coronavirus.,positive,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-17 10:36:15.000,362.4,378.6,362.2,377.9,9204358.0,Zydus gets Mexican regulator’s nod for clinical trials of Pegylated Interferon alpha-2b,"In yet another major development on the treatment front for Covid-19, Zydus Cadila (Cadila Healthcare) has received approval from the Mexican regulatory authority COFEPRIS to conduct clinical trials w",neutral,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-17 13:17:23.000,362.4,378.6,362.2,377.9,9204358.0,Cadila Healthcare Ltd gains for third straight session,"Cadila Healthcare Ltd is quoting at Rs 373.15, up 3.39% on the day as on 12:54 IST on the NSE. The stock is up 61.43% in last one year as compared to a 6.76% slide in NIFTY and a 27.39% slide in the Nifty Pharma index.",positive,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-17 13:31:38.000,362.4,378.6,362.2,377.9,9204358.0,Cadila Healthcare Ltd sees good buying,"Cadila Healthcare Ltd is quoting at Rs 373.15, up 3.39% on the day as on 12:54 IST on the NSE. The stock is up 61.43% in last one year as compared to a 6.76% slide in NIFTY and a 27.39% slide in the Nifty Pharma index.",positive,positive,4.277041942604857,positive,-2.12598425196851,negative
2020-07-19 18:17:23.000,381.0,384.5,372.55,372.9,5945463.0,Stock query: Cadila Healthcare on medium-term uptrend,A strong rally beyond ₹400 will push it higher to the long-term trend-deciding level of ₹430,neutral,positive,-2.12598425196851,negative,-2.8457446808510607,negative
2020-07-20 07:16:00.000,381.0,384.5,372.55,372.9,5945463.0,"Stocks in the news: HDFC Bank, Vodafone Idea, Future Retail, YES Bank, SBI Card and Cadila Healthcare","ACC, Bombay Dyeing, SBI Card, Syngene and Den Networks are scheduled to announce their June quarter earnings on Monday.",neutral,neutral,-2.12598425196851,negative,-2.8457446808510607,negative
2020-07-20 15:44:47.000,376.0,377.6,363.25,365.3,3510702.0,"Cadila Healthcare covid vaccine trials on but pricing, competition hold key","There are several global players rushing to develop a vaccine, and some of them could get the nod much earlier.Pricing is critical given that most of the Indian population may not be able to afford a high-priced vaccine",neutral,neutral,-2.8457446808510607,negative,0.204778156996587,neutral
2020-07-23 14:17:00.000,370.0,374.9,361.5,363.2,4896236.0,Cadila Healthcare shares gain after Zydus gets USFDA nod for cancer drug trials,The company has also initiated a Phase 2 trials of Desidustat in Mexico for COVID-19 patients.,positive,positive,-1.8378378378378408,negative,-2.3917525773195845,negative
2020-07-24 05:30:00.000,370.0,374.9,361.5,363.2,4896236.0,BRIEF-Cadila Healthcare Says India Branded Formulation Business Somewhat Affected Due To Lockdown - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.8378378378378408,negative,-2.3917525773195845,negative
2020-07-30 10:53:00.000,361.5,368.5,361.3,366.15,3382022.0,"Pharma stocks gain led by Dr Reddy’s Labs, stock hits 52-week high; Cadila Health, Lupin rise","Dr Reddy’s Labs was the top gainer hitting new 52-week high followed by Divis Labs, Torrent Pharma, Lupin, Cadila Healthcare, Cipla and Aurobindo Pharma.",positive,positive,1.2863070539419024,positive,6.136889372703772,positive
2020-07-31 16:25:59.000,367.45,396.45,367.3,390.0,15278679.0,"Sensex, Nifty fall for third consecutive session on Friday; here’s what to expect next week","Nifty Pharma surged over 3.5 per cent led by Torrent Pharma, Aurobindo Pharma, Cadila Healthcare and Sun Pharma",neutral,positive,6.136889372703772,positive,0.7575757575757576,neutral
2020-08-02 11:40:00.000,396.0,400.7,387.05,399.0,12194304.0,US generics business to continue its growth momentum: Pharma firm Cadila Healthcare,"According to the Cadila Healthcare’s annual report for fiscal year 2019-20, the company is planning to introduce additional topical, transdermal and injectable products in coming years. The US was the largest contributor to the consolidated revenues of the company with 45 per cent share, it said.",positive,positive,0.7575757575757576,neutral,1.7336683417085368,positive
2020-08-03 13:22:00.000,398.0,405.55,390.45,404.9,9401321.0,Cadila Healthcare rises on USFDA tentative nod to market Parkinsons disease drug,Shares of the drug maker rose 1.43% to Rs 394 after the company said it received tentative approval from the US-based drug regulator to market Carbidopa and Levodopa extended-release capsules in multiple strengths.,neutral,positive,1.7336683417085368,positive,-3.1784841075794623,negative
2020-08-03 13:31:15.000,398.0,405.55,390.45,404.9,9401321.0,Cadila Healthcare Ltd jumps 1.56%,"Cadila Healthcare Ltd is quoting at Rs 394.45, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 76.41% in last one year as compared to a 0.62% jump in NIFTY and a 44.45% jump in the Nifty Pharma.",positive,positive,1.7336683417085368,positive,-3.1784841075794623,negative
2020-08-05 05:30:00.000,409.0,411.5,392.45,396.0,19555677.0,BRIEF-India’s Cadila Healthcare June-Qtr Consol Net Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 07:21:00.000,409.0,411.5,392.45,396.0,19555677.0,"Market Ahead, Aug 5: Top factors that could guide markets today","Over 65 companies, including Adani Gas, Apollo Tyres, Butterfly Gandhimathi, Canara Bank, and Cadila Healthcare, are scheduled to release their June quarter results today",neutral,neutral,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 07:55:00.000,409.0,411.5,392.45,396.0,19555677.0,"Top stocks in focus: Axis Bank, Cadila Healthcare, Tata Consumer, Unichem Labs, Apollo Tyres",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 08:28:08.000,409.0,411.5,392.45,396.0,19555677.0,"Markets may be volatile; Vodafone, Sun Pharma shares in focus","Wall Street shares ended higher after choppy trade as hopes mounted US leaders would agree on another coronavirus stimulus package.Among major companies which will announce earnings today are DLF, Godrej Properties, Canara Bank, Adani Gas, Jyothy Labs and Cadila Healthcare.",negative,positive,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 08:36:06.000,409.0,411.5,392.45,396.0,19555677.0,"Market LIVE: Shares likely to be volatile, SGX Nifty flat","Trend in SGX Nifty suggests a flat opening for benchmark indices.Major companies which will announce earnings today are DLF, Godrej Properties, Canara Bank, Adani Gas, Jyothy Labs and Cadila Healthcare",neutral,neutral,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 09:00:22.000,409.0,411.5,392.45,396.0,19555677.0,"Stocks in focus: Axis Bank, TCS, SBI Cards, Bharti Airtel, Sun Pharma, Cadila Healthcare, Adani Gas","DLF, Canara Bank, Adani Gas, Apollo Tyres, Birlasoft, Cadila Healthcare, Dwarikesh Sugar Industries, EID Parry (India), Godrej Properties, Inox Leisure, VIP Industries, etc., are among companies that are scheduled to announce their quarterly earnings today.",neutral,neutral,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 11:19:00.000,409.0,411.5,392.45,396.0,19555677.0,Share market update: Nifty Pharma index flat; Cadila Healthcare up 1%,The Nifty Pharma index was trading 0.41 per cent up at 11363.65.,positive,positive,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 11:59:00.000,409.0,411.5,392.45,396.0,19555677.0,Cadila Healthcare Q1FY21; consolidated profit rises by ~50% yoy,The company recorded a consolidated profit of Rs454cr in Q1FY21.,positive,positive,-3.1784841075794623,negative,-1.41414141414142,negative
2020-08-05 12:04:00.000,396.0,401.8,384.2,390.4,9630090.0,Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6,"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, 2020, has been well tolerated, Cadila Healthcare, the listed entity of the group, said in a regulatory filing. Zydus Cadila Chairman Pankaj R Patel said the …",neutral,positive,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-05 12:08:00.000,396.0,401.8,384.2,390.4,9630090.0,Cadila Healthcare consolidated net profit rises 49.54% in the June 2020 quarter,Sales rise 4.20% to Rs 3549.30 crore,positive,positive,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-05 13:39:00.000,396.0,401.8,384.2,390.4,9630090.0,Cadila Healthcare Q1 results: Net profit up 50% at Rs 454 crore,"The company had posted a net profit of Rs 303.6 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to BSE.",positive,positive,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-05 13:49:12.000,396.0,401.8,384.2,390.4,9630090.0,Cadila Healthcare June quarter net profit up 50% at Rs454 cr,"Consolidated revenue from operations of the company stood at ₹3,639.9 crore for the quarter under consideration, as against ₹3,496.3 crore for the same period year ago",positive,neutral,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-05 13:58:00.000,396.0,401.8,384.2,390.4,9630090.0,Cadila Healthcare slips 4.5% from day’s high post June quarter results,"The stock of the pharmaceutical firm declined 4.5 per cent from its intra-day high of Rs 411.60, also its 52-week high, touched earlier in the day.",neutral,negative,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-05 14:26:11.000,396.0,401.8,384.2,390.4,9630090.0,Cadila Healthcare standalone Q1 net up 15-fold y-o-y at ₹398 crore,"Revenues increase to ₹1,796 crore",positive,positive,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-06 09:16:28.000,396.0,401.8,384.2,390.4,9630090.0,Dolat Capital: Cadila Healthcare’s Top-Line Driven By API; Pinning Hope On Injectables,Dolat Capital: Cadila Healthcare’s Top-Line Driven By API; Pinning Hope On Injectables,neutral,neutral,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-06 09:36:00.000,396.0,401.8,384.2,390.4,9630090.0,Cadila Healthcare share price falls after Q1 numbers; here’s what brokerages have to say,The company has posted 49.5 percent jump in its Q1 net profit at Rs 454 crore against Rs 303.6 crore.,negative,positive,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-06 10:55:00.000,396.0,401.8,384.2,390.4,9630090.0,"Buy Cadila Healthcare, target price Rs 460: Motilal Oswal","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 40064.17 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.41414141414142,negative,0.1537279016141342,neutral
2020-08-06 12:21:05.000,390.3,395.3,387.55,390.9,4603041.0,COVID-19 vaccine: Zydus Cadila to begin phase II of human trial today,"Coronavirus COVID19 vaccine latest update: On Wednesday, Cadila Healthcare, the listed entity of the Zydus Cadila group, stated that ZyCoV-D was found to be safe and well-tolerated in phase I clinical trial",neutral,positive,0.1537279016141342,neutral,2.746693794506615,positive
2020-08-06 14:47:00.000,390.3,395.3,387.55,390.9,4603041.0,Cadila Healthcare stock slips post Q1 earnings; here’s what brokerages say,"Following the result update, Cadila Healthcare shares fell 1.57% to the intraday low of Rs 389.55 on BSE against the earlier close of Rs 395.95. The stock also hit an intraday high of Rs 401.80 during today’s session, after opening at Rs 396",neutral,negative,0.1537279016141342,neutral,2.746693794506615,positive
2020-08-07 14:02:00.000,390.3,395.3,387.55,390.9,4603041.0,Buy Cadila Healthcare; target of Rs 460: Motilal Oswal,"Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 460 in its research report dated August 06, 2020.",neutral,positive,0.1537279016141342,neutral,2.746693794506615,positive
2020-08-07 14:13:00.000,390.3,395.3,387.55,390.9,4603041.0,Hold Cadila Healthcare; target of Rs 445: Sharekhan,"Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 445 in its research report dated August 05, 2020.",neutral,positive,0.1537279016141342,neutral,2.746693794506615,positive
2020-08-10 11:37:00.000,393.2,409.8,392.15,404.0,7939965.0,"D-Street Buzz: Pharma stocks rally led by Divis Labs, Cipla; Lupin, Sun Pharma gain 3% each","Lupin gained over 5 percent followed by Sun Pharma and Dr Reddy’s Labs up 3 percent each while Biocon, Cadila Healthcare and Aurobindo Pharma were the other gainers.",positive,positive,2.746693794506615,positive,-2.923114713829534,negative
2020-08-10 17:09:00.000,407.1,408.6,393.0,395.2,3345846.0,"L&T, financials drive Sensex 142 points higher; Nifty above 11,250","Nifty Pharma rallied 5.46 per cent led by up to 12 per cent gains in Divis Labs, Lupin, Cipla, Aurobindo Pharma and Cadila Healthcare.",positive,positive,-2.923114713829534,negative,-2.427307206068273,negative
2020-08-12 12:01:00.000,393.5,394.55,385.25,386.0,5402957.0,Stock market update: Pharma stocks fall; Cadila Healthcare loses nearly 3%,The Nifty Pharma index was trading 1.61 per cent down at 11582.45.,negative,negative,-1.905972045743329,negative,1.7179487179487152,positive
2020-08-12 12:15:00.000,393.5,394.55,385.25,386.0,5402957.0,"D-Street Buzz: Pharma stocks under pressure; Lupin, Biocon, Divis Labs, Cipla shed 2% each","Lupin, Cadila Healthcare, Divis Laboratories and Biocon shed over 2 percent each while Sun Pharma and Aurobindo Pharma were down a percent.",negative,neutral,-1.905972045743329,negative,1.7179487179487152,positive
2020-08-13 05:30:00.000,393.5,394.55,385.25,386.0,5402957.0,BRIEF-Cadila Healthcare Gets Final Approval From FDA For Sevelamer Carbonate Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.905972045743329,negative,1.7179487179487152,positive
2020-08-13 13:57:24.000,390.0,400.35,386.05,396.7,7427423.0,Coronavirus drug: Zydus Cadila launches Remdesivir at cheapest rates in India,Cadila Healthcare Managing Director Dr Sharvil Patel told PTI that the company would like to enable more and more patients to access the critical drug in their treatment of the novel Coronavirus.,positive,positive,1.7179487179487152,positive,-0.4885381435550517,neutral
2020-08-14 01:28:52.000,390.0,400.35,386.05,396.7,7427423.0,Zydus Cadila launches India’s cheapest remdesivir version Remdac,"“Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of Covid-19,” said Sharvil Patel, MD, Cadila Healthcare MD, said.",positive,positive,1.7179487179487152,positive,-0.4885381435550517,neutral
2020-08-19 12:23:00.000,397.0,400.8,395.05,398.9,2401997.0,Stock market update: Pharma stocks gain; Cadila Healthcare rises over 1%,The Nifty Pharma index was trading 0.32 per cent up at 11618.2.,positive,positive,0.4785894206549062,neutral,0.2997751686235295,neutral
2020-08-25 12:21:00.000,390.0,391.15,385.1,388.85,2184507.0,Stock market update: Pharma stocks down; Cadila Healthcare sheds over 1%,The Nifty Pharma index was trading 0.38 per cent down at 11528.75.,negative,negative,-0.294871794871789,neutral,0.3856041131105398,neutral
2020-09-02 10:29:00.000,380.1,384.4,372.7,382.5,3404623.0,Zydus Cadila gets final approval from USFDA for Cisatracurium Besylate Injection; stock up 1%,The drug will be manufactured at Liva plant of Cadila Healthcare Limited.,positive,neutral,0.6314127861089127,neutral,1.0443864229765014,positive
2020-09-02 12:07:54.000,383.0,389.35,379.85,387.0,2421350.0,Zydus Cadila gets USFDA nod for muscle relaxant injection,Cadila Healthcare says Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial,neutral,positive,1.0443864229765014,positive,-0.7872982548222018,neutral
2020-09-03 12:40:00.000,381.05,390.5,374.3,378.05,3456688.0,Cadila Health gains after USFDA nod for Midodrine Hydrochloride tablets,Cadila Healthcare rose 0.96% to Rs 385.60 after the company said it received final approval from the US drug regulator to market Midodrine Hydrochloride tablets in multiple strengths.,positive,positive,-0.7872982548222018,neutral,-3.329851136066858,negative
2020-09-09 05:30:00.000,363.0,371.8,360.0,371.25,3584284.0,BRIEF-Cadila Healthcare Gets Tentative U.S. FDA Nod For Empagliflozin And Linagliptin Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.272727272727273,positive,-2.785216925549004,negative
2020-09-09 14:23:00.000,373.4,374.95,360.4,363.0,5221855.0,Cadila Healthcare gets USFDA nod for diabetes drug,The drug major received tentative approval from the US drug regulator to market Empagliflozin and Linagliptin tablets in the strengths of 10 mg/5 mg and 25 mg/5 mg.,neutral,positive,-2.785216925549004,negative,1.6164383561643774,positive
2020-09-15 17:18:23.000,377.15,390.0,375.1,389.05,5042536.0,COVID-19 Vaccine Update: Centre says ‘excellent safety’ of 2 indigenous COVID candidate vaccines revealed during Phase-I trials,"Phase-I clinical trials have revealed “excellent safety” of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya…",positive,positive,3.155243271907738,positive,1.4010282776349583,positive
2020-09-15 22:45:00.000,377.15,390.0,375.1,389.05,5042536.0,"COVID-19 vaccine: 3 candidates under clinical trials, Serum Institute to begin Phase 3 study soon","COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR ch",neutral,neutral,3.155243271907738,positive,1.4010282776349583,positive
2020-09-18 05:30:00.000,395.05,423.0,395.05,409.0,19625028.0,BRIEF-Cadila Healthcare Gets Final U.S. FDA Nod For Potassium Chloride Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-18 11:37:00.000,395.05,423.0,395.05,409.0,19625028.0,Cadila Healthcare surges on USFDA nod for mineral supplement,Cadila Healthcare jumped 5.52% to Rs 415.95 after the company received US drug regulators final approval for Potassium Chloride extended-release tablets.,positive,positive,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-18 11:42:00.000,395.05,423.0,395.05,409.0,19625028.0,Cadila Healthcare in talks with RDIF to bring COVID-19 vaccine to India; shares hit 52-week high,"RDIF has agreed to supply 10 crore doses of the world’s first coronavirus vaccine to Dr Reddy’s Laboratories. However, it wanted to scale up the supply of the vaccine and hence started talks with at least four Indian drug makers, including that of Zydus Cadila.",positive,positive,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-18 12:19:00.000,395.05,423.0,395.05,409.0,19625028.0,Zydus Cadila gets American health regulator’s approval to market mineral supplement,"Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (1,500 mg), Zydus Cadila, part of Cadila Healthcare group.",neutral,positive,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-18 13:00:00.000,395.05,423.0,395.05,409.0,19625028.0,Zydus Cadila gets USFDA nod to market mineral supplement,"Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (1,500 mg), Zydus Cadila, part of Cadila Healthcare group, said in a BSE filing.",neutral,positive,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-18 13:51:14.000,395.05,423.0,395.05,409.0,19625028.0,Cadila Healthcare gains 6% on US FDA nod for mineral supplement,Zydus Cadila has received final approval from the US Food and Drug Administration to market Potassium Chloride extended-release tablets,positive,positive,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-18 18:48:41.000,395.05,423.0,395.05,409.0,19625028.0,Coronavirus vaccine: These seven companies have licence to manufacture Covid-19 vaccine in India; check list,"Among the listed entities which have been allowed by the CDSCO to manufacture the vaccines for limited use are Serum Institute of India, Cadila Healthcare, Bharat Biotech International Limited, Biological E Limited, Reliance Life Sciences Pvt Limited, Aurbindo Pharma Limited, and Gennova Biopharmace…",neutral,neutral,3.5311985824579137,positive,-4.565270041172188,negative
2020-09-21 13:31:03.000,397.9,398.5,381.25,392.9,4923147.0,"Cadila Healthcare Ltd spurts 0.48%, gains for fifth straight session","Cadila Healthcare Ltd is quoting at Rs 411.65, up 0.48% on the day as on 12:49 IST on the NSE. The stock is up 66.26% in last one year as compared to a 1.06% slide in NIFTY and a 54.25% slide in the Nifty Pharma.",positive,positive,-1.2565971349585323,negative,-3.3924050632911333,negative
2020-09-22 02:29:00.000,397.9,398.5,381.25,392.9,4923147.0,"CRISIL reaffirms rating on Cadila Healthcare’s Rs1,300cr commercial paper",CRISIL said instruments with this rating are considered to have a very strong degree of safety regarding timely payment of financial obligations.,neutral,positive,-1.2565971349585323,negative,-3.3924050632911333,negative
2020-09-23 14:36:00.000,381.75,383.8,374.15,375.25,3623769.0,Stock market update: Nifty Pharma index slips 2%; Cadila Healthcare down 3%,The index was trading 1.7 per cent down at 11674.8.,negative,negative,-1.7026850032743943,negative,1.6490765171503958,positive
2020-09-24 10:55:00.000,381.75,383.8,374.15,375.25,3623769.0,Zydus Cadila gets tentative USFDA nod to market anti-cancer drug,"Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.",positive,positive,-1.7026850032743943,negative,1.6490765171503958,positive
2020-09-25 05:30:00.000,379.0,389.1,375.5,385.25,3897214.0,BRIEF-Cadila Healthcare Gets Final U.S. FDA Nod For Dimethyl Fumarate Delayed-Release Capsules - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.6490765171503958,positive,0.2441531739912589,neutral
2020-09-25 10:33:00.000,379.0,389.1,375.5,385.25,3897214.0,Cadila Healthcare gets final approval for sclerosis drug,Cadila Healthcare rose 0.39% to Rs 377.50 after the company said it received US drug regulators final approval for Dimethyl Fumarate delayed-release capsules.,positive,positive,1.6490765171503958,positive,0.2441531739912589,neutral
2020-09-25 11:19:00.000,379.0,389.1,375.5,385.25,3897214.0,Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug,"Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed release capsules, (Tecfidera) in the strengths of 120 mg and 240 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing.",neutral,positive,1.6490765171503958,positive,0.2441531739912589,neutral
2020-09-25 11:22:00.000,379.0,389.1,375.5,385.25,3897214.0,Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drug,"Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed release capsules, (Tecfidera) in the strengths of 120 mg and 240 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing.",neutral,positive,1.6490765171503958,positive,0.2441531739912589,neutral
2020-10-05 13:16:19.000,417.55,423.45,412.4,415.8,6742579.0,Cadila Healthcare Ltd jumps 1.59%,"Cadila Healthcare Ltd is quoting at Rs 404.6, up 1.59% on the day as on 12:59 IST on the NSE. The stock is up 77.5% in last one year as compared to a 3.32% gain in NIFTY and a 65.63% gain in the Nifty Pharma index.",positive,positive,-0.4191114836546521,neutral,-0.5158968206358674,neutral
2020-10-06 09:00:00.000,417.55,423.45,412.4,415.8,6742579.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term","Mitessh Thakkar of mitesshthakkar.com suggests buying Cadila Healthcare with a stop loss of Rs 408, target at Rs 428 and Dabur India with a stop loss of Rs 509, target at Rs 545.",neutral,neutral,-0.4191114836546521,neutral,-0.5158968206358674,neutral
2020-10-08 10:30:00.000,415.0,438.7,414.2,435.35,11795037.0,Cadila Healthcare rises 4% on launch of pressurized Metered Dose Inhaler,Forglyn pMDI is priced at Rs 495 per pack and has been developed in-house using Zydus innovations in formulation technology,neutral,neutral,4.903614457831331,positive,-0.1146788990825688,neutral
2020-10-08 12:06:00.000,436.0,447.9,435.0,435.5,9833884.0,Cadila Healthcare spurts on new product launch,Cadila Healthcare jumped 4.32% to Rs 430.70 after the company announced the launch of Indias first pressurized metered dose inhaler for patients suffering from chronic obstructive pulmonary disease.,neutral,positive,-0.1146788990825688,neutral,0.0913242009132368,neutral
2020-10-09 08:59:00.000,436.0,447.9,435.0,435.5,9833884.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani for short term","Ashwani Gujral of ashwanigujral.com recommends buying Cadila Healthcare with a stop loss of Rs 430, target at Rs 456 and Biocon with a stop loss of Rs 460, target at Rs 485.",neutral,neutral,-0.1146788990825688,neutral,0.0913242009132368,neutral
2020-10-13 09:05:00.000,438.5,446.3,427.2,428.9,5004904.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani for short term","Sudarshan Sukhani of s2analytics.com suggests buying Cadila Healthcare with a stop loss of Rs 423, target at Rs 470 and HCL Tech with a stop loss of Rs 851, target at Rs 898.",neutral,neutral,-2.189281641961237,negative,-0.0116686114352418,neutral
2020-10-16 05:30:00.000,413.6,432.2,411.3,429.9,6962090.0,"BRIEF-Cadila Healthcare Ltd - Gets Final USFDA Approval For Fingolimod Capsules, Verapamil Hydrochloride Injection - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,3.941005802707919,positive,-3.188804771736632,negative
2020-10-16 11:29:00.000,413.6,432.2,411.3,429.9,6962090.0,"Cadila Healthcare gets USFDA nod for fingolimod capsules, verapamil hydrochloride injection",The group now has 305 approvals and has so far filed over 390 ANDAs since the commencement of the filing process in FY 2003-04.,neutral,neutral,3.941005802707919,positive,-3.188804771736632,negative
2020-10-16 13:45:00.000,413.6,432.2,411.3,429.9,6962090.0,Stock market update: Nifty Pharma index up over 1%; Cadila Healthcare rises 3%,The index was trading 1.39 per cent up at 11799.15.,positive,positive,3.941005802707919,positive,-3.188804771736632,negative
2020-10-16 18:45:00.000,413.6,432.2,411.3,429.9,6962090.0,Cadila Healthcare share rises 4% on USFDA nod to market Fingolimod capsules,Cadila Healthcare stock jumped nearly 4% today after Zydus Cadila Healthcare received final nod from the USFDA to market Fingolimod capsules. The share gained up to 3.99% to Rs 432.20 against previous close of Rs 415.60 on BSE.,positive,positive,3.941005802707919,positive,-3.188804771736632,negative
2020-10-19 08:02:00.000,435.9,435.9,419.8,422.0,3597138.0,"Stocks in the news | HDFC Bank, IIFL Securities, Route Mobile, HSIL, RIL, Shoppers Stop, SRF","Avenue Supermarts, Dr Reddy’s Labs, IndusInd Bank, Cadila Healthcare, Prestige Estates Projects, Sadbhav Infrastructure Project, Likhitha Infrastructure, Infosys, Suzlon Energy, NLC India are also among the stocks in focus today",neutral,neutral,-3.188804771736632,negative,1.9047619047619049,positive
2020-10-19 09:22:00.000,435.9,435.9,419.8,422.0,3597138.0,Cadila Healthcare receives USFDA final nod for ursodiol capsules,The drug maker received final approval from US drug regulator for ursodiol capsules and tentative approval for linagliptin and metformin hydrochloride tablets.,neutral,positive,-3.188804771736632,negative,1.9047619047619049,positive
2020-10-20 05:30:00.000,420.0,430.95,417.35,428.0,4538431.0,BRIEF-Cadila Healthcare Says Zydus Cadila Gets FDA’s Final Nod For Solifenacin Succinate Tablets - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.9047619047619049,positive,-0.7473143390938787,neutral
2020-10-20 10:37:00.000,420.0,430.95,417.35,428.0,4538431.0,Cadila Healthcare gains after final USFDA approval for solifenacin succinate tablets,Cadila Healthcare rose 0.37% to Rs 424.05 after the drug major received final approval from the US drug regulator to market solifenacin succinate tablets.,positive,positive,1.9047619047619049,positive,-0.7473143390938787,neutral
2020-10-20 11:21:00.000,420.0,430.95,417.35,428.0,4538431.0,Zydus Cadila gets USFDA nod for overactive bladder treatment drug,"The company has received final approval from the United States Food and Drug Administration (USFDA) to market Solifenacin Succinate tablets, in the strengths of 5 mg and 10 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.",neutral,positive,1.9047619047619049,positive,-0.7473143390938787,neutral
2020-10-23 08:07:00.000,428.0,434.65,423.05,423.4,4435147.0,"Stocks in the news | Nestle India, TCS, Bharti Infratel, Hexaware Tech, Tech Mahindra, Welspun","Pricol, Crompton Greaves Consumer Electricals, Duroply Industries, Foseco India, HDFC Asset Management Company, Gokaldas Exports, Cadila Healthcare, Munjal Auto Industries, Alembic Pharma, L&T Finance Holdings, Music Broadcast, Vishal Fabrics, Coforge, 3i Infotech, Cochin Shipyard, JK Tyre &…",neutral,neutral,-1.0747663551401925,negative,-1.6568742655699205,negative
2020-10-23 11:43:00.000,428.0,434.65,423.05,423.4,4435147.0,CRISIL reaffirms Cadila Healthcare rating at A1+; stock up over 1%,"The instrument of rating was on the Rs1,300cr Commercial Paper (enhanced from Rs250cr) of the company.",positive,neutral,-1.0747663551401925,negative,-1.6568742655699205,negative
2020-10-23 12:00:00.000,428.0,434.65,423.05,423.4,4435147.0,Cadila Healthcare share price rises 2% post USFDA approval,"The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.",positive,neutral,-1.0747663551401925,negative,-1.6568742655699205,negative
2020-10-28 05:30:00.000,425.0,427.8,416.9,417.8,2571320.0,"BRIEF-Cadila Healthcare Says Issued, Placed For Listing Commercial Papers Upto 6.25 Bln Rupees - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.694117647058821,negative,-0.7194244604316548,neutral
2020-11-02 05:30:00.000,418.0,423.45,404.0,405.55,2952156.0,BRIEF-India’s Cadila Healthcare Sept-Quarter Consol Net Profit Rises - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.9784688995215287,negative,3.571428571428571,positive
2020-11-02 08:00:00.000,418.0,423.45,404.0,405.55,2952156.0,"Companies and stocks to track today: November 2, 2020","Scrips likely to see action: Maruti Suzuki, Tata Motors, M&M, Eicher Motors, Hero MotoCorp, TVS Motor, Bajaj Auto, Equitas SFB, NTPC, Bandhan Bank, PNB, HDFC, Escorts, ZEEL, Cadila Healthcare, Grasim, Nxtdigital",neutral,neutral,-2.9784688995215287,negative,3.571428571428571,positive
2020-11-02 10:11:00.000,418.0,423.45,404.0,405.55,2952156.0,Cadila Healthcare Q2 net profit up 4-fold at Rs473.4cr,"Cadila Healthcare reported rise of 13.47% in top line sales for the Sep-20 quarter at Rs3,820cr.",positive,positive,-2.9784688995215287,negative,3.571428571428571,positive
2020-11-02 19:49:00.000,420.0,464.0,416.0,435.0,30129222.0,Cadila Healthcare Q2 net profit jumps over four-fold to Rs 473.4 crore,"The company had posted a net profit of Rs 107.2 crore for the corresponding period of the previous financial year, Cadila Healthcare said in a BSE filing.",positive,positive,3.571428571428571,positive,0.6980203684632135,neutral
2020-11-02 19:58:00.000,420.0,464.0,416.0,435.0,30129222.0,Cadila Healthcare Q2 results: Net profit jumps over four-fold to Rs 473.4 cr,"Consolidated total revenue from operations of the company stood at Rs 3,820 crore for the quarter under consideration. It was Rs 3,366.6 crore for the same period a year ago, it added.",positive,neutral,3.571428571428571,positive,0.6980203684632135,neutral
2020-11-03 09:35:00.000,420.0,464.0,416.0,435.0,30129222.0,Cadila Healthcare rallies 9% on strong September quarter results,"In Q2FY21, Cadilas Ebitda margins improved by 370 basis points at 22.6% against 18.9% in Q2FY20.",positive,positive,3.571428571428571,positive,0.6980203684632135,neutral
2020-11-03 09:59:00.000,420.0,464.0,416.0,435.0,30129222.0,Cadila Healthcare hits the roof after stellar Q2 performance,"Cadila Healthcare hit an upper circuit of 10% at Rs 451.15 after consolidated net profit soared 411% to Rs 423.60 crore on 16% jump in net sales to Rs 3,762.30 crore in Q2 September 2020 over Q2 September 2019.",neutral,positive,3.571428571428571,positive,0.6980203684632135,neutral
2020-11-03 11:04:03.000,420.0,464.0,416.0,435.0,30129222.0,Volumes jump at Cadila Healthcare Ltd counter,"Cadila Healthcare Ltd saw volume of 4.58 lakh shares by 10:54 IST on BSE, a 4.06 fold spurt over two-week average daily volume of 1.13 lakh shares",neutral,positive,3.571428571428571,positive,0.6980203684632135,neutral
2020-11-03 11:30:36.000,420.0,464.0,416.0,435.0,30129222.0,"Dolat Capital: Cadila Healthcare Posts In-Line Q2, Vaccine Data Key Monitorable","Dolat Capital: Cadila Healthcare Posts In- Line Q2, Vaccine Data Key Monitorable",neutral,neutral,3.571428571428571,positive,0.6980203684632135,neutral
2020-11-03 12:04:00.000,436.95,444.4,432.6,440.0,6331990.0,Cadila Healthcare shares hit 52-week high as Q2 profit jumps 4-fold,CLSA has maintained buy call on the stock and has raised target to Rs 540 from Rs 525 per share,positive,positive,0.6980203684632135,neutral,-0.9977578475336296,negative
2020-11-03 12:04:12.000,436.95,444.4,432.6,440.0,6331990.0,Jamna Auto Industries Ltd leads gainers in ‘A’ group,"Magma Fincorp Ltd, Cadila Healthcare Ltd, Prism Johnson Ltd and Amber Enterprises India Ltd are among the other gainers in the BSEs A group today, 03 November 2020.",positive,neutral,0.6980203684632135,neutral,-0.9977578475336296,negative
2020-11-03 13:08:00.000,436.95,444.4,432.6,440.0,6331990.0,Cadila Healthcare surges 10% on 4-fold jump in Q2 profit,"We remain positive on Cadila on account of robust launch momentum, build-up of a complex product pipeline including injectables and transdermals, and the completion of remediation at Moraiya, said Motilal Oswal Securities.",positive,positive,0.6980203684632135,neutral,-0.9977578475336296,negative
2020-11-03 16:34:00.000,436.95,444.4,432.6,440.0,6331990.0,Cadila Healthcare stock hits fresh 52-week high on four fold rise in Q2 profit,Share of Cadila Healthcare hit an yearly high of Rs 451 rising up to 10% against previous close of Rs 410.15 on BSE.,positive,positive,0.6980203684632135,neutral,-0.9977578475336296,negative
2020-11-04 08:16:00.000,436.95,444.4,432.6,440.0,6331990.0,"Trade Spotlight: Amber Enterprises, Cadila Healthcare and RBL Bank in focus","Stocks like Amber Enterprises rallied by about 6 percent, Cadila Healthcare gained more than 6 percent, and RBL Bank closed with gains of about 3 percent on Tuesday.",neutral,positive,0.6980203684632135,neutral,-0.9977578475336296,negative
2020-11-05 17:07:00.000,442.9,444.35,430.4,431.3,4198389.0,Buy Cadila Healthcare: target of Rs 530: Sharekhan,"Sharekhan is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 530 in its research report dated November 03, 2020.",neutral,positive,-2.6191013772860616,negative,0.3554230681036355,neutral
2020-11-06 08:44:39.000,442.9,444.35,430.4,431.3,4198389.0,Maintain ‘hold’ on Cadila Healthcare with TP at Rs 425,"Trials ongoing for Covid-19 vaccine and other Covid treatments, though financial benefits not clear at present Maintain Hold; raise TP to Rs 425 (from Rs 405). Key catalyst - regulatory approval for Covid-19 vaccine in India.",neutral,positive,-2.6191013772860616,negative,0.3554230681036355,neutral
2020-11-06 10:43:00.000,442.9,444.35,430.4,431.3,4198389.0,Slideshow | Brokerages raise target in these 12 stocks. Do you own any?,"DLF, ICICI Bank, Cadila Healthcare, HDFC are among 12 stocks whose target price was raised by brokerages.",positive,neutral,-2.6191013772860616,negative,0.3554230681036355,neutral
2020-11-06 16:45:00.000,442.9,444.35,430.4,431.3,4198389.0,Sell Cadila Healthcare; target of Rs 357: Prabhudas Lilladher,"Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 357 in its research report dated November 03, 2020.",neutral,positive,-2.6191013772860616,negative,0.3554230681036355,neutral
2020-11-12 11:47:00.000,418.4,435.4,413.85,427.0,9028307.0,Cadila Healthcare shares up 4% on completion of phase-II trial of COVID vaccine,"Based upon the results from its Phase 2 study, Zydus Cadila now plans to conduct a Phase 3 clinical trial in India.",positive,neutral,2.0554493307839445,positive,-0.455660708026636,neutral
2020-11-12 12:31:00.000,427.95,432.75,424.1,426.0,5429135.0,Cadila Healthcare gains on concluding Phase II trials of COVID-19 vaccine,"Cadila Healthcare rose 2.87% to Rs 428.10 after the drug major announced that it has successfully completed a Phase II clinical trial in CoVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, PegiHep.",positive,positive,-0.455660708026636,neutral,0.3271028037383124,neutral
2020-11-12 15:49:00.000,427.95,432.75,424.1,426.0,5429135.0,Cadila Healthcare completes phase-2 trial of Hepatitis C drug for Covid-19,"95% subjects in the test who received a single dose of PegiHepTM along with SOC became virus free as assessed by RT-PCR on day 14, compared to 68% of those who only received SOC",positive,neutral,-0.455660708026636,neutral,0.3271028037383124,neutral
2020-11-12 16:29:19.000,427.95,432.75,424.1,426.0,5429135.0,Cadila completes Phase-II trials of Covid-19 treatment therapy,"Cadila Healthcare Ltd on Thursday announced successful completion of the Phase-II clinical trial of its biological therapy Pegylated Interferon alpha-2b, ‘PegiHep’ on Covid-19 patients, paving the way",neutral,positive,-0.455660708026636,neutral,0.3271028037383124,neutral
2020-11-13 19:38:00.000,428.0,430.0,427.35,429.4,447126.0,"ICICI Bank, Infosys among top Diwali picks by HDFC Securities","HDFC Securities top Diwali picks for making investments comprise Bharti Airtel,Infosys,Cadila Healthcare,ICICI Bank,United Spirits,Gujarat Gas among others",neutral,neutral,0.3271028037383124,neutral,-0.3703703703703756,neutral
2020-11-27 09:34:00.000,439.0,459.0,432.2,448.25,19394212.0,Cadila Healthcare shares up 3% on plans to launch COVID-19 vaccine by March 2021,"Zydus Cadila said it will apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December, and expects to launch it by March 2021.",positive,positive,2.1070615034168565,positive,-1.1108690917011592,negative
2020-11-27 11:56:00.000,439.0,459.0,432.2,448.25,19394212.0,Cadila Healthcare advances 5% as drugmaker may introduce Covid vaccine by March,"Zydus has conducted phase-2 trials on 1,000 participants. Preliminary results show that it is safe as no safety concerns have been observed so far, people tracking the trials said. The indications are safe and the trial is under control, one of them said.",positive,neutral,2.1070615034168565,positive,-1.1108690917011592,negative
2020-11-27 12:42:00.000,439.0,459.0,432.2,448.25,19394212.0,Cadila Health spurts on buzz of likely vaccine launch by March 2021,Cadila Healthcare jumped 6.20% to Rs 448.55 after the media reported that the company is expected to introduce its Covid-19 vaccine by March next year.,neutral,positive,2.1070615034168565,positive,-1.1108690917011592,negative
2020-11-27 12:42:00.000,439.0,459.0,432.2,448.25,19394212.0,Cadila’s COVID-19 vaccine by March 2021? Share hits 52-week high,Cadila Healthcare share price touched a fresh 52 week high in early trade today after Zydus Cadila said it would apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December and plans to launch it by March 2021.,positive,positive,2.1070615034168565,positive,-1.1108690917011592,negative
2020-11-27 13:42:00.000,439.0,459.0,432.2,448.25,19394212.0,Stock market update: Pharma stocks advance; Cadila Healthcare leaps 6%,The Nifty Pharma index was trading 0.62 per cent up at 11873.9.,positive,positive,2.1070615034168565,positive,-1.1108690917011592,negative
2020-11-30 12:37:39.000,459.1,459.4,442.3,454.0,6866462.0,Modi Visits India Vaccine Makers as Astra Considers Fresh Trial,"Modi crisscrossed the country to meet officials at Cadila Healthcare, Bharat Biotech and the Serum Institute of India.",neutral,neutral,-1.1108690917011592,negative,-0.4966887417218543,neutral
2020-12-04 11:27:00.000,464.0,475.8,458.05,471.2,7383894.0,Cadila Healthcare rises after DCGI nods Phase 3 trial of Pegylated Interferon Alpha-2b,Cadila Healthcare rose 0.72% to Rs 466.15 after the company received approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India.,neutral,positive,1.551724137931032,positive,0.0211909302818441,neutral
2020-12-04 12:12:17.000,464.0,475.8,458.05,471.2,7383894.0,"D-Street Buzz: Over 200 stocks hit 52-week high on BSE; UltraTech, Airtel, ICICI Bank up 2-3%","UltraTech Cement, Hindalco Industries, Bharat Forge, Adani Ports, Motherson Sumi Systems, Voltas, Titan Company, Tech Mahindra, Cadila Healthcare, Mahindra & Mahindra and Maruti Suzuki are some of the major names that hit new 52-week high on BSE.",positive,neutral,1.551724137931032,positive,0.0211909302818441,neutral
2020-12-09 14:25:00.000,468.6,475.45,464.0,468.6,2900949.0,Cadila Health gains after USFDA grants fast track designation to Saroglitazar,Cadila Healthcare rose 1.14% to Rs 470.25 after the US drug regulator granted fast track designation to the company for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC).,positive,positive,0.0,neutral,-1.0510669922497056,negative
2020-12-09 17:58:37.000,468.6,475.45,464.0,468.6,2900949.0,Zydus gets ‘Fast Track Designation’ by USFDA for Saroglitazar,Pharma major Cadila Healthcare Limited on Wednesday announced that the company has received an approval from the US Food and Drug Administration (USFDA) for ‘Fast Track Designation’ to Saroglitazar,neutral,positive,0.0,neutral,-1.0510669922497056,negative
2020-12-24 17:33:00.000,477.8,491.7,470.0,490.0,5245995.0,Market Movers: Mrs Bectors shares double on debut; over 100 shares hit fresh 52-week high,"Some 39 stocks on the BSE flashed the ’buy signal on the MACD indicator during the day. They included Vedanta, Firstsource Solutions, NHPC, Reliance Industries, Cadila Healthcare, NIIT and Jubilant Life, among others.",positive,neutral,2.553369610715778,positive,-2.3365897874911807,negative
2020-12-24 22:15:47.000,477.8,491.7,470.0,490.0,5245995.0,"Zydus Cadila Plans To Test Its COVID-19 Vaccine On 30,000 Volunteers In Late Stage Trial",Cadila Healthcare said its vaccine was found to be well tolerated and immunogenic in the Phase I/II clinical trials.,neutral,positive,2.553369610715778,positive,-2.3365897874911807,negative
2020-12-28 07:25:32.000,496.45,499.25,484.0,484.85,6395238.0,"Stocks In The News | Cadila, Reliance Capital, Punjab & Sind Bank, Cadila Healthcare","Vedanta, NIIT, Spandana Sphoorty Financial, Kellton Tech, Paisalo Digital, Sakthi Sugars, Engineers India, Fiem Industries, are also among the stocks in focus today.",neutral,neutral,-2.3365897874911807,negative,-1.885245901639342,negative
2021-01-04 09:35:32.000,494.0,494.0,479.1,486.2,6126568.0,Cadila Healthcare Shares Rise 3% On DCGI Nod To Phase III Clinical Trials Of COVID-19 Vaccine,"In Phase II, the vaccine ZyCoV-D was found to be safe and elicited a strong immunogenic response.",neutral,positive,-1.5789473684210549,negative,0.4028925619834687,neutral
2021-01-04 10:27:00.000,494.0,494.0,479.1,486.2,6126568.0,Cadila Healthcare gains 3% as DCGI plays phase III trials of Covid vaccine,"The company will now be initiating Phase III clinical trials in around 30,000 volunteers.",positive,neutral,-1.5789473684210549,negative,0.4028925619834687,neutral
2021-01-04 12:45:00.000,484.0,489.5,480.25,485.95,2205779.0,Cadila Healthcare share rises 3% on DCGI nod to Phase III trial of COVID-19 vaccine,Cadila Healthcare share rose over 3% today after regulator Drugs Controller General of India (DCGI) gave its nod to Phase III clinical trials of the Ahmedabad-based company’s Covid-19 vaccine ZyCoV-D. Csdila Healthcare share touched an intraday high of R,positive,positive,0.4028925619834687,neutral,-0.9259259259259258,negative
2021-01-08 11:33:48.000,485.0,489.4,483.5,484.8,2206343.0,"D-Street Buzz: Pharma Stocks Gain Led By Sun Pharma, Biocon; CLSA Picks DRL, Downgrades Aurobindo Pharma","CLSA has a buy on Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs and has a sell on Biocon and Lupin. The research firm has downgraded Aurobindo Pharma to underperform from outperform.",neutral,positive,-0.0412371134020595,neutral,1.2114989733059502,positive
2021-01-08 12:26:47.000,485.0,489.4,483.5,484.8,2206343.0,Will take Covid vaccine if PM Modi takes first shot: RJD’s Tej Pratap Yadav,"India has given approval to three vaccines — Covishield developed by AstraZeneca in partnership with India-based Serum Institute, Covaxin by Bharat Biotech and Virus-2019-nCov-Vaccine by Cadila Healthcare.",neutral,positive,-0.0412371134020595,neutral,1.2114989733059502,positive
2021-01-11 13:31:26.000,496.0,497.25,489.45,490.8,2521310.0,Cadila Healthcare Ltd in demand,"Cadila Healthcare Ltd is quoting at Rs 493.15, up 1.65% on the day as on 12:49 IST on the NSE. The stock is up 92.22% in last one year as compared to a 17.09% spurt in NIFTY and a 65.52% spurt in the Nifty Pharma index.",neutral,positive,-1.0483870967741913,negative,-1.2170385395537524,negative
2021-01-12 22:24:14.000,493.0,494.5,481.65,487.0,2732444.0,COVID-19 Vaccine | India’s Cadila To Develop 100-150 Million Doses Of ZyCoV-D By 2021-end,"Cadila Healthcare, in a statement issued on January 12, reiterated that its vaccine candidate - ZyCoV-D - has demonstrated promising results in the first and second phase of clinical trials.",neutral,positive,-1.2170385395537524,negative,3.6344969199178623,positive
2021-01-18 22:52:40.000,474.1,487.0,474.1,485.0,2103100.0,Cadila Healthcare Q3 PAT Seen Up 37.6% YoY To Rs. 373.9 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher.",neutral,positive,2.299093018350554,positive,0.4136504653567736,neutral
2021-01-25 07:29:19.000,465.35,473.65,455.5,469.0,3531378.0,"Stocks In The News | RIL, Yes Bank, Tata Motors, Oberoi Realty, Gland Pharma, JM Financial, IIFL Finance","Birla Corp, UltraTech Cement, Supreme Industries, Mahindra Lifespace, Piramal Enterprises, Grasim Industries, Crompton Greaves Consumer, Yes Bank, JSW Steel, Polycab India, Cadila Healthcare, Tata Power, HDFC Life Insurance are also among the stocks in focus today.",neutral,neutral,0.7843558611797523,neutral,-1.677888212033776,negative
2021-01-25 17:01:12.000,465.35,473.65,455.5,469.0,3531378.0,Buy Cadila Healthcare; Target Of Rs 655: Emkay Global Financial,"Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report dated January 22, 2021.",neutral,positive,0.7843558611797523,neutral,-1.677888212033776,negative
2021-01-28 11:04:00.000,457.0,466.6,452.25,461.8,2581437.0,Cadila Healthcare rises after USFDA grants orphan drug designation for Saroglitazar Mg,Cadila Healthcare rose 0.69% to Rs 465.40 after the company was granted orphan drug designation by the US drug regulator for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC).,neutral,positive,1.0503282275711183,positive,-2.487562189054726,negative
2021-02-04 11:16:00.000,482.0,482.4,475.25,478.65,3853248.0,Cadila Health announces completion of phase-I trials of malaria drug,Cadila Healthcare announced that its antimalarial compound ZY19489 (MMV253) in development with Swiss-based product development partnership Medicines for Malaria Venture (MMV) has now completed Phase I clinical evaluation.,neutral,positive,-0.6950207468879716,neutral,-1.5958549222797904,negative
2021-02-05 09:31:00.000,482.5,488.95,471.85,474.8,8262149.0,Cadila Healthcare Q3 PAT grows 41% to Rs527cr on better operating metrics,"Cadila Healthcare reported 4.33% growth in gross revenues for the Dec-20 quarter on consolidated basis at Rs3,796cr",positive,positive,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-05 13:16:26.000,482.5,488.95,471.85,474.8,8262149.0,Cadila Healthcare Ltd sees sustained buying,"Cadila Healthcare Ltd is quoting at Rs 486.2, up 1.46% on the day as on 12:44 IST on the NSE. The stock is up 78.03% in last one year as compared to a 23.2% gain in NIFTY and a 57.09% gain in the Nifty Pharma.",positive,positive,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-05 14:02:00.000,482.5,488.95,471.85,474.8,8262149.0,Cadila Healthcare Q3 PAT jumps 41% YoY,"Cadila Healthcare reported 41% rise in consolidated net profit to Rs 527.2 crore on a 6.2% rise in net sales to Rs 3,753.70 crore in Q3 FY21 over Q3 FY20.",neutral,positive,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-05 14:58:00.000,482.5,488.95,471.85,474.8,8262149.0,Cadila Healthcare consolidated net profit rises 41.00% in the December 2020 quarter,Sales rise 6.20% to Rs 3753.70 crore,positive,positive,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-05 15:40:22.000,482.5,488.95,471.85,474.8,8262149.0,Cadila Healthcare Q3 Net Profit Up 41% To Rs 527 Crore,"The company had posted a net profit of Rs 373.9 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to BSE.",neutral,positive,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-05 16:02:00.000,482.5,488.95,471.85,474.8,8262149.0,Cadila Healthcare Q3 results: Net profit up 41% to Rs 527 crore,"The company had posted a net profit of Rs 373.9 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a filing to BSE.",positive,positive,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-05 21:41:25.000,482.5,488.95,471.85,474.8,8262149.0,Cadila standalone Q3 net falls 35% to ₹140 crore,"Cadila Healthcare Ltd on Friday reported a standalone net profit of ₹140 crore for the quarter ended December 2020, down 34.6 per cent against ₹214 crore in the previous-year period. Its standal",neutral,negative,-1.5958549222797904,negative,-0.8786610878661064,neutral
2021-02-10 15:30:04.000,468.0,472.35,464.05,470.75,2200740.0,Buy Cadila Healthcare; Target Of Rs 555: ICICI Direct,"ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated February 06, 2021.",neutral,positive,0.5876068376068376,neutral,-0.5833068193869976,neutral
2021-02-10 19:24:47.000,468.0,472.35,464.05,470.75,2200740.0,Cadila Healthcare: Give ‘buy’ rating with TP of Rs 481,"The q-q decline was owing to inventory correction for some of the products, according to the management",positive,negative,0.5876068376068376,neutral,-0.5833068193869976,neutral
2021-02-12 16:04:46.000,471.45,479.0,466.6,468.7,3025867.0,Buy Cadila Healthcare; Target Of Rs 550: Motilal Oswal,"Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 550 in its research report dated February 06, 2021.",neutral,positive,-0.5833068193869976,neutral,-0.1927607624759,neutral
2021-02-19 11:39:50.000,466.3,466.3,447.05,451.6,3278788.0,Cadila Healthcare Stock Trades Lower Even After USFDA Nod For Blood Pressure Drug,The drug will be manufactured at the group’s formulation facility in Ahmedabad.,neutral,neutral,-3.15247694617199,negative,-3.655555555555553,negative
2021-02-19 11:42:00.000,466.3,466.3,447.05,451.6,3278788.0,Cadila Healthcare gets USFDA nod for droxidopa capsules,"The drug maker has received final approval from the drug regulatory body, United States Food & Drug Administration (USFDA) to market droxidopa capsules, 100 mg, 200 mg, and 300 mg (US RLD: Northera Capsules).",neutral,positive,-3.15247694617199,negative,-3.655555555555553,negative
2021-02-25 07:23:16.000,441.0,444.4,436.15,438.8,3126396.0,"Stocks To Watch: Axis Bank, Cadila Healthcare, Indiabulls Real Estate, Maruti Suzuki, Max Financial",Here are the stocks to watch in trade today...,neutral,neutral,-0.4988662131519248,neutral,0.0690925840626465,neutral
2021-02-25 07:30:59.000,441.0,444.4,436.15,438.8,3126396.0,"Stocks In The News | Affle India, PNB Gilts, Dredging Corporation Of India, Monte Carlo Fashions","Cadila Healthcare, Nureca, Piramal Enterprises, Ladderup Finance, Ashapura Minechem, Dollar Industries, IRB Infrastructure Developers, are also among the stocks in focus today.",neutral,neutral,-0.4988662131519248,neutral,0.0690925840626465,neutral
2021-02-25 09:20:00.000,441.0,444.4,436.15,438.8,3126396.0,Cadila Healthcare gains as unit acquires experimental drug from Cyprium,Cadila Healthcare rose 1.12% to Rs 438.75 after the pharmaceutical company said that its US subsidiary has acquired experimental drug from Cyprium for treating Menkes disease.,positive,positive,-0.4988662131519248,neutral,0.0690925840626465,neutral
2021-02-25 12:30:09.000,434.2,443.8,430.1,434.5,3233531.0,Cadila Healthcare Share Price Gains Over 2% On USFDA Final Approval,"The share touched its 52-week high of Rs 509.35 on January 15, 2021 and a 52-week low of Rs 212.70 on March 13, 2020.",neutral,negative,0.0690925840626465,neutral,-0.2974828375286067,neutral
2021-02-25 13:15:00.000,434.2,443.8,430.1,434.5,3233531.0,Cadila Healthcare rises after USFDA nod for anti-depressant drug,"Cadila Healthcare gained 1.97% to Rs 442.45 after the drug maker said it received a final approval from the US drug regulator to market nortriptyline hydrochloride capsules 10 mg, 25 mg, 50 mg and 75 mg.",neutral,positive,0.0690925840626465,neutral,-0.2974828375286067,neutral
2021-02-25 13:22:57.000,434.2,443.8,430.1,434.5,3233531.0,Zydus Cadila Gets USFDA Nod For Antidepressant Drug,"Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in strengths of 10 mg, 25 mg, 50 mg and 75 mg, Cadila Healthcare said in a regulatory filing.",neutral,positive,0.0690925840626465,neutral,-0.2974828375286067,neutral
2021-02-25 15:56:00.000,434.2,443.8,430.1,434.5,3233531.0,Zydus Cadila | USFDA: Zydus Cadila gets USFDA nod for antidepressant drug,"Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in strengths of 10 mg, 25 mg, 50 mg and 75 mg, Cadila Healthcare said in a regulatory filing.",neutral,positive,0.0690925840626465,neutral,-0.2974828375286067,neutral
2021-02-26 05:30:00.000,434.2,443.8,430.1,434.5,3233531.0,Why Brokerages Feel Cadila Healthcare Will Move Up 28%,Why Brokerages Feel Cadila Healthcare Will Move Up 28%,neutral,neutral,0.0690925840626465,neutral,-0.2974828375286067,neutral
2021-02-26 09:24:52.000,434.2,443.8,430.1,434.5,3233531.0,"RailTel Corp of India, Bank of Baroda, Cadila Healthcare: Top Stocks for Investors Today","The stock market on Thursday, February 25 closed in the green for the third consecutive day where the Bombay Stock Exchange (BSE) reclaimed the 51,000 mark while the Nifty50 jumped to the 15,000 mark.",neutral,positive,0.0690925840626465,neutral,-0.2974828375286067,neutral
2021-03-09 07:37:00.000,453.0,453.2,441.55,443.0,1934513.0,"Stocks in the news: BPCL, Tata Motors, Cadila Healthcare, Max Financial & Godrej Properties",Zydus Cadila is likely to release the phase III data of its Covid-19 vaccine by the end of this month or early next month.,neutral,neutral,-2.207505518763797,negative,0.6853932584269689,neutral
2021-03-22 06:54:19.000,427.55,438.0,425.75,430.6,2027926.0,"Hot Stocks | BPCL, Cadila Healthcare, Axis Bank Three Trading Ideas For Short Term","On the higher side, 14,875–15,050 are the levels to watch out for, while on the lower side, 14,450-14,350 is a key support. zone.",neutral,neutral,0.7133668576774672,neutral,-0.3230272265805208,neutral
2021-03-24 05:30:00.000,430.0,436.45,426.0,427.0,2143880.0,BRIEF-India’s Cadila Healthcare Says Remdesivir Now Priced At 899 Rupees,BRIEF-India’s Cadila Healthcare Says Remdesivir Now Priced At 899 Rupees,neutral,neutral,-0.6976744186046512,neutral,-1.8604651162790695,negative
2021-03-24 11:34:00.000,430.0,436.45,426.0,427.0,2143880.0,Cadila Healthcare announces settlement of patent litigation for generic Revlimid in US,"Cadila Healthcare and its subsidiary Zydus Pharmaceuticals (USA) Inc. have reached an agreement with Celgene Corporation (Celgene), a wholly owned subsidiary of Bristol Myers Squibb relating to patents for Revlimid (lenalidomide).",neutral,positive,-0.6976744186046512,neutral,-1.8604651162790695,negative
2021-03-24 18:56:00.000,430.0,431.6,417.6,422.0,2099742.0,Cadila Healthcare share rises over 1% after subsidiary announces settlement of patent litigation in US,Share of Cadila Healthcare rose up to 1.15% to Rs 436.05 against previous close of Rs 431.05 on BSE,positive,positive,-1.8604651162790695,negative,-0.7092198581560284,neutral
2021-03-24 19:08:11.000,430.0,431.6,417.6,422.0,2099742.0,"Cadila Healthcare, U.S. Arm Reach Patent Litigation Settlement For Revlimid",Cadila Healthcare along with its arm Zydus Pharmaceuticals has reached settlement of patent litigation with Celgene Corporation.,neutral,positive,-1.8604651162790695,negative,-0.7092198581560284,neutral
2021-03-25 05:30:00.000,430.0,431.6,417.6,422.0,2099742.0,BRIEF-Cadila Healthcare Subscribes To Partnership Interest In ABCD Technologies,BRIEF-Cadila Healthcare Subscribes To Partnership Interest In ABCD Technologies,neutral,neutral,-1.8604651162790695,negative,-0.7092198581560284,neutral
2021-03-25 07:12:29.000,430.0,431.6,417.6,422.0,2099742.0,"Stocks to Watch: Bank of India, TVS Motors, Cadila Healthcare, Adani Group","Adani Road Transport Ltd (ARTL) on Wednesday said it has won a ₹1,039.90 crore highway project from NHAI in Telangana",neutral,positive,-1.8604651162790695,negative,-0.7092198581560284,neutral
2021-03-25 09:34:00.000,430.0,431.6,417.6,422.0,2099742.0,"Buy Cadila Healthcare, target price Rs 550: Motilal Oswal","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 44118.12 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.8604651162790695,negative,-0.7092198581560284,neutral
2021-03-25 10:21:47.000,430.0,431.6,417.6,422.0,2099742.0,Cadila Healthcare - Revlimid Settlement Enhances Business Visibility: Motilal Oswal,Cadila Healthcare - Revlimid Settlement Enhances Business Visibility: Motilal Oswal,neutral,neutral,-1.8604651162790695,negative,-0.7092198581560284,neutral
2021-03-25 13:11:00.000,423.0,424.65,415.2,420.0,2215953.0,Cadila Healthcare gets tentative USFDA nod for antiretroviral medication,The drug maker on Thursday announced that it has received tentative approval from the US drug regulator for emtricitabine and tenofovir disoproxil fumarate tablets.,neutral,positive,-0.7092198581560284,neutral,2.5943396226415096,positive
2021-03-25 14:41:30.000,423.0,424.65,415.2,420.0,2215953.0,Buy Cadila Healthcare; Target Of Rs 655: Emkay Global Financial,"Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report dated March 24, 2021.",neutral,positive,-0.7092198581560284,neutral,2.5943396226415096,positive
2021-03-30 21:29:51.000,435.1,447.2,432.85,440.6,2729209.0,"Motilal Oswal maintains ‘Buy’ rating on Cadila Healthcare, revised TP Rs 550",Expects a 19% earnings CAGR over FY20–23,neutral,neutral,1.2640772236267523,positive,-0.6741573033707865,neutral
2021-04-05 08:35:02.000,444.8,449.0,434.45,441.0,2931487.0,Cadila Healthcare Seeks Regulatory Approval For COVID-19 Drug,"Indian drugmaker Cadila Healthcare Ltd said on Monday it would seek local regulatory approval to treat COVID-19 patients with an already approved Hepatitis C drug, following promising interim results from a late-stage trial.",neutral,positive,-0.8543165467625924,neutral,3.748447555605728,positive
2021-04-05 09:23:00.000,444.8,449.0,434.45,441.0,2931487.0,Cadila seeks regulatory approval for COVID-19 drug,Indian drugmaker Cadila Healthcare Ltd said on Monday it would seek local regulatory approval to treat COVID-19 patients.,positive,positive,-0.8543165467625924,neutral,3.748447555605728,positive
2021-04-05 09:26:00.000,444.8,449.0,434.45,441.0,2931487.0,Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India,"India’s Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.",neutral,positive,-0.8543165467625924,neutral,3.748447555605728,positive
2021-04-05 10:53:03.000,444.8,449.0,434.45,441.0,2931487.0,Cadila Healthcare seeks regulatory approval for Covid-19 drug,"A single dose repurposed drug, when taken early, could help Covid patients recover faster and avoid complications seen in the advanced stages of the disease.",positive,positive,-0.8543165467625924,neutral,3.748447555605728,positive
2021-04-06 11:55:35.000,442.85,459.75,440.8,459.45,3669742.0,"Cadila Healthcare: Street eyeing new covid drug approval, vaccine launch","India sales remain strong, with domestic formulations marking a strong 21% year-on-year growth, helped by speciality business and covid portfolio during Q3",neutral,positive,3.748447555605728,positive,0.2282112584220722,neutral
2021-04-07 07:48:53.000,460.1,464.7,454.15,461.15,3258159.0,"Hot Stocks | Can Bet On Divi’s Laboratories, Cadila Healthcare, IG Petrochemicals For Short Term","The next higher levels to be watched are around 14,800-14,900 for Nifty. Any pullback towards 14,600-14,500 should be used as a buying opportunity.",neutral,positive,0.2282112584220722,neutral,1.3012151844284356,positive
2021-04-08 10:01:02.000,464.95,475.8,462.5,471.0,3464427.0,"Cadila Healthcare Share Price Up On USFDA Approvals For Cancer, BP Drugs",Zydus Cadila has received final approvals from the USFDA to market Ibrutinib capsules and Macitentan tablets.,neutral,positive,1.3012151844284356,positive,9.704417840872976,positive
2021-04-08 11:25:00.000,464.95,475.8,462.5,471.0,3464427.0,"Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug","Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.",neutral,positive,1.3012151844284356,positive,9.704417840872976,positive
2021-04-08 13:21:51.000,471.95,517.75,471.8,517.75,22854006.0,"Zydus Cadila Gets USFDA Nod For Cancer And High Blood Pressure, Treatment Drug","Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.",neutral,positive,9.704417840872976,positive,-2.423949782713667,negative
2021-04-12 10:45:41.000,517.75,532.0,494.35,505.2,26744294.0,"Sensex down 1400 points: Rising COVID-19 cases work in favour Sun Pharma, Cadila Healthcare, Fortis Healthcare, Vimta Labs, Solara Active Pharma stocks","The rising COVID-19 cases in the country pulled the equity benchmark Sensex by over 1,400 points in early trade on Monday. While heavyweights are struggling due to this, COVID-19 has worked in the favour of pharmaceuticals and healthcare companies share price. At 10.12 am, Cadila Healthc…",neutral,neutral,-2.423949782713667,negative,-3.90625,negative
2021-04-12 13:04:10.000,512.0,513.3,478.55,492.0,9388092.0,"Cadila Healthcare Ltd spurts 0.76%, rises for fifth straight session","Cadila Healthcare Ltd is quoting at Rs 518.35, up 0.76% on the day as on 12:49 IST on the NSE. The stock is up 46.53% in last one year as compared to a 59.48% jump in NIFTY and a 44.89% jump in the Nifty Pharma.",positive,positive,-3.90625,negative,2.0305081321345613,positive
2021-04-13 16:54:00.000,512.0,513.3,478.55,492.0,9388092.0,"Nifty Pharma shed 1% amid rising COVID cases; Heavyweights Cadila, Dr Reddys, Lupin drag","Cadila Healthcare was the biggest laggard at Rs482.55 per piece lower by 3.43%, while Dr Reddy’s was 3.14% down dragged the sector most",negative,negative,-3.90625,negative,2.0305081321345613,positive
2021-04-14 00:39:44.000,494.95,513.0,486.2,505.0,12900807.0,Appetite increases for pharma stocks,"Stocks of Dr Reddy’s, Cipla and Cadila Healthcare have already gained 10-14% this month so far",positive,positive,2.0305081321345613,positive,3.4845949404468923,positive
2021-04-16 09:39:10.000,507.95,530.0,500.35,525.65,15412655.0,Weekly Tactical Pick | Cadila Healthcare,Covid opportunity and a traction in complex pharma pipeline are big positives for Cadila,neutral,positive,3.4845949404468923,positive,-1.542056074766355,negative
2021-04-22 00:01:00.000,563.9,573.0,541.6,552.05,19170318.0,"Cadila Healthcare testing two-shot regimen for ZyCoV-D, data likely by May","The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg",neutral,neutral,-2.101436424898036,negative,3.847193440850511,positive
2021-04-22 07:45:22.000,563.9,573.0,541.6,552.05,19170318.0,"Trade Spotlight: What Should Investors Do With Apollo Hospitals, Cadila Healthcare & Max Healthcare?","Stocks like Apollo Hospitals rose over 4 percent, Cadila Healthcare rallied over 5 percent, and Max Healthcare witnessed profit booking after hitting a fresh 52-week high on Tuesday.",neutral,positive,-2.101436424898036,negative,3.847193440850511,positive
2021-04-22 10:38:37.000,563.9,573.0,541.6,552.05,19170318.0,"D-Street Buzz: Pharma Stocks Edge Higher As Virus Cases Continue To Surge; Cadila Health, Apollo Hospitals Hit New 52-week High","The share price of JB Chemical and Pharmaceuticals was up over 4 percent, hitting new 52-week high on BSE followed by Morepen Labs, Panacea Biotec, Vivimed Labs, Neuland Labs, Laurus Labs, Cadila Healthcare and Apollo Hospitals.",neutral,positive,-2.101436424898036,negative,3.847193440850511,positive
2021-04-22 13:17:02.000,554.95,577.35,540.0,576.3,27182120.0,Cadila Healthcare Ltd rises for fifth straight session,"Cadila Healthcare Ltd is quoting at Rs 562.8, up 1.18% on the day as on 12:49 IST on the NSE. The stock is up 69.8% in last one year as compared to a 53.8% jump in NIFTY and a 43.83% jump in the Nifty Pharma.",positive,positive,3.847193440850511,positive,-5.950413223140496,negative
2021-04-23 09:17:00.000,554.95,577.35,540.0,576.3,27182120.0,Cadila gets USFDA nod for Anti-Arrhythmic Drug,Cadila Healthcare on Friday announced that it has received final approval from the USFDA to market Propafenone Hydrochloride extended release capsules.,neutral,positive,3.847193440850511,positive,-5.950413223140496,negative
2021-04-23 11:41:32.000,554.95,577.35,540.0,576.3,27182120.0,Zydus Cadila gets USFDA approval to market anti-arrhythmic drug,"Pharmaceutical company Zydus Cadila, part of Cadila Healthcare Group on Friday said it has received final approval from the US health regulator to market anti-arrhythmic drug.Propafenone is known as an anti-arrhythmic drug. It works by blocking the activity of certain electrical signals in…",positive,positive,3.847193440850511,positive,-5.950413223140496,negative
2021-04-23 14:59:00.000,554.95,577.35,540.0,576.3,27182120.0,Cadila Health gains after DGCI approves Virafin for moderate COVID-19 cases,"Cadila Healthcare added 2.87% to Rs 568.10 after the company received emergency use approval from India’s drug regulator for the use of Pegylated Interferon alpha-2b, ‘Virafin’ in treating moderate COVID-19 infection in adults.",positive,neutral,3.847193440850511,positive,-5.950413223140496,negative
2021-04-23 15:22:06.000,554.95,577.35,540.0,576.3,27182120.0,Cadila Healthcare Shares Climb 4% On Receiving DCGI Approval For A COVID-19 Drug,"Cadila said in its Phase III clinical trials, the therapy had shown better clinical improvement in the patients suffering from COVID-19.",neutral,positive,3.847193440850511,positive,-5.950413223140496,negative
2021-04-23 16:41:51.000,554.95,577.35,540.0,576.3,27182120.0,Cadila Healthcare’s Drug Gets Approval For Covid-19 Treatment,The company’s drug has received restricted emergency use approval for treating moderate Covid-19 infection in adults.,neutral,negative,3.847193440850511,positive,-5.950413223140496,negative
2021-04-23 22:53:00.000,554.95,577.35,540.0,576.3,27182120.0,Cadila Healthcare’s Hepatitis C drug gets approval for emergency use,Approval from the drug regulator follows late-stage study of the medicine,positive,neutral,3.847193440850511,positive,-5.950413223140496,negative
2021-04-25 19:22:49.000,605.0,605.0,565.1,569.0,31912116.0,Movers and Shakers: Stocks that will see action this week,"Cadila Healthcare (₹570.9)Hits new all-time highThe stock of Cadila Healthcare, which had been moving down gradually since the beginning of the year, found support at ₹420 by the end of March. The 200",neutral,negative,-5.950413223140496,negative,-0.7936507936507936,neutral
2021-04-26 10:22:39.000,605.0,605.0,565.1,569.0,31912116.0,Cadila Healthcare - ‘Virafin’ Approval Bodes Well To Tackle Rising Covid-19 Cases: Motilal Oswal,Cadila Healthcare - ‘Virafin’ Approval Bodes Well To Tackle Rising Covid-19 Cases: Motilal Oswal,neutral,neutral,-5.950413223140496,negative,-0.7936507936507936,neutral
2021-04-30 10:54:53.000,559.8,578.85,558.1,570.7,9758164.0,COVID Impact On May Series! Traders Should Refrain From Carrying Long Positions,"We witnessed a good amount of long rollovers seen in Dr. Lal Path Lab, Navin Fluorine, Pfizer, Cadila Healthcare, Bajaj Finserv, SRF, National Aluminium, Glenmark, Tata Steel, Deepak Nitrate, Hindalco, Aarti Inds, etc., says Purohit.",neutral,neutral,1.9471239728474616,positive,1.5740499173841125,positive
2021-04-30 17:39:41.000,559.8,578.85,558.1,570.7,9758164.0,"After Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma, now Ipca Laboratories invests Rs 25 crore in ABCD Technologies","Mumbai-based pharmaceuticals company Ipca Laboratories will complete the purchase of 4.03 per cent stake by April 30, 2021 in ABCD Technologies LLP (which will be renamed as IndoHealth Services LLP), stated the pharma company in its filing. The pharma company will be investing Rs 25 crore in ABCD…",neutral,neutral,1.9471239728474616,positive,1.5740499173841125,positive
2021-05-05 14:31:00.000,607.95,610.85,592.65,601.75,11480835.0,Cadila extends tenure of joint venture with Bayer Pte,Drug firm Cadila Healthcare on Wednesday said it has inked a pact to extend the tenure of a joint venture with Bayer Pte ltd for two months to explore possibilities of further collaboration.,positive,positive,-1.0198207089398872,negative,0.0248406061107853,neutral
2021-05-06 15:20:00.000,603.85,611.9,599.0,604.0,7976225.0,Cadila Healthcare extends tenure of JVA with Bayer PTE for two months,The purpose of entering into the JVA is for carrying on business of marketing of pharmaceutical products.,positive,neutral,0.0248406061107853,neutral,2.469439658708664,positive
2021-05-09 10:22:05.000,609.45,630.0,606.0,624.5,17609663.0,India’s Cadila Healthcare Eyes Nod for Covid Vaccine By June: FE,"Cadila Healthcare plans to submit trial data for its Covid-19 vaccine by end of May, reports Financial Express.",neutral,neutral,2.469439658708664,positive,0.7420410117290318,neutral
2021-05-10 11:26:26.000,609.45,630.0,606.0,624.5,17609663.0,"D-Street Buzz: Pharma Stocks Rise Led By Dr Reddy’s Labs, Cadila Health; Glenmark Hits New 52-week High","Torrent Pharma and Alkem Labs jumped over 5 percent each followed by Dr Reddy’s Labs, Cadila Healthcare, Divis Labs and Sun Pharma which added 2-3 percent each.",neutral,positive,2.469439658708664,positive,0.7420410117290318,neutral
2021-05-11 15:53:00.000,634.95,673.7,632.5,649.2,29731970.0,Largecap-focussed PMSes lagged in April; midcap specialists fared better,"Kotak AMC Pharma Fund finished as the top performer of the month, returning 13.39 per cent. Sun Pharma, Dr Reddys Labs, Cipla, Cadila Healthcare and Aurobindo Pharma were the top five holdings in its portfolio.",positive,positive,2.2442712024568863,positive,-5.93607305936073,negative
2021-05-12 05:30:00.000,634.95,673.7,632.5,649.2,29731970.0,BRIEF-Cadila Healthcare Unit To Sell Animal Healthcare Established Markets Undertaking,BRIEF-Cadila Healthcare Unit To Sell Animal Healthcare Established Markets Undertaking,neutral,neutral,2.2442712024568863,positive,-5.93607305936073,negative
2021-05-12 11:37:00.000,634.95,673.7,632.5,649.2,29731970.0,Cadila Health gains on selling India-focused animal health biz,Cadila Healthcare rose 2.60% to Rs 646.10 after the company’s subsidiary announced plans to sell its India focused animal health business to Multiples Alternate Asset Management led consortium.,positive,positive,2.2442712024568863,positive,-5.93607305936073,negative
2021-05-12 16:55:00.000,634.95,673.7,632.5,649.2,29731970.0,"Nifty Pharma holds steady amid fragile markets; Cadila, Torrent Pharma, Lupin lift the performance",Cadila Healthcare was the top bull surging by 3.5% at Rs651.80 per piece.,positive,positive,2.2442712024568863,positive,-5.93607305936073,negative
2021-05-12 18:06:00.000,634.95,673.7,632.5,649.2,29731970.0,Cadila Healthcare share hits 52-week high as firm to sell animal health business,"The consortium, including Canada Pension Plan Investment Board and Rakesh Jhunjhunwala-backed RARE Enterprises, has agreed to purchase the Undertaking through an SPV controlled by them, in the name of Zenex Animal Health India Private Limited for Rs 2,921 crore",positive,neutral,2.2442712024568863,positive,-5.93607305936073,negative
2021-05-12 22:00:52.000,634.95,673.7,632.5,649.2,29731970.0,"Cadila Healthcare arm to sell animal health business for Rs 2,921 crore to CPPIB, Rakesh Jhunjhunwala’s RARE Enterprises","Cadila Healthcare on Wednesday said its wholly-owned subsidiary Zydus Animal Health and Investment has entered into definitive pacts for sale of its animal healthcare established markets undertaking to Multiples Alternate Asset Management-led consortium for Rs 2,921 crore.The consortium, i…",neutral,positive,2.2442712024568863,positive,-5.93607305936073,negative
2021-05-13 16:30:00.000,657.0,662.65,615.0,618.0,15860033.0,"Uttar Pradesh to spend up to $1 billion to buy vaccines, in talks with Pfizer, Sputnik V",Uttar Pradesh has also held pre-bid talks with Indian vaccine companies the Serum Institute of India - licensed to make the AstraZeneca and Novavax shots - Bharat Biotech and Cadila Healthcare as part of a global tender to buy 40 million doses over the next few months.,neutral,positive,-5.93607305936073,negative,-2.0568227290916403,negative
2021-05-13 18:04:36.000,657.0,662.65,615.0,618.0,15860033.0,Uttar Pradesh to spend up to $1.36 billion on COVID shot,Uttar Pradesh has also held pre-bid talks with Indian vaccine companies the Serum Institute of India (SII) - licensed to make the AstraZeneca and Novavax shots - Bharat Biotech and Cadila Healthcare as part of a global tender to buy 40 million doses over the next few months,neutral,positive,-5.93607305936073,negative,-2.0568227290916403,negative
2021-05-16 01:45:58.000,624.75,628.4,610.0,611.9,5723083.0,Cadila Healthcare To Sell Animal Healthcare Business To Become A Focused Entity: Dolat Capital,Cadila Healthcare To Sell Animal Healthcare Business To Become A Focused Entity: Dolat Capital,neutral,neutral,-2.0568227290916403,negative,-1.285807291666663,negative
2021-05-21 11:17:38.000,619.0,621.7,607.9,615.4,4121814.0,Covid-19 drugs and vaccines to drive Cadila Healthcare’s prospects,"The company received emergency use approval for Pegylated Interferon alpha-2b, ‘Virafin’ in treating moderate COVID-19 infection in adults. Priced at ₹11,995/dose, it is said to cut the need for oxygen supply",neutral,positive,-0.5815831987075966,neutral,0.362610797743755,neutral
2021-05-24 09:17:00.000,620.5,639.95,617.5,622.75,12414431.0,Cadila Healthcare launches breast cancer treatment drug,"Cadila Healthcare on Monday announced the launch of Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar for treating both early and advanced HER2 positive breast cancer.",neutral,positive,0.362610797743755,neutral,-0.5432177664163569,neutral
2021-05-27 07:35:00.000,632.4,638.0,621.3,626.15,12710712.0,"Stocks in the news: BPCL, Sun Pharma, Eicher Motors, Berger Paints and Cadila Healthcare","UCO Bank, Aegis Logistics, Solar Industries, HEG, Metropolis, Fine Organic, India Grid, Wockhardt are among companies that will announce their March quarter results today.",neutral,neutral,-0.9882985452245416,negative,-0.8853792773390872,neutral
2021-05-27 08:10:00.000,632.4,638.0,621.3,626.15,12710712.0,"Market Ahead Podcast, May 27: Top factors that could guide markets today","A total of 93 companies, including Eicher Motors, Sun Pharma, Cadila Healthcare, and Page Industries are set to release their quarterly earnings today",neutral,neutral,-0.9882985452245416,negative,-0.8853792773390872,neutral
2021-05-27 08:27:37.000,632.4,638.0,621.3,626.15,12710712.0,"Stocks to Watch: BPCL, Burger King India, Cadila, Gati, Jaypee Infratech","Major companies that will announce March quarter results today are Sun Pharma, Eicher Motors, Cadila Healthcare, Page Industries, UCO Bank, India Grid and Wockhardt",neutral,neutral,-0.9882985452245416,negative,-0.8853792773390872,neutral
2021-05-27 09:20:00.000,632.4,638.0,621.3,626.15,12710712.0,Cadila Healthcare seeks nod to undertake trials for antibodies cocktail,Cadila Healthcare said the company has sought DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID infection.,neutral,positive,-0.9882985452245416,negative,-0.8853792773390872,neutral
2021-05-27 10:39:00.000,632.4,638.0,621.3,626.15,12710712.0,"Cadila Healthcare Q4 PAT surges 73% yoy; US formulations business revenue at Rs1,509cr",EBIDTA grew by 8% on a yoy basis to Rs855cr during the fourth quarter,positive,positive,-0.9882985452245416,negative,-0.8853792773390872,neutral
2021-05-27 14:04:00.000,626.85,627.95,612.5,621.3,6398805.0,Cadila Healthcare standalone net profit declines 24.96% in the March 2021 quarter,Sales rise 14.20% to Rs 1949.70 crore,negative,positive,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-27 14:30:00.000,626.85,627.95,612.5,621.3,6398805.0,Cadila Healthcare consolidated net profit rises 73.26% in the March 2021 quarter,Sales rise 3.56% to Rs 3756.20 crore,positive,positive,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-27 15:09:00.000,626.85,627.95,612.5,621.3,6398805.0,Cadila Healthcare Q4 PAT spurts 73% to Rs 679 cr,"On a consolidated basis, the drug maker’s net profit surged 73.25% to Rs 679 crore on 2.52% increase in total revenue from operations to Rs 3,846.70 crore in Q4 March 2021 over Q4 March 2020.",neutral,positive,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-27 17:05:00.000,626.85,627.95,612.5,621.3,6398805.0,Cadila Healthcare Q4 results: Net profit up 73% at Rs 679 crore,"Consolidated total revenue from operations stood at Rs 3,846.7 crore for the quarter under consideration. It was Rs 3,752.1 crore for the same period a year ago, it added.",positive,neutral,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-28 09:04:43.000,626.85,627.95,612.5,621.3,6398805.0,"Cadila Healthcare Q4 Review - India Sales, Operating Leverage Drives Earnings: Motilal Oswal","Cadila Healthcare Q4 Review - India Sales, Operating Leverage Drives Earnings: Motilal Oswal",neutral,neutral,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-28 10:19:00.000,626.85,627.95,612.5,621.3,6398805.0,"Buy Cadila Healthcare, target price Rs 740: Motilal Oswal","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 63031.83 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-28 12:41:51.000,626.85,627.95,612.5,621.3,6398805.0,Accumulate Cadila Healthcare Target Of Rs 696: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Cadila Healthcare with a target price of Rs 696 in its research report dated May 28, 2021.",neutral,positive,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-28 12:43:47.000,626.85,627.95,612.5,621.3,6398805.0,Accumulate Cadila Healthcare; Target Of Rs 678: Arihant Capital,"Arihant Capital recommended Accumulate rating on Cadila Healthcare with a target price of Rs 678 in its research report dated May 28, 2021.",neutral,neutral,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-28 12:45:21.000,626.85,627.95,612.5,621.3,6398805.0,Buy Cadila Healthcare; Target Of Rs 701: Dolat Capital Market,"Dolat Capital Market is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 701 in its research report dated May 28, 2021.",neutral,positive,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-28 17:55:06.000,626.85,627.95,612.5,621.3,6398805.0,Cadila Healthcare Q4 Review - Margin Supported By Lower Research And Development: ICICI Securities,Cadila Healthcare Q4 Review - Margin Supported By Lower Research And Development: ICICI Securities,neutral,neutral,-0.8853792773390872,neutral,-0.4032258064516129,neutral
2021-05-31 08:40:00.000,620.0,620.0,611.55,617.5,4384437.0,Cadila Healthcare gets USFDA nod Fluphenazine Hydrochloride Tablets,"Cadila Healthcare has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg.",neutral,positive,-0.4032258064516129,neutral,0.0888817065287763,neutral
2021-05-31 12:35:42.000,618.8,627.65,616.5,619.35,3532113.0,Buy Cadila Healthcare; Target Of Rs 740: Motilal Oswal,"Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 740 in its research report dated May 28, 2021.",neutral,positive,0.0888817065287763,neutral,1.5839663811216993,positive
2021-05-31 13:39:14.000,618.8,627.65,616.5,619.35,3532113.0,Buy Cadila Healthcare: Target Of Rs 720: Sharekhan,"Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated May 27, 2021.",neutral,positive,0.0888817065287763,neutral,1.5839663811216993,positive
2021-06-01 10:35:55.000,618.8,627.65,616.5,619.35,3532113.0,Hold Cadila Healthcare; Target Of Rs 640: ICICI Direct,"ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 640 in its research report dated May 28, 2021.",neutral,positive,0.0888817065287763,neutral,1.5839663811216993,positive
2021-06-03 11:45:00.000,628.9,641.45,628.05,634.0,4518330.0,Cadila Healthcare gets USFDA nod for lung cancer drug,The drug major has received tentative approval from the US drug regulator to market osimertinib tablets in the strengths of 40 mg and 80 mg.,neutral,positive,0.8109397360470699,neutral,0.3941352672237111,neutral
2021-06-03 13:02:00.000,634.3,644.8,632.35,636.8,5482531.0,Zydus Cadila gets tentative USFDA nod to market lung cancer treatment drug,"The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.",positive,positive,0.3941352672237111,neutral,-0.476599734354257,neutral
2021-06-03 13:17:19.000,634.3,644.8,632.35,636.8,5482531.0,"Cadila Healthcare Ltd soars 1.24%, Gains for third straight session","Cadila Healthcare Ltd is quoting at Rs 635.2, up 1.24% on the day as on 12:49 IST on the NSE. The stock is up 75.13% in last one year as compared to a 55.93% gain in NIFTY and a 40.15% gain in the Nifty Pharma index.",neutral,positive,0.3941352672237111,neutral,-0.476599734354257,neutral
2021-06-04 08:48:08.000,634.3,644.8,632.35,636.8,5482531.0,Market may open flat ahead of RBI policy announcements,"Stocks to watch out for today: Standard Industries, Lupin, KP Energy, Confidence Petroleum, and Cadila Healthcare",neutral,neutral,0.3941352672237111,neutral,-0.476599734354257,neutral
2021-06-04 12:34:13.000,634.3,644.8,632.35,636.8,5482531.0,"Cadila Healthcare - R&D On Track For Covid Vaccine, Niche Product Development: Motilal Oswal","Cadila Healthcare - R&D On Track For Covid Vaccine, Niche Product Development: Motilal Oswal",neutral,neutral,0.3941352672237111,neutral,-0.476599734354257,neutral
2021-06-11 13:51:22.000,655.0,668.9,650.95,666.9,8796446.0,Cadila Healthcare Ltd in demand,"Cadila Healthcare Ltd is quoting at Rs 659.35, up 1.34% on the day as on 12:54 IST on the NSE. The stock is up 76.16% in last one year as compared to a 58.37% gain in NIFTY and a 43.86% gain in the Nifty Pharma index.",neutral,positive,1.816793893129768,positive,-1.944652206432311,negative
2021-06-14 09:13:00.000,668.5,668.55,639.15,655.5,4117726.0,"Buy Cadila Healthcare, target price Rs 692: Chandan Taparia","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 68073.76 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.944652206432311,negative,-1.6028087314913757,negative
2021-06-14 10:20:00.000,668.5,668.55,639.15,655.5,4117726.0,Cadila Healthcare gets USFDA approval for Brivaracetam tablets,"The drug maker has secured a tentative approval from the US drug regulator to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg.",positive,positive,-1.944652206432311,negative,-1.6028087314913757,negative
2021-06-14 12:00:45.000,655.1,657.9,644.0,644.6,2915970.0,Zydus Cadila Gets USFDA Tentative Nod For Epilepsy Treatment Drug,"Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said in a regulatory filing.",neutral,positive,-1.6028087314913757,negative,-2.4201054917778504,negative
2021-06-14 15:25:00.000,655.1,657.9,644.0,644.6,2915970.0,Zydus Cadila’s epilepsy drug Brivaracetam gets USFDA tentative nod,"Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said",neutral,positive,-1.6028087314913757,negative,-2.4201054917778504,negative
2021-06-18 14:17:35.000,623.8,626.2,603.6,621.25,5209668.0,Cadila Healthcare Ltd stays slippery,"Cadila Healthcare Ltd is quoting at Rs 618.8, down 0.23% on the day as on 13:19 IST on the NSE. The stock jumped 70.92% in last one year as compared to a 52.16% rally in NIFTY and a 40.99% spurt in the Nifty Pharma index.",negative,positive,-0.4087848669445262,neutral,1.7338709677419355,positive
2021-06-21 14:58:00.000,635.0,635.5,626.5,629.7,2859626.0,"Cadila, Bayer to extend JV partnership for three years: Statement",Cadila Healthcare and Bayer (South East Asia) have decided to extend the operations of their joint venture by three years with effect from June,neutral,neutral,-0.8346456692913314,neutral,-1.533112059427856,negative
2021-06-21 15:24:00.000,635.0,635.5,626.5,629.7,2859626.0,Cadila Healthcare and Bayer to extend JV partnership for three years,"Bayer Zydus Pharma will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and oncology.Ahmedabad-based Zydus Cadila discovers, develops, manufactures, and markets a broad range of healthcare therapies",positive,neutral,-0.8346456692913314,neutral,-1.533112059427856,negative
2021-06-21 15:24:00.000,635.0,635.5,626.5,629.7,2859626.0,"Cadila, Bayer extend JV partnership for three years","“The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit of the patients,” Cadila Healthcare Managing Director Sharvil Patel said.",positive,neutral,-0.8346456692913314,neutral,-1.533112059427856,negative
2021-06-24 11:15:00.000,623.8,624.4,615.1,617.45,2672809.0,Cadila Healthcare get tentative USFDA nod for fingolimod capsules,"Fingolimodis an immunomodulating drug, indicated for the treatment of relapsing forms of multiple sclerosis (MS).",neutral,neutral,-1.0179544725873533,negative,1.173234080427219,positive
2021-06-25 10:53:00.000,617.95,633.0,616.5,625.2,3094245.0,Cadila Healthcare gains after USFDA nod for pemetrexed for injection,Pemetrexed is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.,positive,neutral,1.173234080427219,positive,1.7722921117176882,positive
2021-07-01 09:17:00.000,649.1,649.1,633.15,639.4,5395401.0,Cadila Healthcare applies to DCGI for EUA to launch ZyCoV-D vaccine,Cadila Healthcare said it has applied for Emergency Use Authorization (EUA) to the office of Drug Controller General of India (DCGI) for ZyCoV-D - its Plasmid DNA vaccine against COVID-19.,neutral,neutral,-1.494376829456177,negative,-0.4271844660194175,neutral
2021-07-01 17:23:50.000,643.75,644.3,636.8,641.0,3026138.0,‘Target is to produce 10 crore vaccine doses in a year’: Cadila Healthcare MD on ZyCoV-D,"After applying applies for emergency use authorisation for COVID-19 vaccine with DCGI, Sharvil Patel, Managing Director of Cadila Healthcare on Thursday told that the pharmaceutical company expects to produce 1 crore vaccine doses of ZyCov-D per month from August onwards and 5 crore doses by Dece…",neutral,neutral,-0.4271844660194175,neutral,0.3110419906687403,neutral
2021-07-02 13:07:00.000,643.75,644.3,636.8,641.0,3026138.0,Cadila Healthcare receives final approval for HIV drug,Cadila Healthcare on Friday announced that it has received final approval from the US drug regulator to market emtricitabine and tenofovir disoproxil fumarate tablets.,positive,positive,-0.4271844660194175,neutral,0.3110419906687403,neutral
2021-07-04 13:31:00.000,643.0,646.2,638.4,645.0,2464426.0,"Cadila Healthcare arm recalls 21,240 bottles of diabetes drug in US",Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus.,neutral,positive,0.3110419906687403,neutral,-1.4943863724351494,negative
2021-07-04 17:30:00.000,643.0,646.2,638.4,645.0,2464426.0,"Cadila Healthcare arm recalls over 20,000 bottles of diabetes drug in US",Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus,negative,positive,0.3110419906687403,neutral,-1.4943863724351494,negative
2021-07-04 17:34:34.000,643.0,646.2,638.4,645.0,2464426.0,"Cadila Healthcare arm recalls 21,240 bottles of diabetes drug in US","Viona Pharmaceuticals is recalling 21,240 bottles of metformin hydrochloride extended-release tablets, USP 750 mg, on account of ‘CGMP Deviations: FDA analysis detected n-nitrosodimethylamine (NDMA) levels in excess of the acceptable daily intake limit’",neutral,negative,0.3110419906687403,neutral,-1.4943863724351494,negative
2021-07-12 08:05:00.000,642.5,647.9,638.6,644.25,3096436.0,"Two stock ideas by Vaishali Parekh: Buy CESC, Cadila Healthcare","Cadila Healthcare’s stock has taken base near Rs 600 levels on two occasions recently, forming a good support zone",neutral,positive,0.2723735408560311,neutral,-0.6242774566473919,neutral
2021-07-13 11:55:44.000,648.75,651.9,641.0,644.7,2975826.0,Cadila Healthcare Q1 PAT Seen Up 63.9% YoY To Rs 744 Cr: KRChoksey,"Net Sales are expected to increase by 8.7 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs 3,956 crore, according to KRChoksey.",neutral,positive,-0.6242774566473919,neutral,-0.3100775193798449,neutral
2021-07-15 11:08:25.000,643.4,645.5,636.0,639.2,1985128.0,"Cadila arm completes sale of animal health business for Rs 2,921 cr","Cadila Healthcare on Thursday said its wholly-owned subsidiary Zydus Animal Health and Investment has completed sale of its animal healthcare established markets undertaking to Multiples Alternate Asset Management-led consortium for Rs 2,921 crore.“The transaction of sale and disposal is c…",neutral,neutral,-0.6527820951196661,neutral,0.7267896217568133,neutral
2021-07-15 11:13:18.000,643.4,645.5,636.0,639.2,1985128.0,"Cadila Healthcare Arm Completes Sale Of Animal Health Business For Rs 2,921 Crore","“The transaction of sale and disposal is completed /closed today i.e. July 14, 2021,” Cadila Healthcare said in a regulatory filing.",neutral,neutral,-0.6527820951196661,neutral,0.7267896217568133,neutral
2021-07-15 17:30:00.000,639.8,645.9,638.75,644.45,1965021.0,"Stocks in news: Infosys, Marico, Maruti Suzuki, TCS and more","Stocks in news: Infosys, Marico, Cadila Healthcare, Reliance Power and more",neutral,neutral,0.7267896217568133,neutral,-0.7377494758095829,neutral
2021-07-20 15:32:00.000,638.9,638.9,615.0,621.0,3619083.0,"4 Covid vaccine candidates in human trial stage, 1 in pre-clinical stage, govt tells Rajya Sabha","In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd’s DNA-based vaccine candidate is in phase three clinical trial. It has also submitted the interim data for emergency use authorisation.",neutral,neutral,-2.8016904053842504,negative,-0.6072712744706279,neutral
2021-07-20 17:30:00.000,638.9,638.9,615.0,621.0,3619083.0,"COVID-19: 4 vaccines in human trial stage, 1 in pre-clinical stage, says Centre","In a written response in Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd’s DNA-based vaccine candidate is in phase three clinical trial",neutral,positive,-2.8016904053842504,negative,-0.6072712744706279,neutral
2021-07-21 08:26:19.000,625.75,630.85,616.35,621.95,2696816.0,"COVID-19 Vaccine Update: 4 Candidates In Human Trial Stage, Says Centre",Jitendra Singh said Cadila Healthcare Ltd’s DNA-based vaccine candidate is in phase three clinical trial and it has submitted the interim data for emergency use authorisation.,neutral,positive,-0.6072712744706279,neutral,-0.8690054715159281,neutral
2021-07-26 13:51:41.000,615.0,622.0,591.0,597.5,6184437.0,Cadila Healthcare Ltd down for fifth straight session,"Cadila Healthcare Ltd is quoting at Rs 607.35, down 1.28% on the day as on 13:19 IST on the NSE. The stock jumped 70.32% in last one year as compared to a 42.42% rally in NIFTY and a 45.69% spurt in the Nifty Pharma index.",negative,positive,-2.845528455284553,negative,-3.193277310924369,negative
2021-08-11 08:11:38.000,576.8,577.4,557.3,563.7,5771045.0,"Stocks to Watch: RIL, Vedanta, Zomato, JSPL, IndusInd Bank","Aster DM Healthcare, Bajaj Electricals, Bata India, CESC Ltd, Cadila Healthcare, Cummins India, Equitas Holdings, GE Power India, GIC Housing, Greaves Cotton Ltd, IDFC Ltd, India Cements, New India Assurance, Pidilite Industries, among other companies will post their Q1 results today",neutral,neutral,-2.2711511789181538,negative,-2.9236117301007383,negative
2021-08-11 08:18:41.000,576.8,577.4,557.3,563.7,5771045.0,"Markets likely to consolidate; financial services, auto stocks in focus","Some of the key earnings today are Bata India, Pidilite Industries, Cadila Healthcare, Bajaj Electricals, Cummins India, Aster DM Healthcare, CESC, Endurance Technologies and IDFC.",neutral,neutral,-2.2711511789181538,negative,-2.9236117301007383,negative
2021-08-11 08:25:00.000,576.8,577.4,557.3,563.7,5771045.0,"Market Ahead Podcast, August 11: Top factors that could guide markets today","Bata India, Cadila Healthcare, Endurance Tech, Antony Waste Handling Cell, Bajaj Electricals, HEG, IDFC, and Pidilite are among 300 companies slated to post their quarterly earning",neutral,neutral,-2.2711511789181538,negative,-2.9236117301007383,negative
2021-08-11 13:49:00.000,560.95,560.95,542.1,544.55,4933257.0,Cadila Healthcare Q1 PAT jumps 29% YoY to Rs 587 cr,"On a consolidated basis, the drug major posted a 29% rise in net profit to Rs 587 crore on 15% rise in revenue from operations to Rs 4025 crore in Q1 FY22 over Q1 FY21.",neutral,positive,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 14:00:00.000,560.95,560.95,542.1,544.55,4933257.0,Cadila Healthcare standalone net profit rises 0.43% in the June 2021 quarter,Sales rise 19.27% to Rs 2032.00 crore,positive,positive,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 14:56:00.000,560.95,560.95,542.1,544.55,4933257.0,Cadila Healthcare consolidated net profit rises 29.34% in the June 2021 quarter,Sales rise 14.41% to Rs 3917.40 crore,positive,positive,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 15:21:00.000,560.95,560.95,542.1,544.55,4933257.0,"Important results today: Cadila Healthcare, Antony Waste, Pidilite Industries, PNC Infratech among others","Bata India, Cadila Healthcare, Endurance Tech, New India Assurance, Antony Waste Handling Cell, Bajaj Electricals, HEG, India Cement, VIP Industries and Pidilite are among 300 companies slated to post their quarterly earnings.",neutral,neutral,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 15:46:00.000,560.95,560.95,542.1,544.55,4933257.0,Cadila Healthcare Q1 results: Net profit rises 29% to Rs 587 cr,"Consolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the same period a year ago.",positive,neutral,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 16:28:38.000,560.95,560.95,542.1,544.55,4933257.0,"Cadila Healthcare Q1 Net Jumps 29%, Led By Domestic Formulation Sales","Total income from operations for the quarter was Rs 4,025 crore, up 15 percent on a YoY basis. Earnings before interest, depreciation and tax (EBIDTA) for the quarter was Rs 933 crore, up by 18 percent YoY.",neutral,positive,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 17:30:00.000,560.95,560.95,542.1,544.55,4933257.0,"Stocks in news: Zomato, Reliance Infrastructure, Cadila Healthcare, JSPL and more","On Tuesday, Sensex ended at a record high, tracking gains in index majors HDFC, Bharti Airtel and Infosys amid a largely positive trend in global markets",neutral,positive,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-11 21:10:32.000,560.95,560.95,542.1,544.55,4933257.0,Cadila Healthcare Q1 net profit up 29% to Rs 587 cr; revenue up 14%,,positive,neutral,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-12 09:34:53.000,560.95,560.95,542.1,544.55,4933257.0,"What Should Investors Do With Cadila Healthcare After Q1 Earnings: Buy, Sell Or Hold?",The pharma company reported a 29 percent year-on-year jump in net profit at Rs 587 crore for the quarter ended June 30 led by strong growth in domestic formulation business and COVID-19 drug sales,neutral,positive,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-12 11:16:09.000,560.95,560.95,542.1,544.55,4933257.0,"Cadila Healthcare Q1 Review - In Line, Execution In Specialty To Drive Growth: Dolat Capital","Cadila Healthcare Q1 Review - In Line, Execution In Specialty To Drive Growth: Dolat Capital",neutral,neutral,-2.9236117301007383,negative,2.366972477064216,positive
2021-08-12 15:31:18.000,545.0,566.15,536.45,557.9,6651644.0,GIC Housing Finance Ltd leads losers in ‘A’ group,"Lupin Ltd, GE Power India Ltd, Aurobindo Pharma Ltd and Cadila Healthcare Ltd are among the other losers in the BSE’s ‘A’ group today, 12 August 2021.",positive,negative,2.366972477064216,positive,-4.642409033877035,negative
2021-08-12 20:14:17.000,545.0,566.15,536.45,557.9,6651644.0,Cadila Healthcare Q1 Review - Domestic Formulations Drive Earnings: Motilal Oswal,Cadila Healthcare Q1 Review - Domestic Formulations Drive Earnings: Motilal Oswal,neutral,neutral,2.366972477064216,positive,-4.642409033877035,negative
2021-08-13 10:19:00.000,545.0,566.15,536.45,557.9,6651644.0,Cadila Healthcare gets final approval for mesalamine capsules,The drug major on Friday announced that it has received final approval from the US drug regulator to market mesalamine extended-release capsules in the strength of 0.375 g.,positive,positive,2.366972477064216,positive,-4.642409033877035,negative
2021-08-16 13:18:00.000,532.0,539.8,526.6,529.5,3377729.0,"Results Review For Bharat Petroleum Corporation, Cadila Healthcare, Hero Motocorp","Results Review For Bharat Petroleum Corporation, Cadila Healthcare, Hero Motocorp",neutral,neutral,-0.4699248120300752,neutral,0.7169459962756095,neutral
2021-08-17 16:51:00.000,537.0,545.6,531.1,540.85,3165203.0,Zydus Cadila gets tentative approval from USFDA for cancer drug,"Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close.",positive,negative,0.7169459962756095,neutral,-1.0648148148148149,negative
2021-08-18 09:24:00.000,537.0,545.6,531.1,540.85,3165203.0,Cadila Healthcare gets USFDA nod for cancer drug,The drug major informed that it received tentative approval from the US-based drug regulator to market lenalidomide capsules in the multiple strengths.,neutral,positive,0.7169459962756095,neutral,-1.0648148148148149,negative
2021-08-19 14:14:22.000,540.0,548.0,521.55,534.25,5101043.0,Buy Cadila Healthcare; Target Of Rs 670: Motilal Oswal,"Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 11, 2021.",neutral,positive,-1.0648148148148149,negative,-2.4555160142348678,negative
2021-08-20 20:23:01.000,540.0,548.0,521.55,534.25,5101043.0,DCGI Approves Cadila Healthcare’s ZyCoV-D COVID Vaccine For All Above 12 Years Of Age,"The vaccine has to be administered in three doses – the first dose, and the remaining doses after 28 and 56 days.",neutral,neutral,-1.0648148148148149,negative,-2.4555160142348678,negative
2021-08-20 20:44:15.000,540.0,548.0,521.55,534.25,5101043.0,"ZyCoV-D, World’s 1st DNA Plasmid Covid-19 Vaccine Gets Approval: All About India’s 2nd Homegrown Jab","ZyCoV-D, a three-dose Covid-19 vaccine by Ahmedabad-based pharmaceutical firm Cadila Healthcare (Zydus Cadila), was on Friday received approval for Emergency Use Authorisation from the Drug Controller General of India (DCGI) and it will be administered to people 12 years and above.",neutral,positive,-1.0648148148148149,negative,-2.4555160142348678,negative
2021-08-23 07:25:33.000,562.0,577.0,542.0,548.2,20487360.0,"Stocks To Watch: Cadila Healthcare, Power Grid, Aurobindo Pharma, Infosys, Max Healthcare",Here are the stocks to watch in trade today...,neutral,neutral,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 07:36:29.000,562.0,577.0,542.0,548.2,20487360.0,"Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 08:23:00.000,562.0,577.0,542.0,548.2,20487360.0,"Nuvoco Vistas, Aurobindo Pharma, Cadila Healthcare in spotlight",Shares of Nuvoco Vistas Corporation will debut on the bourses today. The issue price has been fixed at Rs 570 per share.,neutral,neutral,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 08:48:00.000,562.0,577.0,542.0,548.2,20487360.0,Cadila Healthcare receives EUA from DCGI for ZyCoV-D,Cadila Healthcare said that the company has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19.,neutral,positive,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 09:07:41.000,562.0,577.0,542.0,548.2,20487360.0,"Stocks to Watch Today: Infosys, HDFC Bank, Adani Enterprise, Cadila Healthcare, More",Equity Benchmark Sensex and Nifty both ended in red on Friday- bears continued to pull down the Dalal Street.,neutral,negative,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 09:32:12.000,562.0,577.0,542.0,548.2,20487360.0,Cadila Healthcare Share Price Rises 7% After DCGI Approves ZyCoV-D COVID Vaccine,ZyCoV-D is the world’s first Plasmid DNA Vaccine for COVID-19,neutral,neutral,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 11:21:00.000,562.0,577.0,542.0,548.2,20487360.0,Cadila jumps nearly 8% after Covid-19 vaccine gets India emergency use nod,Shares of Cadila Healthcare Ltd jumped 7.9% on Monday after India last week approved the drugmaker’s Covid-19 vaccine for emergency use in adults and children aged 12 years and above,positive,positive,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 11:53:00.000,562.0,577.0,542.0,548.2,20487360.0,Cadila Healthcare gets final USFDA nod for tofacitinib tablets,The drug maker on Monday announced that it has received final approval from the US drug regulator to market tofacitinib extended-release tablets 11 mg and 22 mg in the United States.,neutral,positive,-2.4555160142348678,negative,-0.526411326919582,neutral
2021-08-23 13:54:56.000,550.9,552.95,534.5,548.0,5025026.0,Cadila Healthcare up 5% after DCGI approves Zydus Cadila’s ZyCoV-D Covid vaccine,"With this approval, India now has its first Covid-19 vaccine for adolescents in the 12-18 age group",positive,positive,-0.526411326919582,neutral,-1.2347920828037169,negative
2021-08-23 13:55:06.000,550.9,552.95,534.5,548.0,5025026.0,Buy Cadila Healthcare; Target Of Rs 720: Sharekhan,"Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 720 in its research report dated August 11, 2021.",neutral,positive,-0.526411326919582,neutral,-1.2347920828037169,negative
2021-08-23 17:30:00.000,550.9,552.95,534.5,548.0,5025026.0,"Stock Market Updates: Sensex up 400 points, Nifty above 16,550; Cadila Healthcare zooms 5%","At 09:20 hours, the 30-share BSE index was trading 405 points or 0.73 per cent higher at 55,713.43, and the broader NSE Nifty was up 107 points or 0.65 per cent to 16,557.90",positive,positive,-0.526411326919582,neutral,-1.2347920828037169,negative
2021-08-23 17:30:00.000,550.9,552.95,534.5,548.0,5025026.0,Cadila Healthcare share price zooms 8% after DCGI approves needle-free COVID-19 vaccine,The company informed that the thermostability of the vaccine will help in easy transportation and storage of the vaccine and reduce any cold chain breakdown challenges leading to vaccine wastage,neutral,positive,-0.526411326919582,neutral,-1.2347920828037169,negative
2021-08-24 08:00:11.000,550.9,552.95,534.5,548.0,5025026.0,Cadila Healthcare - Receives Emergency Use Authorisation From DCGI For ZyCov-D Covid Vaccine: KRChoksey,Cadila Healthcare - Receives Emergency Use Authorisation From DCGI For ZyCov-D Covid Vaccine: KRChoksey,neutral,neutral,-0.526411326919582,neutral,-1.2347920828037169,negative
2021-08-24 11:33:23.000,550.9,552.95,534.5,548.0,5025026.0,Cadila Healthcare - ZyCoV-D Vaccine Nod In Increasingly Competitive Domestic Market: Prabhudas Lilladher,Cadila Healthcare - ZyCoV-D Vaccine Approved In Increasingly Competitive Domestic Market: Prabhudas Lilladher,neutral,neutral,-0.526411326919582,neutral,-1.2347920828037169,negative
2021-08-24 17:45:14.000,550.7,551.25,540.5,543.9,2458039.0,Buy Cadila Healthcare Target Of Rs 695: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 695 in its research report dated dated August 24, 2021.",neutral,positive,-1.2347920828037169,negative,-0.6987863184994401,neutral
2021-08-24 19:13:00.000,550.7,551.25,540.5,543.9,2458039.0,Will three-dose Covid vaccine give Cadila Healthcare a booster shot?,"Analysts do see a lift to its sales, even as some of them are not factoring in sales beyond FY23 amid uncertainty over booster shots. The pricing of the dose would influence the likely gains for Cadila, with initial brokerage estimates pegging the blended price in Rs 150-320 (per dose) range.",neutral,positive,-1.2347920828037169,negative,-0.6987863184994401,neutral
2021-08-26 17:22:03.000,542.45,551.7,539.2,550.85,2221114.0,Cadila Healthcare to rollout Covid vaccine for 12+ from October: Report,"Reports said the details of Covid-19 vaccination of children between 12 and 17, including prioritising those with health complications, will be announced before the Zydus Cadila vaccine is rolled out in October",neutral,neutral,1.5485298184164396,positive,0.3978300180831909,neutral
2021-08-27 08:22:40.000,542.45,551.7,539.2,550.85,2221114.0,"Stocks to Watch: BHEL, BPCL, MMTC, Cadila, HDFC Bank, IndiGo, Spicejet","Cadila Healthcare will supply coronavirus vaccine for children between 12 and 17 from October, a health ministry official said on Thursday",neutral,positive,1.5485298184164396,positive,0.3978300180831909,neutral
2021-09-01 17:30:00.000,554.0,561.0,553.0,556.5,1666641.0,"LIC acquires over 6.64 lakh shares of Cadila Healthcare, takes stake to above 5%","The insurance company said it acquired 6,64,104 shares of Cadila Healthcare, amounting to an additional stake of 0.065 per cent in the company.",neutral,neutral,0.4512635379061371,neutral,-0.8314707197138985,neutral
2021-09-06 11:23:00.000,556.05,557.8,551.5,556.6,1238281.0,Cadila Healthcare gets tentative USFDA nod for sitagliptin,"The drug maker on Monday announced that its subsidiary has received tentative approval from the US drug regulator for its new drug application for sitagliptin base 25, 50 and 100 mg tablets.",neutral,positive,0.0989119683481824,neutral,-0.4219788112767145,neutral
2021-09-20 08:10:14.000,556.35,559.9,541.5,543.15,2002377.0,"Stocks To Watch : Wipro, Adani Ports, Cadila Healthcare, Zee Entertainment, Ruchi Soya and More",The Indian market on Monday is expected to open on a flat note- thanks to mixed global cues.,neutral,positive,-2.3726071717444137,negative,0.9157509157509158,positive
2021-09-20 08:27:00.000,556.35,559.9,541.5,543.15,2002377.0,"Wipro, Cadila Healthcare, IRB Infra to be watched","Wipro announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore, India. This cloud collaboration space will provide in-house technical expertise, ensure seamless cloud adoption, and accelerate innovation to drive business",neutral,positive,-2.3726071717444137,negative,0.9157509157509158,positive
2021-09-20 08:29:00.000,556.35,559.9,541.5,543.15,2002377.0,Cadila receives final approval for Vortioxetine Tablets,"Cadila Healthcare has received final approval from the USFDA to market Vortioxetine Tablets in the strengths of 5 mg, 10 mg, 20 mg (US RLD: Trintellix Tablets).",positive,positive,-2.3726071717444137,negative,0.9157509157509158,positive
2021-09-20 08:48:44.000,556.35,559.9,541.5,543.15,2002377.0,"Wipro, Zomato, Vodafone Idea, PNB, Yes Bank, Dish TV, Cadila Healthcare stocks in focus","Nifty futures extended losses, were now trading 162 points or 0.92 per cent down at 17439.50 on the Singaporean Exchange. BSE Sensex and Nifty 50 were set to witness a gap-down start today.",neutral,negative,-2.3726071717444137,negative,0.9157509157509158,positive
2021-09-20 17:30:00.000,546.0,552.85,533.55,551.0,1936533.0,"Stocks in news: Wipro, Zomato, Vodafone Idea, Cadila Healthcare, Lupin and more","On September 17, the benchmark indices ended lower after scaling record highs as investors booked profits at higher levels. After moving in a range of 866 points during the day, Sensex closed 125.27 points lower at 59,015 and Nifty slipped 44.35 points to 17,585.",neutral,negative,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-20 18:34:42.000,546.0,552.85,533.55,551.0,1936533.0,Cadila Healthcare Unit Inks Pact To Sell Two Brands To Integrace,"Zydus Healthcare Ltd, a wholly-owned subsidiary of the company, has inked the agreement with Integrace, a part of the portfolio companies of private equity firm True North.",neutral,positive,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 08:00:16.000,546.0,552.85,533.55,551.0,1936533.0,"Stocks to Watch: Cadila Healthcare, HCL Tech, Adani Ports, SBI Cards, Websol Energy and More","The Indian markets, taking mixed cues globally, are expected to open in the positive territory.",neutral,positive,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 08:34:09.000,546.0,552.85,533.55,551.0,1936533.0,"Vodafone Idea, Tata Power, Nestle, Cadila Healthcare, Zydus Healthcare, PNB, HCL Tech stocks in focus","Trends on SGX Nifty suggested a positive opening for BSE Sensex and Nifty 50 on Tuesday, as Nifty futures surged in trade",neutral,positive,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 08:36:00.000,546.0,552.85,533.55,551.0,1936533.0,"HCL Tech, Cadila Healthcare, Glenmark Pharma in spotlight","HCL Technologies announced a five-year, digital transformation deal with MKS Instruments Inc., a global provider of instruments, systems, subsystems and solutions for advanced manufacturing processes, to improve performance, productivity and speed",neutral,positive,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 08:43:00.000,546.0,552.85,533.55,551.0,1936533.0,"Stocks to watch: SBI Card, Adani Ports, Cadila Healthcare, HCL Tech, AU SFB",IT company AGC Networks on Monday said its board has approved the appointment of Essar Group’s Anshuman Ruia as executive director of the company,neutral,positive,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 08:59:11.000,546.0,552.85,533.55,551.0,1936533.0,Stocks that will see action,"Focus on SBI Cards, HCL Tech, ACE, Cadila Healthcare, Adani Ports, RPP Infra, Indian Sucrose",neutral,neutral,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 09:35:37.000,546.0,552.85,533.55,551.0,1936533.0,Cadila Healthcare Share Price Falls On Sale Of Two Brands,Purchaser is a part of the portfolio companies of PE firm True North and said the transaction is not a related party transaction.,neutral,neutral,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 09:48:00.000,546.0,552.85,533.55,551.0,1936533.0,Cadila Healthcare subsidiary inks deal to sell two brands to Integrace,"Zydus Healthcare, a wholly owned subsidiary of Cadila Healthcare, entered into an agreement on Monday, 20 September 2021 with Integrace, the purchaser, to sell two brands viz. Mifegest and Cytolog.",neutral,positive,0.9157509157509158,positive,1.8508437670114195,positive
2021-09-21 17:30:00.000,551.1,563.55,551.1,561.3,1467118.0,"Stocks in news: Hindustan Copper, HCL Tech, Cadila Healthcare, Adani Ports and more","Closing sharply lower, the Indian equity benchmarks Sensex and Nifty, saw a major fall as the volatility index rose 12 per cent on Monday. The fall in the market is seen in line with losses across global markets as investors wait for cues from the US Federal Reserve Bank this week",neutral,negative,1.8508437670114195,positive,0.2652519893899204,neutral
2021-09-22 17:30:00.000,565.5,570.9,563.5,567.0,1787227.0,India to open COVID-19 vaccination for 12-18 years age group in October,"Cadila Healthcare’s ZyCoV-D, the only COVID-19 vaccine approved for children in India, will be available from next month",neutral,positive,0.2652519893899204,neutral,-0.6613173441495459,neutral
2021-09-24 08:10:00.000,567.05,569.6,558.3,563.3,1732211.0,Shilpa Medicare ties with Cadila Healthcare for production of ZyCoV-D vaccine,ZyCov-D is the first DNA plasmid vaccine in the world for human use developed indigenously by CHL against the Covid-19 virus.,neutral,neutral,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 11:25:00.000,567.05,569.6,558.3,563.3,1732211.0,Cadila Healthcare gets USFDA nod to market Apremilast tablets,"The U.S.-based subsidiary of Cadila Healthcare, Zydus Pharmaceuticals received the final approval from the U.S.-based drug regulator, United States Food and Drug Administration to market Apremilast tablets in the strengths of 10 mg, 20 mg, 30 mg.",neutral,positive,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 14:21:00.000,567.05,569.6,558.3,563.3,1732211.0,Shilpa Medicare ties up with Cadila Healthcare for production of ZyCoV-D vaccine,"Shilpa Medicare on Friday announced that it has entered into a definitive agreement with Cadila Healthcare for production and supply of the ZyCov-D vaccine drug from its integrated biologics R&D center at Dharwad, Karnataka.",neutral,positive,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 15:02:23.000,567.05,569.6,558.3,563.3,1732211.0,Cadila Healthcare Enters Pact With Shilpa Medicare For Production Of ZyCoV-D Vaccine,"The company has, “entered into a definitive agreement with Shilpa Medicare, via its wholly owned subsidiary, Shilpa Biologicals for production-supply of the ZyCoV-D vaccine drug substance from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka,” Cadila Healthcare said in a r…",neutral,positive,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 15:19:26.000,567.05,569.6,558.3,563.3,1732211.0,Cadila’s COVID-19 vaccine shot to be produced by Shilpa Medicare,"Cadila Healthcare Ltd`s three-dose COVID-19 vaccine wil be produced by drugmakers Shilpa Medicare Limited, in August, India`s health authorities had given emergency approval for Cadila`s vaccine.",neutral,neutral,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 15:55:37.000,567.05,569.6,558.3,563.3,1732211.0,Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine,Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine,positive,positive,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 17:10:00.000,567.05,569.6,558.3,563.3,1732211.0,Cadila Healthcare signs agreement with Shilpa Biologicals for production of ZyCoV-D vaccine,"ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the Company against the Covid-19 virus. It is also the first COVID-19 vaccine for adolescents in the 12-18 age group, besides the adult population and",positive,neutral,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 21:23:04.000,567.05,569.6,558.3,563.3,1732211.0,Covid-19: Cadila Healthcare Enters Pact with Shilpa Medicare for Production of ZyCoV-D Vaccine,"Drug firm Cadila Healthcare on Friday said it has entered into an agreement with Shilpa Medicare for the production of its COVID-19 vaccine, ZyCoV-D.",neutral,positive,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-24 22:54:39.000,567.05,569.6,558.3,563.3,1732211.0,Shilpa Medicare arm to make ZyCoV-D drug substance,Cadila Healthcare has entered into a definitive agreement with a Shilpa Medicare subsidiary for production-supply of ZyCoV-D vaccine drug substance from the latter’s integrated biologics R&amp;D-c,neutral,positive,-0.6613173441495459,neutral,-1.7003188097768371,negative
2021-09-27 06:35:00.000,564.6,564.65,553.7,555.0,1180788.0,Nifty Pharma stocks trade lower; Divis Lab sinks over 3%,Cadila Healthcare was also under extreme pressure. Lupin and Alkem Lab were only Pharma companies to trade in the green.,negative,neutral,-1.7003188097768371,negative,-1.9459459459459376,negative
2021-10-05 07:12:00.000,562.0,567.05,555.6,562.3,1430243.0,Cadila Healthcare clarifies on getting permission to conduct phase III trial for two-dose Covid vaccine,The company confirms that they have got the permission for conduct of phase III trials for two-dose Covid vaccine.,positive,positive,0.0533807829181413,neutral,-2.966887417218535,negative
2021-10-05 13:04:23.000,566.25,566.25,547.5,549.45,1957857.0,"Cadila Healthcare Ltd spurts 0.28%, gains for five straight sessions","Cadila Healthcare Ltd is quoting at Rs 563.75, up 0.28% on the day as on 12:49 IST on the NSE. The stock is up 35.73% in last one year as compared to a 52.07% gain in NIFTY and a 22.68% gain in the Nifty Pharma.",positive,positive,-2.966887417218535,negative,-0.8558558558558558,neutral
2021-10-05 13:31:05.000,566.25,566.25,547.5,549.45,1957857.0,Cadila Healthcare Ltd stays in winning mode,"Cadila Healthcare Ltd is quoting at Rs 563.75, up 0.28% on the day as on 12:49 IST on the NSE. The stock is up 35.73% in last one year as compared to a 52.07% gain in NIFTY and a 22.68% gain in the Nifty Pharma.",positive,positive,-2.966887417218535,negative,-0.8558558558558558,neutral
2021-10-05 16:50:00.000,566.25,566.25,547.5,549.45,1957857.0,Cadila gets DCGI nod to conduct phase III trials for two-dose Covid vaccine,"Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close.",neutral,positive,-2.966887417218535,negative,-0.8558558558558558,neutral
2021-10-05 17:19:31.000,566.25,566.25,547.5,549.45,1957857.0,Cadila Healthcare Gets DCGI Nod to Conduct Phase III Trials for Two-dose Covid Vaccine,Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-D.,neutral,positive,-2.966887417218535,negative,-0.8558558558558558,neutral
2021-10-06 08:49:18.000,566.25,566.25,547.5,549.45,1957857.0,"Bharti Airtel, RIL, Vodafone idea, SBI, ZEEL, Srei Infra Finance, Cadila Healthcare stocks in focus","Today, stocks such as Bharti Airtel, Reliance Industries, Vodafone idea, SBI, ZEEL, Srei Infra Finance, Cadila Healthcare others will remain in focus",neutral,neutral,-2.966887417218535,negative,-0.8558558558558558,neutral
2021-10-06 17:30:00.000,555.0,557.75,548.9,550.25,1843603.0,"Stocks in news: Zee Entertainment Enterprises, Coal India, Cadila Healthcare, Godrej Consumer and more","Benchmark indices ended higher for the second consecutive session on September 5, powered by gains in index heavyweights Reliance Industries, TCS and Infosys amid a largely positive trend in global markets.",neutral,positive,-0.8558558558558558,neutral,-0.7313109425785401,neutral
2021-10-06 17:39:04.000,555.0,557.75,548.9,550.25,1843603.0,Cadila Healthcare Q2 PAT Seen Up 19% YoY To Rs 563.3 Cr: Prabhudas Lilladher,"Net Sales are expected to decrease by 3.5 percent Y-o-Y (down 8.4 percent Q-o-Q) to Rs 3,685.8 crore, according to Prabhudas Lilladher.",neutral,negative,-0.8558558558558558,neutral,-0.7313109425785401,neutral
2021-10-07 11:27:41.000,555.0,557.75,548.9,550.25,1843603.0,LIC keeps faith in Cadila Healthcare as its holding jumps to 5.68% in Q2,"FPIs, MFs cut holding marginally but retail investors add more",positive,negative,-0.8558558558558558,neutral,-0.7313109425785401,neutral
2021-10-08 13:44:00.000,553.8,553.8,549.0,549.75,1126066.0,Cadila Healthcare gets tentative approval for ance treatment drug,Cadila Healthcare on Friday announced that it received tentative approval from the USFDA to market adapalene and benzoyl peroxide gel.,positive,positive,-0.7313109425785401,neutral,-1.1191335740072286,negative
2021-10-21 13:50:45.000,511.0,518.0,501.0,501.0,1110410.0,Cadila Healthcare Ltd continues to fall,"Cadila Healthcare Ltd is quoting at Rs 507.75, down 1.83% on the day as on 13:24 IST on the NSE. The stock jumped 19.29% in last one year as compared to a 52.37% rally in NIFTY and a 21.48% spurt in the Nifty Pharma index.",negative,positive,-1.9569471624266144,negative,-0.7654075546719727,neutral
2021-10-29 08:22:32.000,492.5,512.0,489.45,503.9,3353442.0,"Stocks to Watch: BPCL, RIL, Zee Entertainment, Bharti Airtel","BPCL, Adani Power, UPL, Vedanta, Adani Transmission, Apollo Tyres, Bandhan Bank, Cadila Healthcare, Equitas Small Finance Bank, GAIL (India), SAIL, Varun Beverages are among the companies scheduled to release their Q2 earnings today",neutral,neutral,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 08:23:24.000,492.5,512.0,489.45,503.9,3353442.0,"Indian stock markets may stay under pressure; Zee, Vedanta, IRCTC in focus","Adani Transmission, Vedanta, BPCL, Dr Reddy’s Laboratories, IRCTC, GAIL (India), JSW Energy, UPL, Cadila Healthcare, Bandhan Bank, SAIL, Adani Power are among the companies scheduled to release their Q2 earnings today",negative,neutral,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 08:53:00.000,492.5,512.0,489.45,503.9,3353442.0,"NTPC, IRCTC, InterGlobe Aviation, DLF in focus","Among key corporate earnings, BPCL, Adani Power, Dr Reddy’s Labs, Shree Cement, UPL, Vedanta, Adani Transmission, Apollo Tyres, Bandhan Bank, Bharat Electronics, Cadila Healthcare, GAIL (India), Glaxosmithkline Pharmaceuticals, Oberoi Realty, among",neutral,neutral,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 12:39:00.000,492.5,512.0,489.45,503.9,3353442.0,Cadila Healthcare consolidated net profit rises 534.20% in the September 2021 quarter,Sales rise 2.38% to Rs 3687.00 crore,positive,positive,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 12:54:00.000,492.5,512.0,489.45,503.9,3353442.0,Cadila Healthcare gains after strong Q2 results,Cadila Healthcare rose 2.27% to Rs 502.95 after the company’s consolidated net profit surged 534.20% to Rs 3002.30 crore on 3.44% increase in net sales to Rs 3784.80 crore in Q2 September 2021 over Q2 September 2020.,positive,positive,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 14:24:10.000,492.5,512.0,489.45,503.9,3353442.0,Cadila Healthcare standalone Q2 net profit at ₹14 crore,"Consolidated EBITDA at ₹861 crore, up 6 per cent y-o-y",neutral,positive,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 14:40:00.000,492.5,512.0,489.45,503.9,3353442.0,"Cadila Healthcare Q2 PAT up by 6% YoY to Rs 597 cr, revenue up 3%","The company’s EBIDTA margin for the quarter was 22.7 per cent, up by 50 basis points",positive,positive,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-10-29 21:42:19.000,492.5,512.0,489.45,503.9,3353442.0,"Cadila Healthcare Q2 results: Profit zooms over 6-fold to Rs 3,002 cr on one-time gain","Cadila Healthcare Q2 results: Profit zooms over 6-fold to Rs 3,002 cr on one-time gain",neutral,neutral,2.3147208121827365,positive,-0.7411067193675889,neutral
2021-11-01 12:39:00.000,503.0,504.2,490.0,495.3,2043049.0,"Results Review For Shree Cement, Dr. Reddy’s Labs, Cadila Healthcare","Results Review For Shree Cement, Dr. Reddy’s Labs, Cadila Healthcare",neutral,neutral,-1.5308151093439342,negative,-1.4580191050779283,negative
2021-11-08 18:19:00.000,509.95,509.95,494.0,498.1,4799511.0,Cadila Healthcare gets Central govt order to supply 10 mn doses of ZyCoV-D,"ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus",positive,neutral,-2.323757231101081,negative,0.8224674022066244,neutral
2021-11-09 06:00:00.000,509.95,509.95,494.0,498.1,4799511.0,Cadila Healthcare (₹494.6): SELL,The outlook for the stock of Cadila Healthcare is negative. The strong rally that was in place since March 2020 reversed direction in May this year after marking a high of ₹673.7. The stock has slippe,neutral,positive,-2.323757231101081,negative,0.8224674022066244,neutral
2021-11-10 12:45:00.000,502.0,502.0,491.0,492.0,1478383.0,Cadila Healthcare gets US FDA nod for Glycopyrrolate injection,"Cadila Healthcare said that it has received final approval from the USFDA to market Glycopyrrolate injection, a generic version of US reference listed drug Robinul.",neutral,positive,-1.99203187250996,negative,0.1218274111675173,neutral
2021-11-18 08:41:00.000,473.0,475.0,461.25,461.5,1777257.0,Cadila Healthcare gets final approval from USFDA for Nelarabine injection,Cadila Healthcare on Thursday received 180-day exclusivity and a final approval from the USFDA to market nelarabine injection in the United States.,positive,positive,-2.431289640591966,negative,-1.59689253344842,negative
2021-11-22 07:50:59.000,463.4,467.0,452.8,456.0,1870126.0,"Stocks To Watch: RIL, Cadila Healthcare, IRB Infra, ONGC, Motherson Sumi, IRCTC",Here are the stocks to watch in trade today...,neutral,neutral,-1.59689253344842,negative,1.8461538461538407,positive
2021-11-22 12:50:00.000,455.0,465.95,451.35,463.4,1111947.0,"Top stocks in focus: Motherson Sumi Systems, IRCTC, Cadila Healthcare, Kesoram Industries, India Grid Trust",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.8461538461538407,positive,-1.1627906976744138,negative
2021-11-24 15:46:00.000,459.35,464.8,456.75,463.5,1287749.0,Cadila Healthcare inks ZyCoV-D commercialization agreement with South Korean firm,Cadila Healthcare said that it has entered into a manufacturing license and technology transfer agreement for its plasmid DNA based COVID-19 (ZyCoV-D) vaccine with Enzychem Lifesciences.,positive,positive,0.903450527919882,positive,3.086956521739128,positive
2021-11-24 16:23:00.000,459.35,464.8,456.75,463.5,1287749.0,Cadila Healthcare enters into agreement with Enzychem Lifesciences,For manufacturing licence and technology transfer for Plasmid DNA Vaccine ZyCoV-D,positive,neutral,0.903450527919882,positive,3.086956521739128,positive
2021-11-24 16:34:33.000,459.35,464.8,456.75,463.5,1287749.0,Cadila Healthcare inks tech transfer pact with Korean Enzychem Lifesciences,The pact will lead to production of 80 million or more doses of ZyCoV-D in 2022,positive,neutral,0.903450527919882,positive,3.086956521739128,positive
2021-11-24 16:58:00.000,459.35,464.8,456.75,463.5,1287749.0,Cadila Healthcare inks ZyCoV-D commercialisation agreement with Korean firm,Cadila will provide manufacturing license and transfer the Plasmid DNA vaccine technology to Enzychem Lifesciences,positive,neutral,0.903450527919882,positive,3.086956521739128,positive
2021-11-25 12:58:08.000,460.0,480.0,458.05,474.2,7092619.0,Sharekhan Maintains ‘buy’ On These 15 Pharma Names Post Q2 Earnings. Take A Look,"Cadila Healthcare, Dr Reddy’s and Sun Pharma among the preferred largecap picks of Sharekhan. Read on to know which stocks Sharekhan is backing and why.",neutral,neutral,3.086956521739128,positive,-5.281763360365976,negative
2021-12-02 14:28:00.000,461.9,465.3,457.05,460.0,1498172.0,Cadila’s Covid vax to be introduced in 7 states first,"The Indian government will initially introduce Cadila Healthcare’s Covid-19 vaccine ZyCoV-D in seven states, including Maharashtra and West Bengal, Reuters reported on Thursday.",neutral,neutral,-0.4113444468499626,neutral,-2.11016123796126,negative
2021-12-03 13:33:41.000,461.9,465.3,457.05,460.0,1498172.0,Covid-19: These 5 vaccines will be available in India for children soon,"Covid-19 vaccine for children: These five vaccines are--Cadila Healthcare’s ZyCoV-D, Bharat Biotech’s Covaxin, Serum Institute’s Covovax, Biological E’s RBD, and Johnson & Johnson and Ad 26COV.2S vaccine",neutral,neutral,-0.4113444468499626,neutral,-2.11016123796126,negative
2021-12-10 09:36:00.000,461.9,471.0,461.9,467.5,1549124.0,Zydus update on clinical trial of Saroglitazar Mg in treatment of PCB (severe liver disease),"Speaking on the new development, Chairman of Cadila Healthcare, Pankaj R. Patel said, Primary Biliary Cholangitis (PBC) is a severe liver disease leading to cirrhosis of the liver, liver failure, and possibly death. PBC patients have limited",positive,neutral,1.2123836328209618,positive,-1.3562195380377151,negative
2021-12-10 10:34:00.000,461.9,471.0,461.9,467.5,1549124.0,Cadila Healthcare gains after USFDA allows clinical trials in patients with PBC,"Cadila Healthcare rose 1.20% to Rs 468.20 after the US-based drug regulator, United States Food and Drug Administration (USFDA) approved the initiation of EPICS-III Phase 2(b)/3 clinical trial in patients with Primary Biliary Cholangitis (PBC).",positive,positive,1.2123836328209618,positive,-1.3562195380377151,negative
2021-12-13 08:36:20.000,471.9,471.9,462.5,465.5,1068821.0,"Tega Industries, Vedanta, PSU Banks, and Cadila Healthcare among stocks in focus today",Chartists believe that the short term trend of Nifty continues to be range-bound with support near 17400-17380.,neutral,positive,-1.3562195380377151,negative,-0.0962566844919761,neutral
2021-12-13 10:33:00.000,471.9,471.9,462.5,465.5,1068821.0,"Buy Cadila Healthcare, target price Rs 540: ICICI Direct","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 47962.34 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.3562195380377151,negative,-0.0962566844919761,neutral
2021-12-14 09:35:00.000,467.5,474.4,458.9,467.05,3437581.0,"Hold Cadila Healthcare, target price Rs 515: Emkay Global","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 48197.80 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.0962566844919761,neutral,-0.6096908760295147,neutral
2021-12-16 11:03:00.000,468.35,468.7,459.0,464.65,1184944.0,Cadila Healthcare receives orphan drug designation for malaria treatment compound,"Cadila Healthcare on Thursday announced that its antimalarial compound ZY19489 (MMV253), has received Orphan Drug Designation from the USFDA.",positive,neutral,-0.7900074730436736,neutral,-1.7167381974248928,negative
2021-12-16 14:01:00.000,466.0,466.0,452.55,458.0,1687960.0,Zydus Cadila receives orphan drug status from USFDA for its novel malaria drug,"Drug maker Cadila Healthcare (Zydus Cadila), on Thursday said its antimalarial drug ZY19489 (MMV253), currently in development together with Medicines for Malaria Venture (MMV), has received orphan drug designation from the USFDA.",positive,positive,-1.7167381974248928,negative,-2.7292576419213974,negative
2021-12-30 09:52:00.000,473.0,482.85,468.1,476.4,5952127.0,"Buy Cadila Healthcare, target price Rs 551: HDFC Securities","Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 48192.68 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.7188160676532721,neutral,0.3009859885832877,neutral
2021-12-31 14:39:00.000,481.75,486.55,476.05,483.2,2291938.0,Cadila Health gains after USFDA nod for Pimavanserin capsules,Cadila Healthcare rose 1% to Rs 484 after received tentative approval from the US drug regulator for Pimavanserin capsules.,positive,positive,0.3009859885832877,neutral,-1.6072532454152095,negative
2021-12-31 17:00:00.000,481.75,486.55,476.05,483.2,2291938.0,Cadila Healthcare’s US arm receives FDA nod to market Pimavanserin capsule,"The approval by the US Food & Drug Administration for the generic Pimavanserin capsules is for the strength of 34 mg, Cadila Healthcare said in a regulatory filing. “The drug will be manufactured at the group’s formulation manufacturing facility at SEZ Ahmedabad,” it said.",neutral,neutral,0.3009859885832877,neutral,-1.6072532454152095,negative
2022-01-04 11:32:51.000,478.8,479.4,464.05,465.0,2374566.0,Cadila Healthcare’s healthy product pipeline adds to earnings visibility,"As the extraordinary gains from covid treatment drug sales during the June quarter softened, the high base in the domestic market added to the muted near-term growth expectations",positive,negative,-2.8822055137844638,negative,-1.418134937688003,negative
2022-01-07 13:51:53.000,459.4,459.7,449.5,450.15,1878164.0,Cadila Healthcare Ltd down for fifth straight session,"Cadila Healthcare Ltd is quoting at Rs 453.6, down 0.77% on the day as on 13:24 IST on the NSE. The stock tumbled 6.5% in last one year as compared to a 23.88% rally in NIFTY and a 4.74% spurt in the Nifty Pharma index.",negative,negative,-2.013495864170657,negative,0.5654728905643667,neutral
2022-01-10 10:53:00.000,450.95,458.0,449.2,453.5,2725046.0,"Investors, promoters put skincare company Curatio Healthcare on the block","Investment banks Edelweiss and Mape Advisory were hired to run the sale process. Feelers were sent to top buyout funds, including Carlyle, KKR, Blackstone, Advent, Apax Partners, TPG and Kedaara, and domestic pharma firms such as Dr Reddy’s, Torrent and Cadila Healthcare.",neutral,neutral,0.5654728905643667,neutral,-1.8061674008810549,negative
2022-01-10 11:53:53.000,450.95,458.0,449.2,453.5,2725046.0,"Ipca, Ajanta, Sun, Torrent report strong sales growth during December: IPM data","The companies that derived large contributions from covid treatment drug sales during 2020 – Cadila Healthcare Ltd, Cipla Ltd , Glenmark Pharmaceuticals Ltd – saw a soft sales growth on a high base of last year",positive,positive,0.5654728905643667,neutral,-1.8061674008810549,negative
2022-01-13 15:09:10.000,447.25,448.75,441.25,442.1,1649920.0,Cadila Healthcare Q3 PAT Seen Up 3.2% YoY To Rs 544 Cr: Prabhudas Lilladher,"Net Sales are expected to decrease by 0.2 percent Y-o-Y (up 0.1 percent Q-o-Q) to Rs 3,788.1 crore, according to Prabhudas Lilladher.",neutral,negative,-1.1514812744549976,negative,-1.227477477477475,negative
2022-01-17 12:00:00.000,444.0,444.0,437.0,438.55,2893260.0,"KPI Global Infrastructure hits the roof on signing PPA with Cadila Healthcare, Organic Inds.",KPI Global Infrastructure was locked in an upper circuit of 5% at Rs 454.55 on signing new long term power purchase agreements (PPA) for the sale of 3.10 MW (AC)/ 4.12 MW (DC) solar power to two clients under its IPP segment.,neutral,positive,-1.227477477477475,negative,-3.8610478359908855,negative
2022-01-20 10:58:00.000,424.5,427.0,416.35,418.5,1805303.0,Cadila Healthcare receives final approval for spasms treatment drug,Cadila Healthcare on Thursday announced that it has received final approval from the USFDA to market vigabatrin tablets in the strength of 500 mg.,positive,positive,-1.413427561837456,negative,-1.7805927342256187,negative
2022-01-20 10:58:00.000,424.5,427.0,416.35,418.5,1805303.0,Cadila Healthcare receives final approval for seizures treatment drug,Cadila Healthcare on Thursday announced that it has received final approval from the USFDA to market vigabatrin tablets in the strength of 500 mg.,positive,positive,-1.413427561837456,negative,-1.7805927342256187,negative
2022-01-20 11:39:11.000,424.5,427.0,416.35,418.5,1805303.0,Zydus Gets Final USFDA Nod To Market Generic Version Of Vigabatrin Tablets,"The approval by the US Food and Drug Administration is for Vigabatrin tablets of 500 mg strength, Cadila Healthcare said in a regulatory filing.",neutral,neutral,-1.413427561837456,negative,-1.7805927342256187,negative
2022-01-20 11:50:00.000,424.5,427.0,416.35,418.5,1805303.0,Zydus gets final US FDA nod to market generic version of Vigabatrin tablets,Cadila Healthcare Ltd on Thursday said group firm Zydus has received final approval from the US health regulator to market its generic version of Vigabatrin tablets to treat babies with infantile spasms and epilepsy in combination with other medications.,neutral,positive,-1.413427561837456,negative,-1.7805927342256187,negative
2022-01-20 12:47:00.000,418.4,420.0,405.65,410.95,2495196.0,Zydus gets final USFDA nod to market generic version of Vigabatrin tablets,Cadila Healthcare said group firm Zydus has received final approval from the US health regulator to market its generic version of Vigabatrin tablets,neutral,positive,-1.7805927342256187,negative,-2.695121951219515,negative
2022-01-27 14:04:54.000,385.15,402.7,385.1,396.35,2989171.0,Cadila Healthcare Ltd drops for fifth straight session,"Cadila Healthcare Ltd is quoting at Rs 381.35, down 3.61% on the day as on 13:24 IST on the NSE. The stock tumbled 17.51% in last one year as compared to a 23.13% rally in NIFTY and a 3.45% spurt in the Nifty Pharma index.",neutral,negative,2.907957938465545,positive,0.6312662458225056,neutral
2022-02-02 10:06:00.000,411.95,417.95,410.2,414.6,3670594.0,Cadila Health gains on supplying 1st consignment of ZyCoV-D,"Cadila Healthcare rose 2.22% to Rs 415.85 after the company said it has started supplying its COVID-19 vaccine, ZyCoV-D, to the Government of India.",positive,positive,0.6432819516931749,neutral,-2.2080883235329387,negative
2022-02-03 13:31:12.000,411.05,417.7,408.0,409.05,1876581.0,Cadila Healthcare Ltd extends winning spree,"Cadila Healthcare Ltd is quoting at Rs 415.95, up 0.35% on the day as on 12:49 IST on the NSE. The stock is down 13.2% in last one year as compared to a 18.7% spurt in NIFTY and a 6.78% spurt in the Nifty Pharma.",positive,positive,-0.4865588127964967,neutral,-3.501280956447486,negative
2022-02-03 16:56:12.000,411.05,417.7,408.0,409.05,1876581.0,Cadila Healthcare Posts 5% Decline In Net Profit At 500 Crore In Q3,"The company had posted a consolidated net profit of Rs 527.2 crore in the same period last fiscal, Cadila Healthcare said in a regulatory filing.",neutral,positive,-0.4865588127964967,neutral,-3.501280956447486,negative
2022-02-04 00:01:00.000,411.05,417.7,408.0,409.05,1876581.0,Vaccine will soon be available for 12-18 age group: Cadila Healthcare,"The government has allowed vaccination of adolescents aged 15 to 18 years with Bharat Biotech’s Covaxin, but is yet to decide on vaccination for those in the 12 to 15 age group.",neutral,neutral,-0.4865588127964967,neutral,-3.501280956447486,negative
2022-02-04 12:51:33.000,411.05,417.7,408.0,409.05,1876581.0,Buy Cadila Healthcare; Target Of Rs 490: Motilal Oswal,"Motilal Oswal is bullish on Cadila Healthcare has recommended buy on the stock with a revised price target (PT) of Rs. 490 in its research report dated February 04, 2022.",neutral,positive,-0.4865588127964967,neutral,-3.501280956447486,negative
2022-02-04 13:07:00.000,411.05,417.7,408.0,409.05,1876581.0,"Results Review for ITC, Titan, Dabur, GAIL (India), Cadila Healthcare, Emami","Results Review for ITC, Titan, Dabur, GAIL (India), Cadila Healthcare, Emami",neutral,neutral,-0.4865588127964967,neutral,-3.501280956447486,negative
2022-02-04 16:13:32.000,411.05,417.7,408.0,409.05,1876581.0,Buy Cadila Healthcare; Target Of Rs 560: Sharekhan,"Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 560 in its research report dated February 03, 2022.",neutral,positive,-0.4865588127964967,neutral,-3.501280956447486,negative
2022-02-07 20:51:30.000,397.0,403.85,393.65,401.0,1421796.0,Accumulate Cadila Healthcare; target of Rs 445: KR Choksey,"KR Choksey recommended accumulate rating on Cadila Healthcare with a target price of Rs 445 in its research report dated February 07, 2022.",neutral,positive,1.0075566750629723,positive,0.8573558648111445,neutral
2022-02-22 09:33:04.000,364.35,368.0,355.6,366.05,2859512.0,Cadila Healthcare falls as rival’s COVID-19 vaccine gets nod for emergency use on adolescents,"Prior to Biological E, Cadila Healthcare and Bharat Biotech’s Covaxin had received the regulator’s emergency approval for use on young adults.",neutral,positive,0.4665843282557949,neutral,0.9809264305177172,positive
2022-02-22 14:04:50.000,367.0,376.65,367.0,370.6,1588747.0,Cadila Healthcare Ltd stays slippery,"Cadila Healthcare Ltd is quoting at Rs 357.75, down 3.61% on the day as on 13:24 IST on the NSE. The stock tumbled 16.9% in last one year as compared to a 15.16% rally in NIFTY and a 6.28% spurt in the Nifty Pharma index.",negative,negative,0.9809264305177172,positive,-3.267605633802823,negative
2022-02-22 17:30:00.000,367.0,376.65,367.0,370.6,1588747.0,Cadila Healthcare shares fall to 52-week low on DCGI nod to rival’s Covid-19 vaccine,Cadila Healthcare stock fell to its 52-week low today after the Drugs Controller General of India (DCGI) cleared the COVID-19 vaccine of competitor Biological E against the company’s own vaccine ZyCoV-D.,negative,negative,0.9809264305177172,positive,-3.267605633802823,negative
2022-02-23 13:19:00.000,355.0,363.95,342.85,343.4,2661899.0,Cadila Healthcare gains on USFDA nod for type-2 diabetes drug,Cadila Healthcare rose 2.06% to Rs 374.30 after the company announced the receipt of final approval from USFDA to market Dapagliflozin Tablets.,positive,positive,-3.267605633802823,negative,1.4838065344556963,positive
2022-02-24 06:28:00.000,355.0,363.95,342.85,343.4,2661899.0,Risk-reward ratio is favourable in select pharma companies: CLSA,"CLSA sees a favourable risk-to-reward ratio in shares of Dr Reddy’s Laboratories, Cadila Healthcare and Torrent Pharma. The brokerage has upgraded Torrent Pharma to ‘buy’ from ‘outperform’ with an unchanged target price of ₹3,550.",positive,positive,-3.267605633802823,negative,1.4838065344556963,positive
2022-02-24 15:59:00.000,350.45,359.0,348.65,355.65,2612155.0,Cadila Healthcare changes name to Zydus Lifesciences Limited,Unveils ‘innovation and care’ centric corporate brand identity,neutral,neutral,1.4838065344556963,positive,2.357954545454549,positive
2022-02-25 17:30:00.000,350.45,359.0,348.65,355.65,2612155.0,"Stocks in news: Coal India, Vodafone Idea, InterGlobe Aviation, Bharat Forge and more","Stocks in news: Linde India, Coal India, Vodafone Idea, InterGlobe Aviation, Bharat Forge, Cadila Healthcare, Minda Industries, KSB and more",neutral,neutral,1.4838065344556963,positive,2.357954545454549,positive
2022-03-07 11:48:15.000,343.7,345.75,331.55,341.7,965276.0,Zydus Lifesciences gets DCGI nod for drug to treat anaemia associated with chronic kidney disease,"The drug firm, formerly known as Cadila Healthcare, said it has received approval for its new drug application (NDA) the product.",neutral,positive,-0.5819028222286878,neutral,1.3738672902660003,positive
2022-03-07 11:59:00.000,343.7,345.75,331.55,341.7,965276.0,Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease,"Zydus Lifesciences on Monday said it has received an approval from the Drug Controller General of India (DCGI) for Oxemia (Desidustat), a first-of-its-kind oral treatment for anaemia associated with chronic kidney disease (CKD). The drug firm, formerly known as Cadila Healthcare, said it has receive…",neutral,positive,-0.5819028222286878,neutral,1.3738672902660003,positive
2022-03-07 12:32:03.000,342.1,347.0,335.75,346.8,971602.0,Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease,"The drug firm, formerly known as Cadila Healthcare, said it has received approval for its new drug application (NDA) the product.",neutral,positive,1.3738672902660003,positive,2.557142857142854,positive
2022-03-09 13:56:45.000,368.0,368.0,361.5,366.4,2090780.0,Zydus Lifesciences jumps over 5% after US arm buys global rights for BridgeBio’s Nulibry,Zydus Lifesciences (earlier known as Cadila Healthcare) says Sentynl will make cash payments upon the achievement of certain regulatory milestones.,positive,neutral,-0.4347826086956583,neutral,2.0242357477278894,positive
2022-06-13 21:02:19.000,350.5,356.4,349.8,352.1,687252.0,Zydus Lifesciences’ Rs 750 cr-share buyback open between June 23-July 6,"The drug firm, earlier known as Cadila Healthcare, has fixed July 15, 2022 as the last date for the settlement of bids on stock exchanges which may even happen early, as per a regulatory filing.",positive,neutral,0.4564907275321035,neutral,-0.7887323943662005,neutral
2022-09-12 14:31:04.000,378.95,378.95,374.5,375.0,714745.0,Zydus Life rises on USFDA nod for schizophrenia drug,"Zydus Lifesciences rose 1.51% to Rs 380 after Cadila Healthcare, U.S. subsidiary of the company has received final approval from the USFDA to market Cariprazine capsules.",neutral,positive,-1.0423538725425487,negative,1.2265804016713873,positive
2023-05-11 09:04:03.000,529.0,529.0,511.6,513.45,1228932.0,"Stocks to watch today — May 11, 2023","Buzzing stocks: L&T, Oil India, Asian Paints, HDFC Bank, HDFC AMC, Godrej Consumer, McLeod Russel, Lehar Footwears, Cadila Healthcare, RVNL, Siemens, Sanofi India, Dr Lal Path Labs, AB Capital, CARE Rating, PTC India Fin, Eicher, Gillette, Religare",neutral,neutral,-2.9395085066162485,negative,0.0194779898714496,neutral
